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The ability of neurons to dynamically regulate their response to changing inputs is 
essential for the correct development and function of a nervous system capable of 
learning and memory.  The post synaptic compartment of excitatory synapses 
contains a dense proteinaceous complex of molecules that link excitatory 
glutamatergic neurotransmission to downstream signalling pathways that ultimately 
result in modification of the synapse.   One of the most abundant of such 
postsynaptic signalling molecules, synaptic GTPase activation protein, SynGAP, 
represents a key signalling link between the activation of the NMDA sensitive 
glutamate receptor to outcomes such as the structural rearrangement of synaptic 
sites and altered synaptic content of AMPA type glutamate receptors, molecular 
processes that underly learning and memory.    
The primary finding of this thesis is that different isoforms of SynGAP, which varies 
at it N terminus through alternative transcription start sites and at its C terminus 
through alternative splicing, can differentially affect the function of the synapse.  
Using primary murine neuronal cultures  we show that despite being crucial for the 
survival of the mouse the absence of SynGAP does not effect mean dendritic spine 
morphology and density or miniature excitiatory post synaptic currents under a 
range of experimental conditions (days in vitro 10 – 14, with and without serum, high 
and low cell plating density).  In order to examine the effects of different SynGAP 
isoforms we cloned two full length transcripts (SynGAP A-alpha-2 and SynGAP E-
alpha-1) which were used to construct a range of isoforms.  Whole cell patch 
clamping of SynGAP transfected neurons revealed that the post synaptic expression 
of SynGAPs which terminate as an alpha-1 isoform can lead to the elimination of 
mEPSCs, while isoforms that terminate as an alpha-2 isoform can lead to synaptic 
strengthening.  The magnitude of the effect in both cases is determined by the 
identity of the N terminus of the protein; SynGAP A-alpha-1 has the largest synaptic 
weakening effect and SynGAP B-and C alpha-2 strenghten the synapse.  The 
changes in miniature electrophysiological properties are not mirrored by changes in 
dendritic spine morphology, whole cell AMPA/NMDA currents, or synaptic 
responsiveness to stimulation suggesting an undefined novel mechanism of action.  
SynGAPs A, B and C appear to be under the control of different promoters which 
are differentially regulated by development and synaptic activity, thus the differential 
function of SynGAP N and C terminal combinations could play a part in the activity 
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1 Chapter One:  Introduction  
1.1 Background 
To survive living organisms must be able to sense and respond to their 
surroundings.  For this to occur, their constituent cells in turn must be able to sense 
and respond to stimuli.  Cells have evolved a range of mechanisms by which 
extracellular cues can be sensed and messages transmitted to within the cell.  The 
stimulus sensing receptor is rarely directly coupled to a response mechanism but 
the cascade of signalling it initiates can change the characteristics of the cell; the 
structure, the intracellular milieu, or the extracellular receptors, so that in future the 
cell may respond differently to the same stimulus.  The focus of this thesis is on one 
protein, Synaptic GTPase activating protein (SynGAP), a key regulator of highly 
conserved signalling pathways used in cells from slime mould to human (2008).   
 
Cells of the brain, like all other cells, sense and respond to their environment.  
However these cells have additional levels of specialisation that allow them to form 
a vast communicating network that can co-ordinate the body, remember its 
experiences and learn from them.  To this end brain cells co-opt and modify the 
basic signalling mechanisms with which all cells are equipped.  SynGAP is one such 
protein that is expressed exclusively in neurons (Chen et al., 1998; Kim et al., 1998).  
It is present at the sites of contact between neurons, the synapses, where it appears 
to form a key link between the activation of post-synaptic receptors by molecules 
released from the presynaptic neurons (specifically the excitatory neurotransmitter 
glutamate) and downstream signalling pathways (Krapivinsky et al., 2004; Vazquez 
et al., 2004; Rumbaugh et al., 2006).  When SynGAP mediated regulation is 
compromised the effect on synaptic function is profound; deficits in cognitive 
processes are observed in both humans and animals (Komiyama et al., 2002; 
Hamdan et al., 2009; Muhia et al., ; Pinto et al.) .  
 
Mechanistically SynGAP is a multi-functional GTPase activating protein that 
enhances the inactivation of the small G proteins Ras and Rap, proteins that 
mediate a wide variety of cellular responses (Kim et al., 1998; Pena et al., 2008).   In 
neurons these pathways regulate the synaptic content of neurotransmitter receptors 
and the physical structure of the synaptic site, thus determining how the neuron 
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responds to synaptic input (Pak et al., 2001; Zhu et al., 2002; Goldin & Segal, 2003; 
Alonso et al., 2004).   
 
 
The collection of components required to carry out the intricate processes involved 
in generating and maintaining a living, breathing and thinking organism is 
staggeringly complex.  Early estimates stated that about 100,000 genes would be 
required to make up a mammal; however, the actual number is less than one-
quarter of that, barely four times the number of genes in budding yeast. (Nilsen & 
Graveley).  It is now clear that the additional information is in large part provided by 
alternative splicing, the process by which multiple different functional messenger 
RNAs, and therefore proteins, can be synthesized from a single gene.  SynGAP is 
an excellent example of this phenomenon; it is encoded by one gene but a multitude  
of protein isoforms exist.  The main functional domain, the GAP domain is invariant 
between isoforms, but the protein can vary in amino acid sequence at both its amino 
(N) and carboxy (C) termini.  Intriguingly SynGAP variants are differentially 
regulated in response to synaptic activity and in development, suggesting that they 
may have different roles to play in different circumstances. 
 
The relevance of SynGAP to the function of neurons is the main interest of this 
thesis.  I am particularly interested in the molecular complexity of SynGAP; 
specifically how, if at all, various isoforms differentially alter the outcomes of 
SynGAP regulated processes?  In order to investigate this, the morphological and 
electrophysiological consequences of manipulated SynGAP regulated signalling are 
examined.   
15 
 
1.1.1 Organisation of this thesis 
This chapter gives an overview of the background literature relevant to SynGAP and 
outlines observations on which the hypothesis of this thesis is based.   
 
Chapter Two describes the experimental and analytical methods used in this thesis. 
 
Chapters Three, Four and Five are the main results chapters.  They each provide an 
introduction and a motivation for the work, and briefly reiterate previous work done 
on SynGAP in the area with which they are concerned.  The results are presented 
and discussed. 
 
Chapter Three is concerned with the molecular complexity of the SynGAP gene, 
transcript and protein.  It describes the cloning and construction of various SynGAP 
variants that are used in morphological and functional assays in the remainder of the 
thesis.  During the cloning process a number of novel SynGAP transcripts were 
discovered and these are described. 
 
Chapter Four comprises an analysis of the effect of the removal of all SynGAP 
isoforms and the overexpression of specific SynGAP isoforms on the morphology of 
the sites of excitatory synapses, the dendritic spines. 
 
The key finding of this thesis appears in Chapter Five, which deals with the 
electrophysiological effect of the removal of all SynGAP isoforms and the 
overexpression of specific SynGAPs.  A striking differential effect among SynGAP 
isoforms is described.    
 
Chapter Six presents some final thoughts on all the data taken together and 




1.1.2 Small G protein related deficits in synaptic function 
SynGAP is a regulator of two key signalling molecules of the Ras family of small G 
proteins, Ras and Rap.  The Ras family, classically associated with cell proliferation, 
has been co-opted in terminally differentiated non-dividing neurons to serve in 
activity dependent regulation of neuronal development and function, that is synaptic 
plasticity, as well as the regulation of neuronal survival (Sweatt, 2001).  
 
Accumulating reports have associated genetic mutations of various molecules 
involved in Ras and Rap signalling with several mental disorders causing learning 
disability, further underscoring the essential role of Ras and Rap signalling in both 
the physiology and the pathology of human learning and memory (Pinto et al., 2010; 
Stornetta & Zhu).  Similarly the targeted mutation of small G protein regulators in 
model organisms commonly leads to a host of synaptic plasticity and learning 
deficits. 
 
SynGAP at the synapse 
SynGAP is ideally placed in the post synaptic compartment to regulate the signalling 
pathways that occur there. Neurotransmission by the main excitatory 
neurotransmitter in the brain, glutamate, is mediated by NMDA, AMPA and kainate 
type glutamate receptors.  SynGAP is thought to link signalling through the NMDA 
receptor to downstream pathways, including the ERK/MAPK and p38 MAPK 
signalling pathways, which in turn regulate the synaptic content of AMPA receptors.   
 
SynGAP has been localised to the post synaptic signalling complex of excitatory 
synapses, the post synaptic density (PSD), by a range of techniques; 
immunocytochemistry, PSD purification, electron microscopy and co-
immunoprecipitation with synaptic proteins (Chen et al., 1998; Barnett et al., 2006; 
Moon et al., 2008).  A number of studies using semi-quantitative mass spectrometry 
approaches have highlighted that SynGAP is remarkable in its synaptic abundance.  
It is by far the most abundant G protein related protein in the PSD fraction (Peng et 
al., 2004).  Cheng et al. (2006) have found that it is as abundant as its binding 
partner the scaffolding protein PSD-95, which together with the Ca2+ regulated 
kinase CaMKII, represent the three most prevalent proteins of the core synaptic 































Figure 1. 1 The protein domain structure of SynGAP isoforms. 
The central portion of SynGAP is composed of a PH domain, a C2 domain and a GAP 
domain.  Different N-terminal peptides arise from different transcription start sites. SynGAPs 
A, B and E have unique amino acid sequences and SynGAP C is a truncated form that lacks 
part of the PH domain. C-terminal peptide tail variation arises from alternative mRNA 
splicing.  Peptide lengths in amino acids are given in parentheses. Diagram is not to scale. 
 
 
1.1.3 SynGAP in Behaviour 
The phenotypic outcomes of alteration in SynGAP expression give an indication of 
its importance in normal synaptic function.  
Human Behaviour 
De novo truncating mutations in SYNGAP have been identified in three girls with 
non-syndromic forms of moderate to severe mental retardation (Hamdan et al., 
2009).  These patients exhibit severe language impairment but do not exhibit autistic 
behaviours; they all have normal non-verbal social interactions.  Two patients have 
epilepsy which is controlled by the AMPA type glutamate receptor inhibitors 
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topiramate or valproate, suggesting that AMPA receptor trafficking may be defective.  
Very recently reductions in SYNGAP copy number have also been found in patients 
with autism (Pinto et al.).   
 
Animal Behaviour 
Null mice appear be normal upon birth but fail to thrive and die from postnatal day 2 
to 7.  Heterozygotes are viable, grow normally and are fertile.  Behavioural 
experiments were performed on these animals, who express half the amount of 
SynGAP protein as wild type animals.  The reduction in SynGAP has resulted in 
multiple behavioural traits suggestive of aberrant cognitive and non-cognitive 
processes.   
 
SynGAP +/- animals exhibit subtle spatial learning deficits in the Morris water maze, 
severe working and reference memory deficits in the radial arm maze task, and a 
deficiency in an elevated T-maze.  In contrast, object recognition memory 
performance is not impaired in SynGAP +/- mice (Komiyama et al., 2002; Muhia et 
al.).  
 
In the non-cognitive domain, SynGAP +/- mice are hyperactive in the open field and 
appear less anxious in the elevated plus maze test (Muhia et al.).   Additionally, they 
exhibit enhanced startle reactivity as well as lack of social memory and a propensity 
toward social isolation.  Deficits in cued fear conditioning and working memory 
indicate abnormal function of circuits that control emotion and choice (Guo et al., 
2009).   SynGAP +/- animals display increased vigor in the execution of learned 
operant behaviour without compromising its temporal control, it is thought this may 
be associated with the hyperactivity (Muhia et al., 2009). 
 
1.1.4 SynGAP in Development 
Abnormal adult function may be due to defective development and as such it is often 
difficult to disentangle acute from chronic effects.  Early in development SynGAP is 
expressed in the developing neural tube, somites and heart, and by embryonic day 
(E) 10.5, in the limb buds.  By E14.5 it is expressed in cortex, basal ganglia and 
thalamus, first becoming visible in the hippocampus and hypothalamus at E16.5.  
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Expression levels are highest in the second postnatal week and subsequently 
decline in most areas except the hippocampus (Porter et al., 2005).  This peak in 
expression coincides with a period of profligate synaptogenesis and developmental 
plasticity, again indicating a role for SynGAP in these processes. In adult animals 
SynGAP is present in hippocampus, cortex, olfactory bulbs, striatum, cerebellum 
and the amygdala (Porter et al., 2005; Barnett et al., 2006; Moon et al., 2008). 
    
SynGAP is essential for the postnatal anatomical development of whisker-related 
patterns in the developing somatosensory pathways in mouse forebrain. Normally 
cortical neuronal cell bodies would segregate postnatally into cell dense structures 
called barrels, with thalamocortical axons occupying the cell sparse region in a 
process that is regulated by glutamate neurotransmission (Woolsey & Van der Loos, 
1970; Erzurumlu & Kind, 2001).  Cortical neuronal cell bodies fail to segregate in 
SynGAP -/- brains, and segregation is impaired in SynGAP +/- brains, reinforcing the 
notion that SynGAP represents a link between glutamatergic neurotransmission and 
cellular outcomes (Barnett et al., 2006).   
 
1.1.5 Synaptic plasticity 
SynGAP clearly has a role to play in regulating the development and cognitive 
function of the brain.  What cellular mechanisms underlie this role?  Examination of 
the functional properties of individual neurons and brain regions gives some 
indication as to what processes are involved.  In SynGAP +/- mutant mice, the 
induction of LTP in the hippocampal CA1 region is strongly impaired in the absence 
of any detectable alteration in basal synaptic transmission or NMDA receptor-
mediated synaptic currents (Komiyama et al., 2002; Kim et al., 2003).  This indicates 
that basal synaptic activity of AMPA receptors is normal but that their recruitment 
upon appropriate stimulation is defective.   
 
Synaptic plasticity itself is not explicitly studied in this thesis but the effect of 
SynGAP on the processes that underlie it; synaptic delivery of AMPA receptors and 
the structural maturation of synaptic sites are examined.  It is unlikely that the 
mechanisms that govern these processes in different circumstances are completely 
different but that the basic machinery is modified depending on requirement.  A 
broader definition of synaptic plasticity includes the changes that accompany 
developmental synaptic maturation, these are also examined. 
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Interest in synaptic plasticity stems from the belief that this process underlies crucial 
aspects of adaptive cognitive function, such as learning and memory, and is the key 
mechanism by which neurons acquire their complex function and specificity during 
development (Bliss & Collingridge, 1993; Malenka & Nicoll, 1999).  Long-term 
synaptic plasticity, the sustained synaptic modification after periods of repetitive 
synaptic activity, was first discovered in the rabbit hippocampus (Bliss & Lomo, 
1973) and has since been described in many species and in many other brain 
areas.  Much effort has gone into understanding different forms of synaptic plasticity, 
with the cellular, molecular, and signalling mechanisms best illustrated for NMDA-
sensitive glutamate receptor dependent forms of synaptic plasticity (Kerchner & 
Nicoll, 2008).  The opening of the NMDA receptor and the influx of Ca2+ ions through 
its pore are two essential cellular events that trigger synaptic plasticity.  A common 
mechanism for the expression of synaptic plasticity is mediated by the altered 
synaptic presence of another class of glutamate receptor, the AMPA receptor. 
   
AMPA receptors allow the influx of positive sodium ions into the cells in response to 
glutamate binding, this short lived depolarisation of the transmembrane potential is 
called an excitatory post synaptic potential (EPSP).  Changes in the synaptic 
content of AMPA receptors cause different magnitude depolarisations in response to 
the same stimulus.   Ultimately when the depolarisations cross a threshold, a 
different pattern of action potential firing can result.   Thus the tuning of synaptic 
strength results in changes to the input to output relationship of a given neuron.  
Central to the challenge of understanding synaptic plasticity is the problem of how 
the initiating signals (NMDA receptor activation) are communicated to induce the 
expression mechanism (altered AMPA receptor trafficking) (Kandel, 2000). 
 
 
Physiological and behavioural studies have indicated that Ras family signalling is 
involved in long term potentiation (LTP), memory formation and synaptic 
development (Brambilla et al., 1997; Silva et al., 1997; Atkins et al., 1998; Schafe et 
al., 2000; Giese et al., 2001).   Ras activation in these processes requires Ca2+ 
influx, thus Ras family activity and its downstream signalling cascades serve as key 
biochemical cascades linking activation of NMDA receptors and calcium influx with 
phosphorylation and trafficking of AMPA receptors during synaptic plasticity.  
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Although classical activation of Ras family, via receptor tyrosine kinases and 
adaptor proteins, does occur in neurons in response to neurotrophins, Ras family 
activation in response to membrane depolarisation or glutamatergic signalling 
represents a non-classical pathway.  Precisely how Ca2+ entry leads to Ras activity 
is a question not yet resolved.  Implicated are the Ras regulatory proteins, the GAPs 
and GEFs, particularly those that are directly or indirectly regulated by Ca2+ (Walker 
et al., 2003).   SynGAP represents an excellent candidate to fulfil this role. 
 
Expressions of plasticity: AMPA receptors and dendritic spines 
There are multiple mechanisms for the expression of NMDA receptor mediated 
synaptic plasticity and development including altered presynaptic release, 
modulation of AMPA receptor function by phosphorylation and altered AMPA 
receptor trafficking.  The functional outcome of altered synaptic content of AMPA 
receptors is associated with structural plasticity, whereby functional maturation of 
synapses is accompanied by structural maturation of the synaptic sites.  The second 
and third chapters of this thesis deal specifically with these two phenomena in 
relation to the role of SynGAP.   
 
1.1.6 SynGAP regulates AMPA receptor trafficking 
As mentioned, data from LTP experiments in SynGAP +/- mutant mice indicates that 
basal synaptic activity of AMPA receptors is normal but that their recruitment upon 
appropriate stimulation is defective.  No presynaptic deficits have been found.  Long 
term depression (LTD), when induced by paired pulses at a low frequency (PP-1 
Hz), is unaffected by the reduction in SynGAP expression (Kim et al., 2003).  
However, LTD induction by the bath application of NMDA, which normally induces 
AMPA receptor internalization, is impaired in SynGAP+/- hippocampal slices.(Ehlers, 
2000; Carlisle et al., 2008). 
 
Synaptic AMPA receptor content can also be examined by looking at small AMPA 
mediated excitatory currents that occur spontaneously in the absence of action 
potential mediated neurotransmitter release.  Due to the quantal nature of 
neurotransmitter release in these circumstances the amplitude of these miniature 
excitatory post synaptic currents (mEPSCs) is correlated with the number, or the 
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synaptic strength, of AMPA receptors at the synapse.  The frequency of mEPSCs 
can give us information on the number of synapses; interpretations of AMPA 
mEPSCs will be discussed further in the introduction to Chapter Five.   
 
 
AMPA mEPSCs in cultured SynGAP -/- neurons are increased in frequency 
compared to control however there are conflicting reports regarding mEPSC 
amplitude.  Vazquez and co-workers (2004) see an increase in mEPSC amplitude, 
but Rumbaugh et al. (2006) see no change.  The immunocytochemical appearance 
of AMPA receptor puncta are thought to indicate the presence of synapses.  These 
puncta are increased in size and density when mEPSC amplitude and frequency are 
increased (Vazquez et al., 2004).  However where an increase in frequency, but not 
amplitude was observed the associated immunocytochemisty indicated an increase 
in puncta size, but not density, potentially indicating a conversion of silent to non-
silent synapses (Rumbaugh et al., 2006).  Despite inconsistencies, these data 
indicate that in these culture systems, SynGAP is negatively regulating the insertion 
of AMPA receptors.   
 
Additional evidence for this view comes from the overexpression of a GFP fusion 
protein of SynGAP that results in a depression of mEPSCs and a significant 
reduction in synaptic AMPA receptor surface expression.   Crucially, this effect is 
dependent on an intact C-terminal tail of the particular isoform used, SynGAP alpha-
1, highlighting the importance of this domain for SynGAP function.  Unfortunately 












Figure 1. 2 Dendritic spines are the sites of excitatory synapses 
a) A schematic representation of the morphological changes of dendritic spines during 
development and after LTP and LTD. Taken from (Sala et al., 2008).  b)  A map of glutamate 
sensitivity of a stretch of dendrite. Amplitudes of glutamate-induced currents are represented 
by the pseudo-color code shown at the bottom of this panel.  From Matsuzaki et al. (2001).  
c)  AMPA receptor distribution at synapses (colored in red) in the molecular layer of the 
cerebellum shown by SDS-digested freeze-fracture replica labeling. Dark immunogold 




1.1.7 SynGAP regulates dendritic spine morphology 
Dendritic spines are small actin enriched protrusions that extend from the dendritic 
shaft and form the physical location of many excitatory synapses.  Dendritic spine 
morphology is thought to be intimately linked to the function of synapses.  Changes 
in spine morphology are associated with synaptic plasticity; the strength of a 
synapse is correlated with the size of the spine head, which is, in turn, correlated 
with the size of the postsynaptic density and the content of AMPA receptors (Harris 
& Stevens, 1988; Yuste & Bonhoeffer, 2001; Newpher & Ehlers, 2009) (Figure 1. 2).   
The mechanisms by which these pathways are regulated then must be coordinated.  
Several studies have shown that synaptic stimulation alters the spine cytoskeleton 
24 
(Lin et al., 2005), and that altering the actin dynamics interferes with synaptic 
plasticity (Fukazawa et al., 2003; Rabenstein et al., 2005).  Actin dynamics are 
influenced by NMDA receptor mediated Ca2+  influx that regulates the activity of Rho 
family and Rac small G proteins, which in turn regulate the enzymatic reactions that 
control actin polymerisation (Kennedy et al., 2005).  Spine size is also influenced by 
the additional membrane and proteins that are inserted there by trafficking 
endosomes (Park et al., 2006).   
 
As one would predict of manipulations that cause changes in synaptic AMPA 
receptor content altering SynGAP expression also results in changes to dendritic 
spine morphology.  Vazquez et al. (2004) see a premature development of dendritic 
spines that accompanies the observed increase in mEPSC amplitude in SynGAP -/- 
neurons.  The dendritic spine phenotype is rescued by the reintroduction of SynGAP 
with an intact, but not a mutated, C-terminal alpha-1 tail again hightlighting the 
importance of this region in mediating signalling.  No other SynGAP isoforms were 
examined.  Enlarged dendritic spines are also seen in adult SynGAP +/- 
hippocampus indicating that exaggerated spine development is not merely a 
developmental precociousness (Carlisle et al., 2008).  Deficits were also found in 
elements of actin regulatory signalling pathways and the authors suggest that these 
effects are mediated through altered Ras signalling effecting Rac activity  
 
The above evidence indicates that two key aspects of synaptic function, synaptic 
AMPA receptor insertion and structural synaptic maturation, are negatively regulated 














































































































Figure 1. 3 The effects of altering SynGAP expression 
Schematic summary of the effects of altered SynGAP expression on dendritic spine 
morphology (top panel), AMPA mEPSC amplitude and frequency (middle panel) and AMPA 
receptor puncta size and density (red dots, bottom panel).  Data is drawn from (Vazquez et 
al., 2004)
1
 using homozygous knock out cultured hippocampal neurons, (Rumbaugh et al., 
2006)
2
 homozygous knock out and overexpression in cultured forebrain neurons, 
(Krapivinsky et al., 2004)
3
 siRNA knock down of alpha-1, alpha-2 and gamma in cultured rat 
neurons, (Carlisle et al., 2008)
4
 heterozygous knock out in adult hippocampus. 
26 
 
1.1.8 How does SynGAP regulate neuronal function? 
For SynGAP to mediate its negative regulatory role on synaptic maturation it must 
have a functional GAP domain (Vazquez et al., 2004; Rumbaugh et al., 2006).  This 
implicates the dampening of activity of SynGAP targets in the constraint of synaptic 
maturation.  What is the molecular function of SynGAP and how does it lead to the 
cellular outcomes described above?   
 
The main functional domain of SynGAP is the GAP domain, which can stimulate the 
GTPase activity of the small G proteins Ras and Rap.  The activity of small G 
proteins is dependent on their ability to cycle between tri-or di-phosphate guanosine 
nucleotide (GDP/GTP) binding states.  In the active GTP bound state G proteins are 
capable of recognising and activating downstream effector proteins (Kandel, 2000).  
GAP domains enhance the inactivation of small G proteins by promoting their 
intrinsic GTPase activity.  A large body of work implicates a wide range of small G 
proteins, also known as the Ras superfamily, as critical regulators in a diverse range 
of biological processes (summarised in Appendix Table 2.1).  The Ras branch of the 
Ras superfamily includes the small GTPases Ras and Rap.  Although it was initially 
assumed that the Ras proteins share essentially identical functions it now seems 
that the are functionally distinct (Reuther & Der, 2000).  Interestingly, there is 
evidence that the two pathways can operate antagonistically. Data regarding the 
general cellular roles of Ras and Rap is summarised in Appendix Table 1.2). 
 
Ras and Rap in synaptic plasticity 
It has been proposed that in neuronal cells, Ras, Rap1 and Rap2, are differentially 
stimulated by different forms of synaptic activity via activation of NMDA receptors 
and influx of calcium to independently control three activity-dependent AMPA 
receptor trafficking events1. (Figure 1. 4) (Thomas & Huganir, 2004; Tada & Sheng, 
2006; Gu & Stornetta, 2007; Stornetta & Zhu).  This model entails the synaptic 
                                               
1
 Tetrameric AMPA receptors can be classified into two groups based on their composition of 
subunits encoded by four genes (GluR 1-4).  One group consists of subunits with long 
cytoplasmic tails (GluR1, GluR2L and GluR4), the other group consists of subunits with short 
cytoplasmic tails (GluR2, GluR3 and GluR4c).  Malinow R & Malenka RC. (2002). AMPA 
receptor trafficking and synaptic plasticity. Annual review of neuroscience 25, 103-126..   
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insertion of AMPA receptors being regulated by Ras while the synaptic removal of 
AMPA receptors is mediated by Rap signalling. 
 
 
1) Synaptic potentiation – Ras/ERK / Ras/PI3K – synaptic AMPA receptor 
insertion 
LTP-inducing stimuli activate the Ras/MEK/ERK and Ras/PI3K/protein kinase B 
(PKB/AKT) signalling pathways, which phosphorylate AMPA receptors with long 
cytoplasmic-termini and drive these receptors into synapses (Zhu et al., 2002; 
McCormack et al., 2006). 
 
The link between NMDA receptor activation and Ras activation may be 
calcium/calmodulin-dependent protein kinase II (CaMKII) which is activated by Ca2+ 
prior to Ras activation.  Many studies have demonstrated a key role for CaMKII in 
synaptic plasticity and learning (Lisman et al., 2002).  Crucially, Ras activity is 
required for CaMKII to drive the insertion of AMPARs into synapses (Zhu et al., 
2002).  This is consistent with the suggestion that CaMKII regulates Ras signalling 
via molecules that activate Ras (RasGEFs) and/or RasGAPs, such as SynGAP (Kim 
et al., 2003; Rumbaugh et al., 2006) 
 
 
2)  Synaptic depression –Rap/p38 MAPK – synaptic AMPA receptor  removal 
LTD-inducing stimuli (e.g., low frequency synaptic inputs) activate Rap1, which 
activates p38MAPK and leads to synaptic removal of the AMPA receptors with short 
cytoplasmic-termini (GluR2/3) (Zhu et al., 2002; McCormack et al., 2006).    
Activation of p38 MAPK signalling has been shown to mediate impairments in LTP 
(Butler et al., 2004; Hsieh et al., 2006) and overexpression of Rap1 or Rap2 causes 
a decrease in miniature AMPA mediated currents (Fu et al., 2007). The substrates 
for p38 MAPK that mediate these effects in response activation of NMDA receptors 
remain to be identified. Among the many molecules signalling downstream of p38 
MAPK are transcription factors, protein kinases and the small GTPase Rab5, which 
is essential for early endocytosis (Shi & Gaestel, 2002). An attractive hypothesis is 
that activation of p38 MAPK may accelerate glutamate receptor endocytosis by 
stimulating the formation of the guanyl nucleotide dissociation inhibitor-Rab5 
complex (Huang et al., 2004).  Another potential mechanism involves the 
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phosphorylation of GluR2 to disrupt its interaction with glutamate receptor-
interacting protein/AMPA-binding protein (GRIP/ABP) and reduces the recycling of 
GluR2/3 AMPA receptors and thus depresses synaptic transmission (Matsuda et al., 
2000; Chung et al., 2003). 
 
Furthermore, the identification of two RapGAPs that are enriched in PSDs indicates 
that Rap signalling is probably important at synapses (Pak et al., 2001; Roy et al., 
2002).  Overexpression of one of these RapGAPs (spine-associated RapGAP, 
SPAR), which should inhibit Rap and consequently p38 MAPK signalling, leads to 
increased size of dendritic spines thought to be associated with increased synaptic 
AMPA receptors  (Pak et al., 2001).  This again indicates that Rap1 is involved with 
AMPA receptor removal from the synapse.   
 
 
3)  Synaptic depotentiation – Rap2/JNK – AMPA receptor removal 
Rap2 can control synaptic removal of AMPA receptors with long cytoplasmic-termini 
during depotentiation.  In response to depotentiation-inducing stimuli (e.g. low 
frequency synaptic inputs after LTP) Rap2 appears to stimulate JNK activity (Zhu et 
al., 2005; Kielland et al., 2009).  Although less work has been done elucidating 
Rap2’s role in neurons there is reason to believe that it may be significant.  
Proteomic analysis of the NMDA receptor complex has shown that Rap2 associates 
more closely with it than Rap1 (Husi et al., 2000) and SPAR stimulates Rap2 































Figure 1. 4 A schematic diagram of the components of the post synaptic 
compartment implicated in SynGAP mediated signalling events 
A red asterisk indicates proteins which have been shown to interact with SynGAP, 
specifically SynGAP alpha-1 has been shown to interact with a number of PDZ domain 
containing scaffolding proteins; PSD-95 (Kim et al., 1998; Li et al., 2001) , SAP-102,  (Kim et 
al., 1998; Yoshii & Constantine-Paton, 2007), MUPP1 (Krapivinsky et al., 2004) and MAGI-
SSCAM (Noboru Komiyama, personal communication).  SynGAP beta has been shown to 
interact with CAMKII (Li et al., 2001)..   
 
 
This simple model, whereby Ras signals to potentiation and Rap signals to 
depression is unlikely to be the whole story (Figure 1. 4).  Although the evidence for 
the above outlined roles for Ras signalling are quite strong, the precise roles of 
Rap1 and Rap2 have yet to be determined.  Far less work has been performed on 
the later two molecules, and a lot of the key findings reported by Zhu and co-
workers (points 2 and 3 above) have yet to be replicated in different labs.  However, 
distinctive effects of constitutively active Rap1 and Rap2 on the morphology of 
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growth cones and dendritic spines support the idea that these two GTPases have 
different functions in neurons (Richter et al., 2007).  
 
Behaviourally, ERK signalling is required for certain forms of spatial memory and 
fear-dependent learning but the roles of p38 MAPK have yet to be determined.  
Additionally, other studies have provided compelling evidence that, in certain 
neuronal cell types, Rap signalling can control the activation of ERK owing to its 
ability to activate the ‘Ras’ effector B-Raf isoform (York et al., 1998; Grewal et al., 
2000).  B-Raf is the Raf isoform that is expressed in neuronal processes and so the 
isoform likely involved in synaptic signalling.  One study has suggested that Rap1 
can signal through B-Raf to ERK in normal circumstances (Morozov et al., 2003) but 
this may have been an artefact of overexpression. 
 
Although Ras and Rap in strictly opposing roles is an oversimplification they clearly 
do have distinct roles.  The question then arises; how can SynGAP regulate both of 
them? 
 
Is there evidence for SynGAP regulating both Ras and Rap, and their 
downstream effector pathways (ERK and p38 MAPK)? 
 
Named as a RasGAP by similarity to other RasGAPs, initial experiments on 
SynGAP showed that it does indeed regulate the Ras/ERK/MAPK pathway in vivo 
and in vitro2   ERK activation is up-regulated in neurons from SynGAP knockout 
mice, whereas p38 MAPK function is depressed (Chen et al., 1998; Kim et al., 1998; 
Komiyama et al., 2002; Rumbaugh et al., 2006). Furthermore, overexpression of 
SynGAP alpha-1 decreased ERK activity and potentiated p38 MAPK signalling 
(Rumbaugh et al., 2006).  
                                               
2
 Basal levels of ERK activation were elevated in cultured SynGAP 
-/-
 neurons and could not 
be increased by stimulation (Rumbaugh et al., 2006).  Similar experiments on hippocampal 
slices from SynGAP 
+/-
 mice also reveals increased basal ERK activation.  However NMDA 
stimulation of these neurons, perhaps reflecting a gene dosage effect, did induce a robust 
increase in ERK activation (Komiyama et al., 2002). These experiments indicate that 
SynGAP is a negative regulator of Ras, however Rap and p38 MAPK were not examined by 
these investigators.   
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Carlisle et al. (2008) demonstrate a transient increase in the phosphorylation 
SynGAP in response to NMDA receptor activation which decreases to below 
baseline levels if the stimulation is maintained.  These authors see an increase in 
active Ras that follows the same transient increase and decrease timescale, they 
postulate that SynGAP acts to limit the time over which Ras is active. The knock 
down of SynGAP has resulted in sustained, rather than transient, ERK activation, 
supporting the notion that SynGAP acts to shut down stimulation induced Ras 
activity (Kim et al., 2005).   
 
However, other studies reveal opposing effects; knockdown of SynGAP by  
Krapivinsky (2004). resulted in a marked increase in p38MAPK activity without 
affecting ERK activity.  In response to NMDA receptor activation SynGAP was seen 
to be dephosphorylated, increasing its activity as measured by a deactivation of the 
p38 MAPK pathway   (Krapivinsky et al., 2004)3.   
 
This discrepancy is apparent in conflicting results regarding the effect of the 
reduction of SynGAP expression on AMPA receptor trafficking (Figure 1. 3).   In 
different studies surface AMPA receptor puncta are 1) increased in size and density, 
2) size but not density and 3) decreased in size and density (Krapivinsky et al., 
2004; Vazquez et al., 2004; Rumbaugh et al., 2006).  
 
Thus it appears that SynGAP can regulate both ERK and p38 MAPK pathways in 
vivo.  How can the ability of SynGAP to regulate two potentially opposing pathways 
be reconciled?  What governs its capacity to do so?   
 
                                               
3
 There are many possible sources of discrepancies between these data sets. It is likely that 
these pathways are subject to fine temporal control and as such different time courses make 
it difficult to compare results.  The stimulation of NMDA was achieved in one case by bath 
application of NMDA (Carlisle et al., 2008), and in the other of glutamate and bicuculine 
(Krapivinsky et al., 2004) however in both cases effects were abolished by the NMDA open 
channel blocker MK-801).  In a separate set of experiments, in which SynGAP was not under 
study, an NMDA receptor mediated transient increase in activation of p38 MAPK was 
dependent on the concentration of stimulating NMDA, adding an additional level of 
complexity (Waxman and Lynch, 2005).  Discrepancies also may arise from examination of 
total phosphoryation (Krapivinsky et al., 2004) or the phosphorylation of specific sites 
(Carlisle et al., 2008).  It would be illuminating to know the time course of activation of 
SynGAP phosphorylation, Ras/Rap activity and p38/ERK MAPK activation under the same 
experimental conditions.   
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1.1.9 SynGAP as a bifunctional GAP 
Small G proteins are regulated by two main classes of protein; those that activate G 
proteins by stimulating the dissociation of GDP to be replaced by the more abundant 
GTP, the guanine exchange factors (GEFs); and those that stimulate the inactivation 
of G proteins by catalysing their intrinsic GTPase activity, the GTPase activating 
proteins (GAPs).   
 
The first identified GAP for the Ras superfamily was a RasGAP (p120 GAP) (Adari 
et al., 1988).  It was expected that when a GAP was discovered for Rap it would be 
very similar to RasGAPS.  However RasGAPs and RapGAPs are structurally 
unrelated (Rubinfeld et al., 1991).   Reflecting this difference, the mechanism by 
which Ras and Rap1 GAPs enhance the GTPase activity of their respective 
GTPases is distinct.  (The catalytic mechanism of Rap2 has not been studied 
directly, but it is thought have slower intrinsic and stimulated GTPase activity than 
Rap1 (Ohba et al., 2000).  For RasGAPs a catalytic arginine residue, the arginine 
finger, is supplied by the GAP molecule into the active site of Ras, increasing the 
reaction rate by >1,000-fold (Scheffzek et al., 1997). Instead, Rap1 GAPs provide a 
catalytic asparagine, the asparagine thumb, to stimulate GTP hydrolysis. (Daumke 
et al., 2004; Scrima et al., 2008).  
 
A bifunctional GAP is one that can catalyse the GTPase activity of two classes of G 
protein, in this case Ras and Rap.  Apart from SynGAP the remaining bifunctional 
Ras/RapGAPs that have been identified are all members of the GAP1 family 
(CAPRI, RASAL, GAPIP4BP)4 (Kupzig et al., 2006).   Work on the catalytic 
mechanism of one of these molecules, GAPIP4BP revealed an unusual mechanism, 
the arginine-finger of the GAP domain is crucial for both activities of the bifunctional 
GAP, despite the fact the coordinating active site residue used in Ras is not present 
in Rap1 (Kupzig et al., 2006).  Additionally Pena et al showed that the arginine finger 
residue is important for efficient RapGAP catalysis of SynGAP (Arg/R486 in Figure 
3. 2).  Thus, the catalytic RapGTPase mechanism of the bifunctional GAPs is closer 
to RasGTPase activity than canonical RapGAP activity. 
 
                                               
4
  The fourth member of the GAP1 family , GAP1
m
, displays only Ras GAP activity. 
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What then determines if bifunctional GAP domains work as Ras or RapGAPs?  
Crucially it appears that regions outwith the GAP domain are essential for 
multifunctionality.  By sequence homology SynGAP is closer to a RasGAP than a 
RapGAP and, when examined in isolation the GAP domain functions as a RasGAP, 
but not a RapGAP (Chen et al., 1998; Kim et al., 1998; Pena et al., 2008).  However, 
if GTPase function is assayed when the GAP domain is linked to its C2 domain the 
intrinsic catalysis of Rap is stimulated by approximately 1 × 104 fold  (Pena et al., 
2008).   Moreover, when compared side by side full length SynGAP stimulated Rap 
GTPase activity much more potently than Ras GTPase activity (2-fold maximum 
stimulation of Ras GTPase compared to a 10-fold stimulation of Rap GTPase).     
The authors suggest that the possible contact of the mobile C2 domain with Rap 
and/or the GAP domain would promote catalysis, for example by making accessible 
a catalytic residue of GAP or Rap.   
 
SynGAP is not alone among bifunctional GAPs in its requirement for additional 
domains to allow multifunctionality.   Kupzig et al. (2006) and Sot et al.  have 
demonstrated that bifunctional members of the GAP1 family also require domains 
outside the GAP domain, such as C2 and/or PH/BtK for their RapGAP activities. The 
authors support a similar model to that proposed for SynGAP, that conformational 
changes in the N-terminal C2 and C-terminal PH domains induce a shift in G protein 
specificity by the altered positioning of catalytic residues.  (C2 and PH domains are 
also present in SynGAP and are discussed in more detail later, p44) 
 
An especially interesting example of the regulatory capacity of extra GAP domain 
domains in GAP regulation comes from bifunctional GAPs RASAL and CAPRI.  In 
response to Ca2+ oscillations RASAL associates and dissociates from the 
membrane but CAPRI, due to its membrane interacting PH domain, once 
translocated is refractory to further changes in Ca2+ concentration.  Intriguingly, 
RASAL and CAPRI only operate as RasGAPs when associated with the plasma 
membrane. Thus CAPRI seems to low-pass filter the Ca2+ signal, converting 
different intensities of stimulation into different durations of Ras activity.   In contrast, 
RASAL preserves the Ca2+ frequency information suggesting sophisticated modes 
of Ca2+-regulated Ras deactivation (Walker et al., 2004; Liu et al., 2005).  It is 
unknown how the RapGAP function of these molecules is regulated.   
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More generally GAPs are regulated by either protein-protein or protein-lipid 
interactions, binding of second messengers, and/or posttranslational modifications  
(Bernards & Settleman, 2004).  Regions outwith the GAP domains may provide sites 
for these interactions. 
 
1.1.10 A key observation; differential regulation of Syngap 
variants in development and in response to synaptic activity 
 
The above data indicate that we should look outside the GAP domain in order to 
understand the normal physiological function of SynGAP.  As mentioned the 
SynGAP gene gives rise to a number of alternative mRNA transcripts which encode 
different isoforms (Figure 1. 1).   All isoforms have the same central regions, 
including the GAP domain.  However there are a number of N-terminal isoforms 
(A,B,C,E) that arise from alternative transcription start sites and a number of C-
terminal isoforms (alpha-1, alpha-2, beta, gamma) that are caused by alternative 
splicing.   
 
A key observation that forms the impetus for much of the work in this thesis was 
made in our laboratory by Mark Barnett.  These data suggests that the 5’ alternative 
transcripts are differentially regulated in response to synaptic activity and in 
development (Figure 1. 5). Stimulation of synaptic activity in cultured neurons 
induces the downregulation of SynGAP A transcript but the upregulation of 
SynGAPs B and C 5.  Despite these changes total SynGAP and SynGAP E mRNA 
levels are unchanged.   In the developing mouse cortex, total SynGAP mRNA levels 
increase steadily from birth and peak at post natal day 14 (p14).  SynGAP A and 
SynGAP B mRNA transcript follows this profile but SynGAP C is almost 
undetectable at the earliest ages and is dramatically upregulated at p14.   
 
 
Although we do not know if protein expression levels are correlated with mRNA 
expression (specific antibodies against the different N-termini do not exist) 
                                               
5
  Mouse cortical cultures (DIV 10 – 12) were stimulated with bicuculine (50 µM) and 4 
amino-pyridiine (250 µM) for 4 hours.  SynGAP B and SynGAP C were upregulated (1.69 +/- 
0.07 and 2.5 +/- 0.15 times compared to control levels), SynGAP A was downregulated to 
0.7 +/- 0.1 times compared to control levels (One way ANOVA, Post hoc Tukey t-test, p<0.01 
for all). 
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translation of the different mRNA profiles would lead to different complements of 
SynGAP proteins.  SynGAPs A, B and E each have unique amino acid sequences 
as well as a common region to the N terminus of the PH domain.  SynGAP C is a 
truncated protein and lacks a complete PH domain (amino acid lengths are given in 
Figure 1. 1).  
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Figure 1. 5 SynGAP 5’ variants are differentially regulated in development and in 




Given the recently established role of the SynGAP N-terminal C2 domain in 
determining GTPase specificity and the potentially antagonistic effects of Ras and 
Rap signalling, the differential regulation of 5’ variants led us to hypothesise that 
they may have a role in regulating GTPase activity.   Crucially, most of the isoforms 
have been found in the post synaptic density by mass spectrometry suggesting that 
they may have some functional role to play (Seth Grant, personal communication) 
(alpha-1, beta (Peng et al., 2004)).  The exceptions to this are SynGAP B, E and 
SynGAP C, which does not have any unique amino acid sequence and cannot be 
identified .  
 
We do not know if C-terminal isoform expression is regulated or correlated with N-
termini, but it is known that the C-terminus is important for determining SynGAP’s 
interactions with other proteins.  Altered protein protein interactions may provide a 
mechanism for the regulation of SynGAP by differentially positioning it with respect 
to regulators and effectors, as well as the direct allosteric effect of the interaction.  
The N-terminal isoforms have not been studied, in the literature they appear only 
when first described, and so it is not known if they mediate any interactions.  When 
considering what molecules SynGAP isoforms may interact with and how they may 
be regulated one must also consider the putative interaction domains that are 
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common to all isoforms.  These common regions may complement or override 
potential functionalities of the isoform specific regions. 
 
In the remainder of this chapter I will outline the different SynGAP protein isoforms 
(Figure 1. 4) and how they arise from mRNA variants (Figure 1. 6) before describing 
what is known about SynGAP interactions and potential interactions6.    
 
1.1.11 SynGAP isoforms and how they arise 
Alternative transcription start sites and splicing will be discussed generally in the 
introduction to Chapter Three, which is concerned with the molecular complexity of 
SynGAP transcription and translation.   An overview of the exonic structure of the 







Figure 1. 6 A schematic diagram of the exonic structure of the SynGAP gene. 
The exonic structure of the SynGAP gene is shown in full in the upper panel.  Transcribed 
DNA is illustrated by boxes (unshaded indicates untranslated DNA, shaded and coloured 
indicates translated DNA), intronic DNA is illustrated by a horizontal line.  Isoform specific 
untranslated region (UTR) is indicated by a lower case letter within the box.  Where 
divergence occurs at the same locus the different possible outcomes are shown above and 
below the midline.  Alternatively present sequence is highlighted with dashed lines.  The 
bottom panel shows the exons that contribute to each individual isoform, only isoform 
specific UTR is shown.  Isoform specific protein sequence is shown with different 
colours/shading.  
                                               
6
 This description of the SynGAP gene, mRNA and protein is based on published reports 
(Chen et al., 1998; Kim et al., 1998 ; Li et al., 2001), and sequences deposited in online 
databases (NCBI/GenBank).  It includes, but is not a comprehensive description of, data 
from our laboratory by Mark Barnett and Patrick Stoney on the transcription start sites of 5’ 
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5’ region / N-termini 
Of the four alternative N-termini SynGAPs A, B and E have unique coding regions, 
while SynGAP C does not.  All are associated with unique regions of 5’ untranslated 
region (5’ UTR).  The longest N terminus is SynGAP A.  This form arises from the 
most 5’ transcription start site and has the longest unique region of 5’ UTR (Figure 
1. 6). There are at least two potential initiation codons which are 15 amino acids 
apart, it is unclear which of these is used as the primary initiation codon.   SynGAP 
E is not published and is not present in an online sequence database, however it 
has been cloned multiple times in our laboratory (Mark Barnett, personal 
communication).  It consists of one unique exon and encodes the shortest unique N 
terminus (12 amino acids).  SynGAP B is encoded by a number of unique exons.  
Exons of SynGAPs A, B and E splice into a common exon (exon ‘ABE’).  The next 
exon codes for the N-terminal portion of the PH domain and is also present in the 5’ 
UTR of the transcript for SynGAP C, in which case it is extended upstream to 
include a region of specific SynGAP C 5’ UTR.   SynGAP C translation does not 
begin until the next exon resulting in a truncated protein.     
 
3’ region / C-termini 
There are four major SynGAP C-termini, SynGAP alpha-1, alpha-2, beta and 
gamma that arise through alternative splicing events.  Alternative splicing proceeds 
in a number of ways (Figure 1. 6) including the inclusion or exclusion of  an entire 
exon from the final transcript.  Splicing of this type gives rise to SynGAP gamma 
which occurs when a short exon is included in the transcript; this exon encodes four 
unique amino acids before termination.  However the majority of alternative splicing 
at the 3’ end of SynGAP occurs through the use of alternative splice site selection.  
SynGAP beta is caused by the inclusion of 13 base pairs (bp) at the 5’ end of an 
exon present in all SynGAP transcripts.  The 13 bp causes a frameshift and the 
inclusion of 21 unique amino acids before termination.  The inclusion of an 
additional guanine residue at the next exon-exon boundary determines the 
translation of SynGAP alpha-2.  If only one guanine is present at that position 






Other variation occurs that does not cause a frameshift or have major effects on the 
coding sequence.  An alternative choice of splice junction (upstream of the region 
described above) leads to the inclusion or exclusion of an in-frame 6 bp which codes 
for valine and lysine (VK).  An additional 3 bases (TGG) may also be present at the 
G insert position, thus the possibilities at this position are G / GG / GGTGG.   
 
Given four N-termini and four C-termini there are 16 possible combinations but 
additional complexity is added by absence or presence of amino acids such as the 
in-frame VK insert and possible alternative translation start sites of SynGAP A.   
 
Syngap alpha-1 and alpha-2 transcripts differ by only one base pair so their 
differential detection by RT-PCR or in situ hybridisation, although technically 
possible, is challenging in reality.  Confoundingly, the interpretation of G insert 
status for alpha-1/alpha-2 coding outcomes is only possible if the 13 bp beta insert 
and gamma exons are also known not to be present.  The detection of SynGAP beta 
and gamma would be more feasible given their longer and more 5’ specific exons.  
Antibodies against SynGAP alpha-1 and beta exist, and an antibody against 
SynGAP alpha-2 has very recently become available.  An experiment examining 
differential regulation of the protein isoforms is now possible. 
 
1.1.12 The protein-protein interactions of SynGAP C-terminal 
isoforms  
Some interacting proteins have been established for SynGAPs alpha-1, alpha-2 and 
beta.  There is no published indication of what, if any, proteins interact with the N-
terminal isoforms or SynGAP gamma.   
 
SynGAP alpha-1 interacts with PDZ domain containing proteins 
Two labs independently cloned SynGAP alpha-1 in 1998 in a manner that gave an 




fragments from a library screen using probe sequence derived from tryptic digests of 
purified post synaptic densities (PSDs), indicating that SynGAP is highly enriched in 
the PSD.  Kim et al. (1998)  identified SynGAP alpha-1 in a yeast two hybrid screen 
using a PDZ domain of synapse associated protein 102 (SAP102) as bait.  Since 
then many studies have shown that SynGAP alpha-1 can interact with a number of 
molecules that contain the synaptically prominent protein-protein interaction motif 
the PDZ domain, specifically PSD-95, SAP102 and MUPP1.   
 
PDZ domains are protein-interaction domains that are often found in multi-domain 
scaffolding proteins.  At the synapse a class of PDZ domain containing scaffolding 
proteins, known as MAGUKS, assemble large molecular complexes (Kim & Sheng, 
2004).  PDZ domains bind to, amongst many other targets, the intracellular tails of 
the NMDA receptor and potassium channels and mediate the recruitment of a host 
of PDZ binding proteins to the PSD (Irie et al., 1997).  Although NMDA receptors 
bind directly to PSD-95 family members, AMPA recepotors indirectly associate with 
PSD-95 through auxiliary transmembrane AMPAR regulatory proteins (TARPs) 
(Nicoll et al., 2006).    
Scaffolds can be multimerised through disulfide linkages and as such act to cluster 
receptors and channels.  PDZ scaffolds also bind to the cytoplasmic domain of the 
neuronal cell adhesion molecules, such as neuroligins, implying a role in the 
coordination of the pre and post synaptic compartments (Hirao et al., 1998). 
 
The binding of SynGAP-alpha-1 to the PDZ domain is mediated mainly by its last 
four amino acids, QTRV, which constitute a canonical PDZ binding domain (T/SXV).  
This sequence is essential for SynGAP’s interaction with  PSD-95 (all three PDZ 
domains) and SAP102 (Chen et al., 1998; Kim et al., 1998; Li et al., 2001; 
Krapivinsky et al., 2004).  The interaction of SynGAP-alpha-1 and MUPP1 seems to 
be less specific than that of SynGAP-alpha-1 and PSD-95.  Krapivinksy et al. (2004) 
needed to use a blocking peptide fragment consisting of the final 111 SynGAP 
amino acids to disrupt the SynGAP/MUPP1 interaction.  Approximately half the 
sequence of this peptide is present in all SynGAP isoforms, suggesting that MUPP1 





SynGAP and PSD-95 are present in roughly similar molar quantities at the PSD, so 
one would predict that PSD-95 is SynGAP’s major binding partner in stoichiometric 
terms (Cheng et al., 2006).  Nevertheless, it has become clear that the interaction of 
SynGAP with PSD-95 is not necessary for SynGAP to reach the synapse (Barnett et 
al., 2006), possibly due to SynGAP binding to CaMKII or other PDZ domain 
containing scaffolds. The spatial and temporal expression patterns of the two genes 
are overlapping but distinct, and the phenotypes of the ablation of expression are 
quite different (Migaud et al., 1998; Porter et al., 2005; Barnett et al., 2006).  
Disruption of the MUPP1 interaction also does not prevent SynGAP reaching the 
synapse (Krapivinsky et al., 2004).   
 
The other PDZ scaffolding protein that has been demonstrated for SynGAP alpha-1 
is SAP-102.  Yoshii and Constantine-Paton (2007) co-immunoprecipitated SynGAP 
alpha-1 with SAP102 but not PSD-95 (p14 mouse visual cortex).  The LTP and 
learning deficits caused by SAP102 knock out closely phenocopy those of SynGAP 
+/- mice (reduced induction of LTP and specific spatial memory deficits that can be 
overcome with additional training) (Komiyama et al., 2002; Cuthbert et al., 2007).   
 
It has been established that NMDA receptor activation can have differential effects 
on AMPA receptor trafficking, depending on the subunit composition of the NMDA 
receptor.  This phenomenon is illustrated by the inhibition of NR2B-containing 
receptors which blocks the induction of LTD but not LTP in CA1 synapses, whereas 
specific antagonists of NR2A-NMDARs prevent the induction of LTP without 
affecting LTD (Liu et al., 2004; Massey et al., 2004).  Related evidence indicates 
that a major signalling function of NR2B-NMDARs, particularly in mature neurons, is 
to dampen the magnitude and limit the duration of ERK activation (Kim et al., 2005).  
In this system, SynGAP was preferentially associated with the NR2B, but not 2A, 
subunit suggesting that the differential effects of the subunit activation are mediated, 
at least in part, via SynGAP.  The authors suggest the association of SynGAP to 
NR2B is mediated by the preferential binding of SAP102 to NR2B (rather than 
NR2A).  However, the co-immunoprecipitation evidence on which this claim is based 
indicates only a very mild preference of SAP102 for NR2B (PSD-95 for NR2A) 




experiments also co-immunoprecipitates almost exclusively with NR2B.  It is worth 
remembering that there are many scaffolding proteins and functional redundancy is 




SynGAP alpha-2 interacts with Unc51.1 
SynGAP alpha-2 has been identified as a binding partner for the serine/threonine 
kinase Unc51.1 by a yeast two hybrid screen (Tomoda et al., 2004).  Unc51.1, 
otherwise known as ULK1, is involved in the regulation of autophagy and in neurite 
extension in cerebellar granule neurons (Tomoda et al., 1999).  SynGAP alpha-2 
bound to Unc51.1 baits ‘with slightly higher affinity’ than alpha-1.  The authors state, 
but do not show, that a GFP fusion of the SynGAP alpha-2 tail was localised to 
extending axons, while GFP-SynGAP alpha-1 tail was restricted to the cell soma of 
cerebellar granule cells.  For these reasons only alpha-2 was carried forward in their 
further experiments which show that SynGAP and Unc51.1 cooperate in inducing 
granule cell neurite outgrowth.  Unc51.1 is also expressed in the adult rat 
hippocampus and cortex (Okazaki et al., 2000). 
 
SynGAP beta interacts with CaMKII 
SynGAP beta does not co-immunopreciptate with PSD-95 but despite this is more 
restricted to the PSD fraction than SynGAP-alpha-1 (Chen et al., 1998; Li et al., 
2001).  This synaptic restriction may be mediated by the ability of SynGAP beta to 
bind to Ca2+/calmodulin-dependent protein kinase II (CaMKII), a highly abundant 
synaptic protein.   
 
CaMKII has long been known as one of, if not the most abundant protein at the 
postsynaptic density (Kennedy et al., 1983; Cheng et al., 2006).  It is activated when 
it binds calmodulin in the presence of Ca2+ and, once autophosphorylated, remains 




phosphorylation of PSD components is likely to underlie changes in synaptic 
strength (Lisman et al., 2002). 
 
Regulation of SynGAP by CaMKII 
How SynGAP is regulated by NMDA receptor mediated events remains a 
contentious issue.  It is clear is that SynGAP can be phosphorylated at many sites 
and this phosphorylation is dependent on CaMKII  (Song et al., 2003; Krapivinsky et 
al., 2004; Oh et al., 2004; Song et al., 2004; Carlisle et al., 2008).   Despite 
preferentially binding SynGAP beta all the CaMKII phosphorylation sites identified 
are within regions common to all SynGAPs (Jaffe et al., 2004; Oh et al., 2004).  The 
precise effect of phosphorylation is not firmly established as interpretation of the 
data is confounded by inconsistency in which of the many phosphorylation sites are 
examined.   
 
Phosphorylation of SynGAP enhances its in vitro RasGAP activity (Oh et al., 2004).  
In quiescent neurons SynGAP is phosphorylated at a basal level that is dependent 
on NMDA receptor and CaMKII activity.  The phosphorylation and downstream 
signalling effects of SynGAP in response to stimulation of NMDA receptors seems to 
be finely temporally tuned (Krapivinsky et al., 2004; Carlisle et al., 2008).  Some 
residues in SynGAP are preferentially phosphorylated by the form of CaMKII that is 
autonomously active even after a Ca2+  transient has passed (Dosemeci & Jaffe).  
Interestingly, Ca2+ entry through voltage gated calcium channels in response to 
depolarisation is not sufficient to induce changes in SynGAP phosphorylation, again 
highlighting the importance of the NMDA receptor mediated Ca2+  entry (Krapivinsky 
et al., 2004). 
 
1.1.13 The common protein domains of SynGAP  
The domain structure of SynGAP is similar to other GAPs which, like GEFs, are 
usually multi domain proteins and have domains such as PH, C2, SH3 and SH2 eg 
p120RasGAP, CAPRI. RASAL  (Bernards, 2003; Pamonsinlapatham et al., 2009).   
The role of the SynGAP C2 domain in determining GTPase specificity has been 




could affect SynGAP function.  Often these domains are lipid or protein interacting 
indicating that they serve as localisation signals or scaffolds in the formation of 
protein complexes.  It is thought that these domains play an important part in the 
regulation of GAPs and GEFs (Bos et al., 2007).  Therefore, it is worth mentioning 
the other domains of SynGAP as these have a bearing on its functional properties 
and potentially its regulation.   
 
The N-terminal domains found in SynGAP, the pleckstrin homology domain (PH) 
and the calcium/lipid-binding domain (C2) domain, often interact with the plasma 
membrane but this has never been examined in the case of SynGAP.     
 
PH domain   
Pleckstrin homology (PH) domains, one of the most abundant domain classes in the 
human genome, are structurally conserved functional domains that can undergo 
both protein/protein and protein/lipid interactions (Lemmon, 2004). PH domains can 
mediate inter- and intra-molecular binding events to regulate enzyme activity.  The 
number and variety of host proteins with PH motifs are staggering (over 100 at last 
count).  Despite minimal sequence homology, the three-dimensional structures are 
remarkably conserved and are best known to bind phosphatidylinositol lipids within 
biological membranes (Rebecchi & Scarlata, 1998; Lemmon, 2008).  
 
PH domains are well known effectors of the lipid second messengers PIP3 and PIP2, 
which can be generated transiently upon activation of cell surface receptors 
(Cantley, 2002).  A small subclass of PH domains, including those from Bruton's 
tyrosine kinase (BTK), general receptor for phosphoinositides-1 (GRP1) and protein 
kinase B (PKB; also known as AKT), recognize one or both of these second 
messengers with remarkable specificity and affinity. These PH domains represent 
classic examples of signal-regulated membrane-targeting modules. In each case, 
the isolated PH domain (as a GFP fusion protein) is predominantly cytosolic in 
unstimulated cells, but undergoes a dramatic transient relocalisation to the plasma 
membrane upon signal-dependent generation of the second messengers by PI3K 





However, PH domains that are known to strongly and specifically bind to 
phosphoinositides represent only a small minority of a large and poorly understood 
class of domains  (10% of the approximately 235 PH domains in the human 
proteome) (Lemmon, 2008). 
 
SynGAP C lacks a portion of the PH domain, suggesting a mechanism by which it 
may be differentially regulated or localised compared to other isoforms with intact 
PH domains.  In some cases two halves of PH domains from two separate proteins 
can come together to form a single functional PH domain, presenting a potential 
mechanism for SynGAP C specific interactions  (Lemmon, 2005). 
 
C2 domain 
C2 domains are most well known as Ca2+ dependent membrane binding domains, 
which serve as Ca2+ effectors for divergent Ca2+-mediated cellular processes.  The 
C2 domain represents the second most abundant lipid binding domain behind the 
PH domain (Cho & Stahelin, 2006).   A number of non-mutually exclusive 
mechanisms have been proposed for the Ca2+ mediated membrane binding of C2 
domains that may involve membrane penetration or surface interaction (Grobler et 
al., 1996; Shao et al., 1997; Davletov et al., 1998; Verdaguer et al., 1999).  The 
insertion of C2 domains into the plasma membrane can cause the membrane to 
bend, a process which is involved in the fusion of synaptic vesicles with the plasma 
membrane (Martens et al., 2007).  This has led to the implication of the C2 domains 
as the main functional modules of the fusion machinery proteins, synaptotagmin-1 
and Doc2b, in Ca2+ dependent fusion event (McMahon et al.). 
 
Based on the diversity of Ca2+ responsiveness, it has been suggested that C2 
domains may serve as differential calcium sensors in the cell.  Many C2 domains, 
including C2 domains of conventional PKCs and cPLA2, have been shown to 
translocate to cell membranes in linear response to cellular Ca2+ oscillations (Evans 
et al., 2001; Evans et al., 2006).  If the membrane association of a protein is 
dominated by its Ca2+-responsive C2 domain(s) the host protein can also linearly 
respond to the Ca2+ oscillation. The bifunctional GAP, RASAL (previously mentioned 




associating to and dissociating from the membrane as the cellular Ca2+  
concentration fluctuates (Walker et al., 2004).  However, other protein moieties 
come into play in determining the duration of membrane residence.  CAPRI, a 
structural and functional homolog of RASAL, displays a long-lasting Ca2+ triggered 
translocation that is refractory to cytosolic Ca2+ oscillations due to the interaction of 
its PH domain with the membrane.  Thus an interaction initiated by the Ca2+ 
responsiveness of the C2 domain is maintained by the PH domain (Liu et al., 2005). 
 
It is important to stress, however, that not all C2 domains are capable of Ca2+-
dependent membrane binding. Indeed, a significant subgroup of C2 domains do not 
bind Ca2+ at all, and several are now known to proteinaceous bind targets (Cho & 
Stahelin, 2006). 
 
Other regions of interest 
There is region rich in proline residues (aa 785-815, Figure 3. 2 ) and as such may 
be a target for SH3 binding.  The SH3 domain is a prototypical protein protein 
interaction domain commonly found in a wide range of signalling molecules (Mayer, 
2001).  The protein annotation of SynGAP in the UniProt database highlights this 
region as a potential SH3 binding domain but other bioinformatics tools do not 
indicate this region as such (NCBI Conserved Domains Search, SMART database).  
 
A stretch of 10 histidine residues are located towards the C terminus of SynGAP (aa 
958 – 968, Figure 3. 2).  As far as I am aware there no definite function has been 
established for such a sequence.  Stretches of histidine residues do occur, and are 
conserved, in a diverse range of proteins eg. voltage gated Ca2+ channel, Zic3/4, 
Ubiquitin carboxyl-terminal hydrolase (BLASTP).  Imidazole side chains of histidine 
are known to be important for coordination with metal ions and functionally relevant 
metal and haem binding has been demonstrated in proteins with histidine rich 
regions, however these regions rarely have such long consecutive repeats.  (Jones 





1.2 Hypothesis  
To summarise, SynGAP is a protein that can regulate many, and potentially 
antagonistic, arms of crucial signalling pathways in neurons.  Its synaptic localisation 
combined with the various phenotypes associated with its manipulation suggests 
that it regulates synaptic strength in a dynamic manner.  Evidence suggests that 
regions outwith SynGAP’s central core are involved in determining which pathway it 
can regulate.  The existence of various N- and C-termini, which we have seen to be 
differentially regulated in response to synaptic activity and mediate SynGAPs 
interaction with key molecules at the synapse, is suggestive of a mode of regulation 
of function.  The central hypothesis of this thesis is that different isoforms of 
SynGAP have different functions.  We posit that the different N- and C-termini of 
SynGAP have a role in determining its function, be it by altering its catalytic 
specificity, rate, localisation or partner proteins.  All these specific mechanisms will 
not be examined directly rather the hypothesis will be addressed by examining the 
functional outcomes of manipulated SynGAP expression in neurons.  Two aspects 
of neuronal function, which have been shown to be affected by SynGAP regulated 
processes, namely neuronal morphology and electrophysiology are studied.   The 
effect of removing all SynGAP protein, to assess the dominant function of the 
molecule, and the effect of the expression of individual isoforms is examined  
The question of the biochemical effect of SynGAP isoforms on its target molecules, 
Ras and Rap, is not examined here but should remain to the fore in considering the 





2 Chapter Two:  Methods 
 
The methods used in this thesis are presented here, first methods that are common 
to most of the work, such as primary tissue culture and genotyping.  Methods 
specific to each chapter are shown under the heading of the chapter in which they 
are used. 
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2.2 Common Methods 
2.2.1 Tissue culture 
Primary neuronal tissue culture 
Neurons are grown on 15 mm glass coverslips in 24 well plates for up to 14 days in 
a humidified incubator at 37 oC, 5% CO2.   Coverslips are washed in absolute 
ethanol before sterilisation by baking.  Coverslips are coated with Poly D-Lysine (13 
µg/ml, 70 – 150 kDa, Sigma, P0899) and Laminin from Engelbreth-Holm-Swarm 
murine sarcoma basement membrane (5 µg/ml, Sigma, L2020) in PBS using 400 
µl/well.  While coating coverslips are placed in the incubator for at least 3 hours or 
overnight.  Coverslips are washed at least twice in sterile double distilled water prior 
to the commencement of dissections and are left to dry in the flow hood while 
dissections are performed 
 
Neuronal cultures are established from mouse embryos of timed matings at 
embryonic day 17.5 (E17.5).  The mother is killed by cervical dislocation, the 
abdominal area is sprayed with ethanol as are all the previously baked dissection 
tools.  The birth canal is removed by caesarean section, individual embryos are 
removed and immediately decapitated.  A piece of tail is taken for DNA for 
genotyping if a transgenic culture is being performed.   
 
Dissection 
The heads are placed on ice in pre-chilled dissociation medium.  Brains are 
removed under a dissecting microscope; the skin is torn along the midline and 
peeled off the head.  The head is kept steady against the platform by piercing 
through the nose with curved forceps.  Using straight forceps the skull is cut along 
the midline from the cerebellum at the rear to between the eyes, and snipped 
around the base of both hemispheres.  The skull caps are pulled back from the 
midline to reveal the brain.  The brain is scooped out of the skull base, from the 
cerebellum, with a spatula and placed in ice cold dissociation medium (DM).  All 




SynGAP cultures care is taken to remove the olfactory bulbs with the brain; if the 
nasal skull cuts are rostral enough and care is taken peeling back the skull the 
olfactory bulbs should lift out attached to the brain.  These are used for lacZ staining 
to aid genotyping (Table 2. 1).  The transgenic locus contains the lacZ gene which 
codes for beta-galactosidase.   Conversion of the beta-galactosidase substrate X gal 
(5-bromo-4-chloro-3-indolyl- beta-D-galactopyranoside) to a blue colour indicates 










potassium ferric cyanide 5 mM
potassium ferro cyanide 5 mM
X-Gal 1 mg/ml
made up in PBS  
Table 2. 1 LacZ stain 
 
 
Brains are transferred individually to 35 mm Petri dish containing fresh ice-cold DM 
for further dissection.  If required olfactory bulbs are snipped off and replaced in DM 
on ice.  Removal of the olfactory bulb aids with the removal of the meninges which 
are peeled off, taking care not to gouge the cortices.  Each hemisphere is teased 
away from the thalamus by gently snipping at the connecting tissue.  The 
hippocampi are removed using the tip of the forceps to cut along the entorhinal axis 
with small pinching motions.  If cortices are required striatal tissue is snipped off 
using curved forceps.  The cortex is trimmed of the most ventral part,corresponding 
to the archecortex, leaving the neocortex.  The cerebellum is removed from the 
thalamus, and reserved for DNA extraction in the case of a transgenic culture.   






Prior to beginning brain dissection 25 – 30 U/ml fresh papain suspension 
(Worthington, Lakewood, NJ, USA supplied through Lorne Laboratories, Reading, 
UK) are added to DM supplemented with L-cysteine  (approx 0.5 mg/ml, DM+C) and 
dissolved at 37 oC.  The dissolved enzyme is filter sterilised immediately before the 
tissue is added.  The tissue is incubated for 15 minutes in a 37 oC oven and is 
agitated very gently every five minutes.  After this time the tissue is washed of 
enzyme by serial dilution.  The tissue is transferred using a lightly fire polished 
pipette, a 2ml pipetteman pipette is necessary for the volume of tissue produced in 
pooled cortical cultures.  Four washes are prepared for each piece of tissue in a 
transgenic culture.  The tissue is transferred gently into each wash and let settle, no 
additional manipulation is made, before transferring to the next wash.  The first two 
washes are DM, the second two are growth medium.  The final wash is the medium 
in which the tissue is triturated.  Tissue is triturated for approximately one minute 
using first a lightly fire polished, wide bore, glass pipette, then for an additional 
minute using a pipette fire polished to achieve a narrower bore.  After this time there 
should be no very large visible lumps of tissue remaining.  The cell suspension is let 
to settle for one or two minutes before gently removing the supernatant.  This step is 
excluded for individual hippocampal cultures to maximise the cell yield. 
Cell counting 
50 µl cell suspension is combined with an equal volume Trypan Blue vital exclusion 
dye (Sigma, T8154) and cells which exclude the blue dye are counted in a 
haemocytometer and the cell count calculated.  Cells are plated at a final density of 
200 cells/mm2 (low density) or 1500 cells/mm2 high density.  For 24 well plates cells 
are plated in 500 µl.   
Maintenance 
All the growth medium is aspirated on DIV1 and immediately and gently replaced 
with prewarmed growth medium (1ml).  Additional growth medium (1ml) is added on 
DIV 4.  Neurons are fed again at DIV 7 and 10 by removing half the volume (1ml) 
and replacing with fresh growth medium.  In every instance the time neurons are out 





If FBS is included in the growth medium on DIV 4 cytosine β-D-arabino-furanoside 
hydrochloride (AraC, Sigma, C6645) is added to a final concentration of 4.6 µM.  
AraC blocks DNA replication and is used to stop glia from dividing.  AraC is 
maintained at this concentration with all subsequent medium changes.  
 
Solutions  
Dissociaton medium (DM) (1X); Hank’s Balanced Salt Solution, without Ca2+/Mg2+ 
(Invitrogen, 14175053) supplemented with 10 mM MgCl2, 1 mM kynurenic acid, 10 
mM HEPES.  This is made as a 10X stock solution (DM-S) which is heated to 
dissolve kynurenic acid, filter sterilised and stored at -20 oC in 50 ml aliquots.  Upon 
reconstitution as a 1X solution DM is further supplemented with 0.1 % phenol red 
(Sigma, 0.5% in DPBS, P0290) and 50 U/ml penicillin,50 µg/ml streptomycin 
(Sigma, 100X; 10,000U/ml penicillin / 10mg/ml streptomycin, P0781).   
 
Growth medium; Neurobasal A medium (Invitrogen, 10888-022) supplemented with 
1X B-27 (Invitrogen, 175504-044), 0.25% GlutaMAX (Invitrogen, 35050061), 
Pen/Strep (as DM) and potentially 1 % foetal bovine serum (FBS, Invitrogen, 17504-
157).  See text regarding FBS. 
 
Dissection tools;  Surgical scissors, Iris scissors, Curved Dumont #7 forceps, 
Dumont #5 forceps (×2), Spatula (5 mm width), Pasteur pipettes (x3 
 
Maintenance of HEK293 cells 
HEK 293 cells are maintained in Dulbecco's Modified Eagle Medium (DMEM, 
Invitrogen, 41965-039) supplemented with 10 % foetal bovine serum (FBS), 1mM 
sodium pyruvate and 50 U/ml penicillin/streptomycin (Pen/Strep) in uncoated flasks.  
Cells are passaged when they reach confluence by detachment by brief 
(approximately 1 minute) trypsinisation (0,05% Trypsin-EDTA in growth medium, 
Invitrogen).  Sloughed off cells are diluted with additional growth medium before 
centrifuging (800 rpm, 2 minutes).  The cell pellet is resuspended in growth medium 
and split 1:10.  Half the volume of growth medium is replaced every 4 days.  For 




manner as for neurons except; laminin is omitted and plates are coated for a 
minimum of 30 minutes.  Cells are transfected when at approximately 80 % 
confluence.   
Transfection of cells 
Transfection of neurons 
Neurons are transfected using a proprietry liposome based transfection product, 
Lipofectamine 2000 (Invitrogen).  Transfection is performed from DIV 8 at the 
earliest to DIV 13 at the latest.  Neurons are always used 16 to 36 hrs after the 
transfection complexes are added to the cells.  The following amounts are for one 
well of a 24 well plate.  On the morning of transfection the normal growth medium is 
removed and replaced with 0.5 ml pre warmed transfection medium (TM).  The cells 
are returned to the incubator for at least 3 hours.  200 µl of conditioned TM is 
removed from the well.  Lipofectamine 2000 (1 µl) is diluted in 33 µl conditioned TM 
and left at room temperature in the flow hood for 5 minutes while the DNA is being 
diluted.  0.3 µg total DNA (0.1 µg eGFP and 0.2 µg SynGAP or empty vector) is 
diluted in 33 µl conditioned TM.  All the diluted Lipofectamine 2000 is then pipetted 
gently into the diluted DNA.  The mixture is gently pipetted up and down 3 – 4 times 
and left in the flow hood at room temperature for 20 minutes.  All of the 
DNA/Lipofectamine mixture is then added dropped gently into the original well which 
is swirled gently to ensure even distribution.  The cells are incubated for at least 3.5 
hours before all the transfection medium is removed and replaced with fresh growth 
medium.   
 
Solutions 
Transfection medium (TM); ‘Salt, glucose, glycine’ solution (SGG) supplemented 
with 10 % Minimum Essential Medium (MEM) with Earle's salts, without L-glutamine 
(Invitrogen, 21090-022) and 1.5 % Insulin-transferrin-sodium selenite media 
supplement (ITS, Sigma, I1884, vial reconstituted in 50ml).  1.5 % ITS is equivalent 






Salt, glucose, glycine (SGG); 114 mM NaCl, 32.7 mM NaHCO3, 5.3 mM KCl, 1mM 
MgCl2, 2mM CaCl2, 10 mM HEPES, 1 mM glycine, 20 mM glucose, 0.5 mM sodium 
pyruvate, 0.1 % phenol red (Sigma, 0.5% in DPBS, P0290).     
 
Transfection of cell lines 
Hek cells are transfected in a similar manner to neurons except that the DNA and 
Lipofectamine 2000 are diluted in OptimMEM (Invitrogen) supplemented with 
glucose.  The complexes are added directly to the cells which are left in HEK cell 
growth medium.  The complexes are not removed.  
 
2.2.2 The SynGAP mouse model and genotyping 
The SynGAP knockout mouse 
The SynGAP knockout mouse used in this thesis was generated by Komiyama et al. 
(2002).  Briefly targeting constructs were electroporated into 129 E14TG2a 
embryonic stem (ES) cells.  An internal ribosomal entry site upstream of a beta-
galactosidase reporter gene was introduced to monitor the cellular expression 
pattern.  A coding sequence for hemagglutinin (HA) epitope tag was inserted in 
frame at an XhoI site in the C2 domain at the 3' end of the 5' homology arm and 
followed by stop codons and internal ribosomal entry site (IRES)-lacZ-polyA - 
MC1neo-polyA cassette.  The resultant vector deletes exons encoding the C2 and 
part of the GAP domain.  Chimeric mice were produced by injecting targeted ES 
cells into C57BL/6 blastocysts, and heterozygous mutants were generated from 
these animals.  These were bred initially onto an MF1 genetic background and 
obtained from the Sanger Centre.  In our laboratory the knock out allele was partially 
backcrossed onto a C57/B6/J/ola/HSD.   
 
Genotyping 
DNA for genotyping is extracted from ear notches taken from mice at weaning or, for 
cultures, from tail clips or cerebellar portions from embryonic mice.  The extractions 




manufacturers instructions.  Genotyping using a standard NaCl/Tris/SDS/EDTA 
extraction is not consistently successful.   PCR reactions were carried out using 1U 
HotStart Taq Polymerase (Promega), 0.3 mM dNTPs, 1X HotStart PCR buffer, 0.6 
µM primers and 1 µl of DNA from the extraction described above (generally 20 - 80 
ng).  Thermocycling conditions are listed in Table 2. 3.   A common reverse primer, 
Syn12R; 5’ – CAT ACA AGA ATT GCT GCA TAG AAC – 3’, is used in conjunction 
with either a forward primer complementary to the wild type sequence, Syn11<, 5’ – 
TTC ATG GAG CGG GAA CAC CTC ATA T – 3’, or a forward primer 
complementary to the transgenic cassette, FCass1A, 5’ - CTT CCT CGT GCT TTA 
CGG TAT C – 3’.  The PCR product of the wild type reaction is approximately 2.5 kb 
and the product of the transgenic reaction is approximately 1 kb.   
During the later stages of this work the wild type reaction began to consistently fail.  
It became necessary to perform this reaction using a different Taq polymerase, 
namely Expand Long Template System (Roche, 11681842001).  Component 
concentrations were the same as for Hotstar Taq polymerase reactions.  
Thermocycling condiditons were the same as Table 2. 2 except dNTPs, primers and 
DNA were combined and heated to 95 oC for 15 minutes prior to the addition of 
Expand Polymerase and PCR buffer (manufacturer supplied).   
 
 




1 95 30 s
2 94 10 s
3 56 30 s
4 68 3 m
5 go to Step 2 x 10 -
6 94 10 s
7 56 30 s
8 68 3 m + 20 s/cycle
9 go to Step 6 x 20 -
10 68 7 m
11 4 hold






2.3 Methods of Chapter Three: Molecular Biology 
and Biochemistry 
 
2.3.1 Molecular biology 
PCR 
PCR reactions were carried out using 1U HotStart Taq Polymerase (Promega), 0.2 
mM dNTPs, 1X HotStart PCR buffer,1 µM primers and varying concentrations 
template DNA; typically 1 µl of cDNA from the syntheses described below (~200 ng).   
For the full length amplification of SynGAP from plasmid template; 2.6 U Expand 
High Fidelity Taq (Roch), 1X Expand PCR buffer, 0.2 mM dNTP, 300 nM primers, 
0.1 – 250 ng DNA template were used.  Thermocycling conditions are listed in Table 
2. 3. 
 
Table 2. 3 PCR Thermocycling conditions  
Step Temperature (
o
C) Duration Step Temperature (
o
C) Duration
1 94 2 m 1 96 3 m
2 94 15 s 2 96 30 s
3 60 30 s 3 55* 30 s
4 72 3 m 4 72 1 m
5 go to Step 2 x 10 - 5 go to Step 2 x 32 -
6 94 15 s 6 72 5 m
7 60 30 s 7 4 hold 
8 72 3 m + 5s/cycle
9 go to Step 6 x 18 -
10 72 7 m
11 4 hold
The annealing temperature is 
calculated based on the melting 
temperatures of the primer pair 
minus 5 oC
Thermocycling conditions for full length PCR 
of SynGAP from plasmid template using 





Cloning and subcloning 
Cloning was performed in three ways; the screening of a cDNA library, (described 




restriction enzyme mediated cloning performed in this thesis was technically 
subcloning as they always involved the transfer of a piece of DNA from one vector to 
another.   
T/A cloning   
PCR derived products, even if they involved the addition of specific restriction 
enzyme cleavage sites, were all TA cloned initially.  This allowed the confirmation of 
mutation free sequence before the subcloning of the product to the final vector.  T/A 
cloning relies on the ability of Taq polymerase to add an overhanging A base onto 
the end 3’ ends of all products.  All PCR products of the approximate correct length, 
as assessed and extracted from an electrophoresed agarose gel are ligated into a 
linearised vector with complementary T overhangs.  The linearised vector used is 
pGEMTeasy (Promega) which allows selection of plasmids with inserts by 
blue/white selection.  If no PCR product is inserted and the plasmid religates beta 
galactosidase is expressed and the resultant transformed colonies are blue when 
grown in the presence of beta-gal substrate X-gal.  If PCR product ligates to the 
plasmid the lacZ gene is interrupted and the resultant transformed colonies are 
white.  White colonies are selected for isolation of plasmid DNA.   
 
PCR products were purified for cloning by cutting out the band on an agarose gel.   
DNA was extracted using QIAquick gel extraction protocol (Qiagen) according to 
manufacturers instructions except the DNA was eluted in 30 µl rather than the 50 µl 
specified. Gels were stained with SyberSafe DNA gel stain (Invitrogen) and 
visualised using a blue light Dark Reader transilluminator (Clare Chemical 
research).  Using blue light avoids the mutagenic effects of ultra-violet radiation and 
is no less sensitive.   
    
A-tailing 
As TA cloning relies on a 3’ A overhang added non specifically by Taq polymerase 
the efficiency of cloning can be increased by enzymatically adding A tails in a 
separate step.  The step is necessary when proof reading Taq mixtures, such as 
HighFidelity or Herculase are used; these include enzymes that have 3’ – 5’ 




maximum amount of DNA is used (4 µl from a gel extraction elution), with 1 U Taq 
polymerase (not hotstart), 0.2mM ATP, 1X PCR buffer in 10 µl ddH20 and heated at 
70 oC for 20 minutes.  Ligations are performed as normal (p60). 
 
Restriction enzyme digest 
Restriction enzyme (RE) digests are performed either as a diagnostic test, eg to 
confirm the presence of an insert, or for subcloning.   Typically 10 units of RE (1 µl) 
was used on 10 µg DNA (approximately 2 µl of a miniprepped sample) in a final 
volume of 10 µl using the appropriate buffer, follow be incubation for an hour at the 
recommended temperature (usually 37 oC).  For double digests with compatible 
buffers, to avoid the final glycerol concentration exceeding 5%, 0.5 µl of each 
enzyme (which are stored in 50% glycerol) was used.  Double digests with 
incompatible buffers were performed sequentially.  Buffers and enzymes were 
supplied by Promega and New England Biosciences (NEB).  Guidelines on buffer 
compatibility were from NEB.   
Ligations 
Reactions are performed in a 10 µl volume using 1 µl T4 DNA polymerase 
(Promega) 1 µl pGemTeasy linearised vector (Promega).  The amount of DNA 
template used was between 1 – 4 µl, calculated using the equations in the 
pGemTeasy manual (http://www.promega.com/tbs/tm042/tm042.pdf) for 
optimisation of Vector insert ratio; this depends on the length the of the DNA 
template.  Slow ligations were performed in 1x ligation buffer overnight at 4 oC using 
10x ligation buffer, T4 DNA polymerase (Promega) or for 4 hours at RT using 2x 
Rapid ligation buffer, T4 DNA polymerase (Promega). 
 
Transformation of bacterial cells 
Bacterial cells used for transformation of plasmids were the chemically competent 
JM109 E.coli strain (Promega).  Cells stored at -70 oC were thawed on ice, 50 µl 
cells were used per transformation. 1.5 µl of the above ligations were added and 
gently mixed before incubating the cells on ice for 30 minutes.  Cells were heat 
shocked fro 45 seconds in a heat bath at 45 oC and then were immediately replaced 




recover for 90 minutes at 37 oC before they were plated on prewarmed LB agar 
plates containing appropriate selection antibiotic of the transformed plasmid 
(ampicillin, 100 µg/ml; kanamycin, 30 µg/ml).  If TA cloning / blue white selection 
was being performed the plates were spread with 100 µl of 100 mM IPTG and 20 µl 
of 50 mg/ml X-Gal. For additional details see the Promega Technical manual for 
pGEM-T Easy vector systems, TM042.  Plates were incubated inverted overnight at 
37 oC.       
 
RNA isolation 
Tissue harvesting for RNA work was performed observing the usual precautions for 
RNA work; all dissection tools were baked at 300oC for four hours or more, RNAse 
free plastics were used, tissue was snap frozen on dry ice and stored at -80oC prior 
to use.  RNA was isolated using the RNeasy Mini Kit from Qiagen according to 
manufacturer’s instructions except for the homogenisation step; Buffer RLT was 
added to tissue according to weight (600 µl for 20-30 mg, 350 µl for < 20 mg tissue), 
the tissue was pulled through a 23G hypodermic needle, spun for 3 min 10,000rpm 
in a bench top centrifuge and the supernatant treated according to the 
manufacturer’s protocol.  
 
Glycerol bacterial stocks 
Glycerol stocks of E.coli harbouring clones were created to allow easy generation of 
large quantities of plasmid DNA without the need for retransformation.  LB (5 ml) 
was innocuated from a single colony of a clonally pure streak plate and grown 
overnight, shaking at 37 oC.  The culture was spun and the pellet resuspended in 
2.5 ml 4.4% v/v glycerol, 1M K2HPO4, 1M KH2PO4, MgSO4.  The volume is split and 
frozen at -70 oC in two aliquots.  When streaking from glycerol stocks tubes were 
removed, transferred on ice, scrapped streaked and returned immediately to -70 oC.   
 
Preparation of plasmid DNA 
Plasmid DNA was isolated by mini-prep and maxi-prep depending on the quantity 
and quality of DNA required.  Mini-preps were used for cloning procedures; 4ml LB 




prep was used for the preparation of high quality endo-toxin free DNA for 
transfection of cells; 250ml LB was inoculated.  Mini preps were performed using 
QIAprep spin miniprep Kit (Qiagen) per manufacturers instructions.  Typical yields 
were ~300 ng/µl (50 µl volume). Maxi preps were performed using an endotoxin free 
kit, Endofree Plasmid Maxi kit as per manufacturers instructions except the last two 
steps centrifuge steps which were; precipitating by centrifugation in a endotoxin free 
50 ml plastic Falcon tube for 1 hour at 10,000g at 4 oC, and post washing of the 
DNA pellet centrifuging for 30 min at 10,000g at 4 oC.  Typical yields were ~2000ng / 
µl eluted in 250 µl.  Maxiprepped DNA was diluted to 1000 ng/ µl with sddH20.  DNA 
and RNA concentrations were determined using a Nanodrop spectrophotometer 
(Nanodrop Technologies). 
cDNA synthesis 
cDNA was reverse transcribed from RNA with Moloney Murine Leukemia Virus 
(MMLV) reverse transcriptase (Promega, 9PIM170) primed with random hexamers 
(Promega, C118a). Briefly, 0.5-1 µg RNA (typically 1 µl from the above isolation) 
was diluted with 19.95 µl RNAse free water and heated to 75oC for 5 minutes.  After 
cooling on ice 8.05 µl of the following mix was added, 0.5 µg random hexamers / µg 
RNA, 3mM MgCl2 , 
 500 µM dNTPs. RNAse inhibitor, 1 U / µl in standard PCR buffer.  
After incubation at 42 oC form 5 minutes 2ul MMLV reverse transcriptase was 
added, then incubated for a further hour at 42 oC.  Reactions were terminated by 
heating to 96 oC for 5 minutes.  cDNA samples were stored at -20 oC. 
For attempts at full length PCR of SynGAP cDNA was synthesised with the 
SuperScript III First Strand Synthesis SuperMix from Invitrogen(18080-400) 
according to manufacturer’s instructions.   
 
Annotation of SynGAP domains 
The annotations of protein domains in schematics and alignments (Figure 1. 1, 
Figure 1. 6, Figure 3. 2) is based on the coordinates given in the UniProtKB/Swiss-
Prot record for human SynGAP (accession number Q96PV0, human-1 Figure 3. 2).  
Thus the numbering begins from the most upstream initiator methionine in SynGAP 




GAP (443 – 635, 193 aa) and potential SH3 binding (785 – 815, 31 aa).  These 
coordinates are identical in the rat sequence (UniProtKB/Swiss-Prot Q9QUH6).  
 
A note on primers 
All primers listed here include the names given to primers upon ordering.  This is to 
facilitate the reuse of these primers should it be required.  Additionally I have 
included the position of the primers on a genomic reference sequence, a mouse 
bacterial artificial chromosome (BAC clone RP24-335I14, accession number 
AC144621.3).  This mouse BAC is a 207 kb fragment of mouse chromosome 17 
which includes the SynGAP locus.  Primers were designed to be between 17 and 25 
bp long, of approximately 50% GC content with maximum difference of 5oC between 




mRNA to genomic DNA alignment program; Spidey 
(http://www.ncbi.nlm.nih.gov/spidey/) 
 
Chromatogram viewer; 4Peaks 
Protein domain homology searching:  
* NCBI conserved domains 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) 
* Simple Modular Architecture Research Tool (SMART)  
(http://smart.embl-heidelberg.de) 
 
Cloning and construction of SynGAP variants 
Cloning of SynGAP 
PCR (unsuccessful) 




cDNA template was generated using SuperScript™ II reverse transcriptase for first-
strand synthesis to generate full-length and high-yield cDNA  which should allow 
reverse transcription of long polyadenlyated transcripts.  Expand Long Template 
System (Roche, 11681842001) which is modified to favour the amplification of long 
template, and Herculase Taq (Stratagene) which is modified for the amplification of 
long or GC-rich DNA templates were used.  No full length SynGAPs were cloned. 
Phage library screen (unsuccessful) 
The choice of phage library was limited as many available libraries are made using 
Xho digestion which cleaves SynGAP multiple times.  The mouse brain large insert 
cDNA library (in lambda TiplEx phagemid, Clontech, 634235) was chosen as it is not 
digested with Xho and is size selected for enrichment of large inserts.  The library 
was amplified and lawns of E.coli bacterial cells exposed to phage.  Plaques were 
lifted and probed with radioactive probes against SynGAPs pan, A and B.   No 
positive hits resulted.  PCR screening of the library indicated that no SynGAP 
sequences were present.  Additional PCR screening indicated that other abundant 
molecules were also absent from the library (Arg3.1, PSD 95).   
 
Plasmid library screen 
The cDNA plasmid library used was from Invitrogen (10655025, in pCMV-sport6 ) 
and was derived from young adult C57/Bl6 mouse brain.   
PCR screen of plasmid library (unsuccessful) 
Repeated rounds of PCR screening, division and dilution was performed on an 
aliquot of the plasmid library.  Only aliquots positive for SynGAP were further divided 
for subsequent screening.  No SynGAP clones were isolated from bacterial cells 
transformed with plasmid library aliquots tested positive by PCR for SynGAP.   
GeneTrapper cDNA Positive Selection System on plasmid library 
(unsuccessful) 
GeneTrapper cDNA Positive Selection System (10356020 , Invitrogen) is a method 
for the isolation of specific cDNA sequences from cDNA libraries. The GeneTrapper 
System should capture the clone of interest by solution hybridization of a 




from a total cDNA library in vitro) and selection with paramagnetic beads.  No 
SynGAP clones were isolated in this manner. 
 
Colony hybridisation of plasmid library (successful) 
Large numbers of E.coli were exposed to relatively low numbers of plasmid such 
that each colony transfected contained only one plasmid clone.  The colonies were 
then lysed on nitrocellulose, their DNA denatured in situ and fixed on the filter.  The 
nitrocellulose filters bearing the denatured DNA were then hybridised with a 
radioactively labelled SynGAP DNA probe.  Colonies carrying the sequence of the 
probe were then identified by the location of the dark spot on the autoradiograph.  
The colonies were picked and streaked out to isolate individual colonies.  Colony 
PCR was performed and positive colonies were re-streaked, this process was 
repeated until a pure clonal population (all colonies on a given plate were positive 
for SynGAP) was achieved.  The probes used were for a common region of 









Primer name Primer sequence 5'-3' Position on BAC
pansg_f CGA AGT GCT GAC CAT GAC 183683
pansg_r CGGCTGTTGTCCTTGTTG 187538
sgApro_f CTA TGC ACC GAA CCC AAT AC 175199
sgApro_r ACA GAG ACG GTG CGT CTC AG 177258
B
Primer name RE site added Primer sequence 5'-3', RE site Position on BAC
ACSG31_r EcoRV * GTG TCC AGG TTG GAT ATC TC 190565
ACSGB1_f Age1 TTA CCG GT C TGC TGA CTG ACT GCC TAT C 182847
ACSGC1_f Age1 TTA CCG GTC TCT TCT CCA TGT TCT TC 183485
SGA1_H3B2_f HindIII BglII GTAT AAGCTT AGATCT CAT CCC CGC GAT GTC CTA TG 172038
SGB1_H3B2_f HindIII BglII GTGT AAGCTT AGATCT C TGC TGA CTG ACT GCC TAT C 182844
SGC1_H3B2_f HindIII BglII GTAT AAGCTT AGATCT  C TCT TCT CCA TGT TCT TCC 183484
FLSyn_E1_r EcoR1 GTAT GAATTC CT AGT GGT CTG CGG TGT TCC 201176
* this EcoRV site is endogenous
Primers used for the construction of a range of SynGAP variants








Construction of SynGAP variants 
SynGAP A-alpha-1 construction 
SynGAP A-alpha-1 was constructed by digestion of the two library pulled clones, A-
alpha-2 and E-alpha-1, with Age1 and Sph1.  This digest resulted in the release of 5’ 
regions (2.7 kb for A and 2.5 kb for E) and the 3’ regions on the plasmid backbone 
(7.3 kb for alpha-2 and 6.1 kb for alpha-1).  Digest products were gel 
electrophoresed, extracted and purified.  The 5’ A fragment was ligated to the 
backbone containing the 3’ alpha-1 region, and vice versa.  The resulting plasmids 
were transformed, grown up, purified.  Correct ligations were confirmed by 
restriction enzyme digest (EcoR1 and Bbs1) and then sequenced across the 
junctions (forward primer, Sp6, reverse primer; SphJuncRev, 5'- 
TGATGGGAGGAAGGTGGAC -3').   Identity of the 3’ region was confirmed by 
sequencing encompassing the VK and G insert positions (PreVK_for; 5’ 
ATTCCCAGACTCCATCCACG 3’).  The SynGAP A-alpha-1 clone was found to be 
intact, however no successful ligations occurred for the SynGAP E-alpha-2 clone. 
 
Generation of SynGAPs B/C - alpha-1/alpha-2 
SynGAP B and C 5’ regions for the construction of full length B and C alpha-1 and 
alpha-2 plasmids were cloned by PCR.  cDNA template for the amplification of  
SynGAP B and C fragments was reverse transcribed from RNA from p14 mouse 
cortex.  B (ACSGB1_for, ACSG31_rev) and C (ACSGC1_for, ACSG31_rev) PCR 
fragments were TA cloned into pGemTeasy and sequenced to confirm identity.  An 
Age1 RE site was added to the 5’ end of B and C, an endogenous EcoRV site was 
used at the 3’ end.  Primer sequences are given in Table 2. 4, B. 
 
SynGAPs B and C-alpha-1 and alpha-2 were then created by the digestion of the 5’ 
B and C fragments (in pGemTeasy) and SynGAPs A alpha-1 and alpha-2 (in pCMV 
sport 6) by Age1 and EcoRV.  Digested fragments were gel extracted, purified and 





The resulting plasmids were transformed into E.coli, grown up and purified.  Correct 
ligations were confirmed by restriction enzyme digest (Age1, EcoRV, HindIII; three 
fragments, <2, ~2.5 and 3/4 kb) and then sequenced across the junctions (primers; 
Sp6, XM_1698, XM-3695). 
 
Full length PCR of SynGAP from pCMVsport6 
Due to a lack of appropriate restriction enzyme cleavage sites in order to remove the 
3’ UTR the entire coding region was amplified by PCR and TA cloned into 
pGemTeasy.  Full length SynGAPs were amplified from the pCMVsport6 vector by 
PCR using HYPUR gel purified oligo primers (MWG, Germany) and   Expand High 
Fidelity Taq (Roche, 11732641001).   The HYPUR® technique is based on PAGE 
and removes most truncated failure sequences and achieves purity levels of 90% 
and above.  These primers were used as they increase the chances of producing 
amplified DNA with the full primer sequence which is essential for the addition of the 
restriction enzyme cleavage sites. The forward primers were specific for SynGAP A 
(SGA1_H3B2_f), B (SGB1_H3B2_f) and C (SGC1_H3B2_f) and included additional 
restriction enzyme cleavage sites to facilitate the subcloning of SynGAPs into the 
CMV backbone (-eGFP-C1) plasmid (BglII) and or the inducible expression vector 
pcDNA4/TO (HindIII).  A common reverse primer (FLSyn_E1_r) located at the most 
downstream stop codon (alpha-2, position 201176 on BAC, ac144621) included the 
addition of an EcoR1 site also for this purpose.  Primer sequences are given in 
Table 2. 4. 
 
 
PCR products were ligated into pGEMTeasy and fully sequenced to confirm that no 
mutations were introduced during the PCR.  These constructs were then digested 
with BglII and EcoR1 to release full length SynGAPs which were ligated into a CMV 
backbone which had been similarly digested.  The CMV backbone used was from 
the eGFP-C1 vector (Clontech, accession number U55763) from which the eGFP 
gene had been removedby digestion with Age1 and BspE1 and religation.  The 
resultant constructs were again sequenced across the vector junctions and isoform 






Primer name Primer sequence 5'-3' Position on BAC
XM_721_f * AACAGCCGCCGAGTAGATAACG 187537
XM_1224_f * TGTGACCAACCATTACCG 188040
XM_1698_f * AGAGGACATTGCTGACAGGCTG 190226
XM_2232_f * GATGCGGGACCTCAATAG 191055
XM_2752_f * TCCAGAACCCTCTCTTCC 192430
XM_3263_f * AGCAGAGCCTCAGCAAAG 192958
XM_3610_f AGGTTGCTGTCCCAGGAAG 195459


















Sp6 * GATTTAGGTGACACTATAG vector
T7 * GTAATACGACTCACTATAGGGC vector
Sequencing primers
* Primers highlighted with an asterisks should be sufficient to seqeunce through 
the gene. MBAC 201719_for is within the long UTR  
 
Table 2. 5  Sequencing primers 
 
DNA sequencing and sequence confirmation 
Plasmid DNA was sequenced by primer extension (MWG, Germany or 
Cogenics/Lark, Essex, UK).  Sequencing reads were typically between 300 – 800 bp 
long.  Chromatograms were examined to ensure good quality sequence and 
sequences were clipped to remove poor quality and primer / vector sequence.  
Sequences were aligned against the mouse genomic sequence to confirm exon 




settings).  The mouse bacterial artificial clone RP24-335I14 (accession number 







Figure 2. 1 Example plasmid map of a SynGAP expression vector 
A plasmid map of full length SynGAP A-alpha-2, without UTR, in the expression vector.  The 
expression vector is the backbone of pEGFP-C1 from which eGFP has been removed.  No 






cDNA was synthesised from RNA derived from p14 mouse cortex.  PCR was 
performed using a range of different primer pairs.  Many primer pairs were used in 
order to optimise chances of the amplification of longer products; the 3’ region of 
SynGAP is repeat rich which makes the design of primers challenging.  Forward 
primers were positioned upstream of the isoform specifying alternative inserts and 
reverse primers were positioned within the alternatively spliced UTR exon.  A 
number of reverse primers were designed to lie immediately upstream of the 
polyadenylation but only one of these, 3UTR_5.0_r, resulted in successful 
amplification (Figure 2. 2).   
   










Boundaries of alternative retained intron
from plasmid screen clones SynGAP A-
alpha-2 (+) and E-alpha-1 (-).  
 
Figure 2. 2 Locations of primers for establishing a link between C-terminal coding 
sequence and 3’ UTR. 
A schematic diagram of the 3’ end of SynGAP with positions of primers shown with respect 
to alternatively present sequence.  The diagram is not to scale. 
 










Primers for establishing a link between C terminal coding sequence and 3' UTR
 
 
Table 2. 6  Primers for establishing a link between C-terminal coding sequence 







Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed on samples prepared by boiling in Laemmli buffer containing 5% beta-
mercaptoethanol (Sigma-Aldrich).  Equal amounts of protein (10 µg) were loaded 
per well of a mini-gel apparatus (Bio-Rad).  Protein concentrations were established 
by Bradford assay.  Adherent cell samples were harvested by scraping in lysis buffer 
(200 µl/ well of a 24 well plate).  p14 mouse cortices tissue were homogenised in 
500 µl/pair hemispheres.  7 % resolving gels were made using resolving gel buffer 
(1.5M Trisbase, 0.4% SDS, pH 8.9) supplemented with acrylamide/bis-acrylamide,  
tetramethylethylenediamine (TEMED) and fresh 10% ammonium persulphate (APS).  
Water saturated butan-1-ol was layered on top to prevent access of oxygen.  
Stacking gels were made to 4% using stacking gel buffer (0.5 M Trisbase, 0.4% 
SDS, pH 6.8) also supplemented with the above components.  Gels were run at 
constant current (15-20 mA/gel) in buffer containing Tris, glycine and SDS.  Proteins 
were then electroblotted onto nitrocellulose membrane (Bio-Rad) at constant 
current, either 50 mA/tank overnight, or 200 mA/tank for 2 hours, in buffer containing 
Tris, glycine and methanol.  Molecular weight markers (Kaleidoscope prestained 
markers, Bio-Rad) were run on all gels.  Protein transfer onto the nitrocellulose 
membrane was confirmed by the presence of prestained markers and by staining 
with 1% (w/v) amido black.  
 
Blots were then probed with primary antibodies against the proteins of interest 
overnight or approximately 5 hours at room temperature.  Blots were washed 
repeatedly in tris based saline (TBS) with 0.2% Triton X-100 before adding Alexa 
Fluor conjugated secondary antibodies for incubation for 1 hour at room 
temperature.  Blots were again washed and dried before imaging with the LiCor 
Odyssey infrared imaging system (Li-COR Biosciences UK Ltd, Cambridge, UK).  
The use of fluorescently labelled secondary antibodies allows the detection of 
multiple antigens on the same membrane.  Antibodies were diluted in DMEM 




panSynGAP (1:8000, Cambridge Biosciences, PA1-046), SynGAP alpha-1 (1:2000, 
Upstate, 06-900), SynGAP beta (1:4000, a gift from the laboratory of (Li et al., 
2001)), GFP (1:5000, NeuroMAb), beta actin (1:10,000, AbCam).   Secondary 
antibodies were all used at 1:1000, goat anti rabbit 800, goat anti mouse 680 
(Invitrogen). 
 
Cell markers for subcellular localisation 
The fusion protein markers used to examine subcellular localisation in HEK cells 
were encoded by the following plasmids.  Golgi apparatus; pECFP-Golgi (Clontech, 
6908-1) which encodes a fusion protein of enhanced cyan fluorescent protein 
(eCFP) and a sequence encoding the a region of human beta 1,4-
galactosyltransferase (GT-1) that contains the membrane  anchoring signal peptide 
that targets the fusion protein to the trans-medial region of the Golgi apparatus.  
Endosome; pEYFP-Endo (Clontech, 6936-1) which encodes a fusion protein of 
enhanced yellow fluorescent protein (eYFP) and human RhoB GTPase which 
targets to the vesicles of the endocytic pathway.  Endoplasmic reticulum; dsRed2-
ER (Clontech, 632409) which encodes a fusion protein of  Discosoma sp. Red 
fluorescent protein-2, the ER targeting sequence of calreticulin and the sequence 
encoding the ER retrieval sequence, KDEL.  Autophagosome; LC3-GFP (Addgene 
incorporated, plasmid 11546, Jackson et al., (2005)) consists of a eGFP fusion 
protein with the microtubule-associated protein 1 light chain 3 (LC3) which is 
associated with the autophagosomal membrane after processing.  F-actin was 
stained with phalloidin conjugated to Alexa Fluor 633 (Invitrogen, A22284).  
Phalloidin was prepared according to manufacturers instructions and applied for 20 
minutes to permeabilised cells (5 minutes with 0.1% Triton x-100 in PBS) at the 
concentration of 5 µl methanolic stock solution in 200 µl PBS for each coverslip.  
 
Volume rendering was performed on a Nyquist sampled undeconvolved image stack 






2.4 Methods of Chapter Four: Imaging and 
Analysis 
Cultured cell density assessment 
In order to assess the cell density and cell viability in mature cultures coverslips 
were fixed in the normal way and stained with the nuclear stain Topro3 (1:1000, 
Invitrogen) in PBS for a minimum of 10 minutes. To calculate total nuclei density 
(nuclei / mm2) mounted coverslips were examined using a x20 objective with a 
graticule.  All nuclei, irrespective of morphology, were counted from at least 4 
randomly selected fields of view per coverslip.  2-3 coverslips were counted per 
embryo.  To calculate the level of cell death a x40 objective with a graticule was 
used to count healthy appearing nuclei.  The greater level of magnification was 
required to assess the morphology of the nuclei.  Nuclei were counted as healthy if 
they were round or oval, not fragmented or condensed.     
 
Imaging neurons for protrusion analysis 
GFP expressing pyramidal type neurons were imaged by laser scanning confocal 
microscopy on a Axiovert from Zeiss.  Confocal stacks composed of 30-60 images 
with a Z section interval of 0.13 µm were taken using a x 63 oil immersion objective 
(NA 1.4) with 3.1 zoom.  The dendritic section was placed diagonally across the field 
of view to maximise the imaged length.  Under these conditions the diagonal straight 
line is 66 µm, therefore the dendrite section lengths imaged range from 45-70 µm.  
Apical and basal dendrites from 50 - 200 µm from the cell body were imaged.  
Crossing dendrites were avoided to facilitate analysis.  Neurons that exhibited signs 
of stress, including dendritic beading and blebbing, were not imaged.  At least 3-4 
dendritic segments per neuron, from 3-4 neurons per embryo, where applicable, are 
imaged and analysed.  The stacks were deconvolved using the Huygens Essential 




Protrusion morphology analysis 
A maximum intensity projection of each deconvolved stack was manually analysed 
using the ImageJ plugin NeuronJ (Meijering et al., 2004) (Figure 2. 3).  All 
protrusions up to a certain length (8 µm) were measured.  I do not refer to the 
protrusions as spines because long filopodia are also included under this criterion.  I 
cannot discount the possibility that some of the longer protrusions may be short 
neurites.  The length of each protrusion was measured from the point of attachment 
to the dendritic shaft to the furthest tip.  The widest point of protrusion tip was 
measured as the protrusion width.  The length of the dendritic segment was 
measured in order to calculate the protrusion density.  Bifurcating protrusions were 
analysed as two protrusions.  Three to four dendritic segments of 45-70 µm in length 
were analysed for each neuron. 
 
NeuronJ is an ImageJ plugin designed to facilitate the tracing and quantification of 
elongated structures in two-dimensional images in particular neurites in 
fluorescence microscopy images.  It is not designed specifically for measuring 
dendritic protrusions or spines.  NeuronJ allows the user to define the starting point 
of a tracing. Then by moving the cursor toward the end of the neurite NeuronJ 
applies a search algorithm to find the optimal path towards that point.  The path is 
displayed in realtime as the cursor is moved.  If the presented path deviates from 
what is considered by the user to be the true path the tracing can be fixed by a 
mouse click. The algorithm will begin searching again from that manually fixed point. 
 
For the protrusion analysis in this thesis a section of dendrite is traced along its 
length using the default parameters of NeuronJ.  To trace the protrusions I alter 
certain search parameters to optimise for tracing small thin tracts (Snap window 
size: 1x1, default = 9x9, Path search window size: 100 x 100, default = 900 x 900).  
Each projection is then traced from its point of attachment to the shaft to its tip.  
Each protrusions’ width is then traced at the widest point of its tip.  Bifurcating 
protrusions are traced and counted as two protrusions.  Protrusions up to 8 µm are 
included in the analysis.  Protrusion density is calculated by dividing the dendrite 





Due to limitations of the ‘GFP fill’ approach and confocal microscopy, measurements 
are not necessarily accurate in an absolute quantitative sense, but are valid for 








Figure 2. 3 Dendritic protrusion morphology and density are analysed by manual 
tracing 
A section of dendrite from a GFP filled hippocampal pyramidal type neuron at DIV 14 is 
shown to illustrate the method of analysis.  The dendrite is traced along its length, then each 
projection is traced from the point of attachment to the shaft to its tip (b).  Each protrusions’ 
width is then traced at the widest point of its tip (c).  The measurements for the section of 
dendrite shown are as follows: protrusion density (0.62 protrusions/µm), mean protrusion 
length (1.13 µm) and width (0.58 µm).  The area in the box is shown expanded below. Scale 





Cells were fixed with room temperature freshly thawed 4 % paraformaldehyde in PB.  
Growth medium was aspirated and fix was added directly to the wells without prior 
washing. After 10 minutes at RT fix was aspirated and cells washed at least 3 times 
with PBS.  If not used immediately cells were stored in PBS at 4 oC for a maximum 
of a few days.  For experiments on HEK cells permeablising (0.2 % Triton X-1000, 
quenching (50 mM NH4Cl) and blocking (0.3 % bovine serum albumin, BSA) were 
performed in one step (30 minutes, RT), best results in neurons were obtained when 
these steps were performed separately (10, 10 and 10 minutes, interspersed with 
PBS washes, RT).  Cells were then washed x 3 in PBS before incubation with 
primary antibody in PBS/0.3 % BSA for one hour (pan SynGAP (1:1000, Cambridge 
Biosciences, PA1-046).  Cells were washed again (x 3, PBS) then incubated with 
Alexa fluorescently conjugated secondary antibodies (Invitrogen) in PBS/0.3% BSA 
for 30 minutes.  For antibody incubation coverslips were upturned onto a 100 µl drop 
of antibody solution on a sheet of Parafilm (Pechiney Plastic Packaging Company, 
Chicago, IL).   Nuclei were counterstained with DAPI/Hoescht (Invitrogen) which 
was added to a final 10 minute PBS incubation at 1:1000.  Coverslips were dipped 
in PBS then water before mounting in Mowiol mounting medium and stored at 4 oC 
protected from light.   
 
Protein expression quantification by relative fluorescence levels 
The level of expression of overexpressed SynGAP isoforms was quantified in 
SynGAP -/- neurons by quantitative fluorescence microscopy.  Neurons were co-
transfected with SynGAP and eGFP in the normal way.  SynGAP isoforms were 
detected with the pan SynGAP antibody and dendritic sections were imaged by 
laser scanning confocal microscopy. All immunocytochemistry was performed in one 
batch.  The same laser power and microscope settings were used for all neurons 
and it was ensured that no pixels were saturated.  Fluorescence levels were 
quantified in ImageJ.  Briefly, the integrated density (mean grey value multiplied by 
area) for the whole area of the image was taken.  From this the integrated density of 




of the background by the whole area of the image) was subtracted to yield a value of 
the corrected integrated density.  The corrected integrated density of SynGAP 
antibody fluorescence was divided by the corrected integrated density of eGFP 
fluorescence to yield relative fluorescence level value. 
 
Note on statistics 
The two-sample Kolmogorov-Smirnov test (KS-test) and Mann-Whitney test (MW-
test) are two of the useful and general alternative nonparametric methods of two-
sample t-test. They can be used to test whether two samples come from the same 
distribution. The two-sample Kolmogorov-Smirnov test uses the maximal distance 
between cumulative frequency distributions of these two samples as the statistic. 
However, the Mann-Whitney test takes the difference between mean ranks of these 
two samples as the statistic, is closer to examining the median.  For spine protrusion 
analysis; all data on which a KS test was performed was also analysed by the 





2.5 Methods of Chapter Five: Electrophysiology 
Basic Electrophysiology methods 
Recordings were made on the day in vitro (DIV) indicated. Neurons were kept in a 
37oC incubator prior to transfer to the recording rig in room temperature extracellular 
recording solution (Table 2. 3).  Neurons were continually perfused with room 
temperature extracellular recording solution, except during recordings performed on 
high amplifier gain, i.e. mEPSC recordings, to minimise perfusion artefacts.   Each 
coverslip was used for a maximum of 45 minutes or for three usable cells.  Wild type 
coverslips were alternated with SynGAP -/- coverslips to minimise effects of, for 
example, variation in internal and extracellular recording solution batch or aliquot, or 
systematic variation in access resistance due to drift in the diameter of patch 
electrode pulled by the electrode puller.  Thick walled (0.86 mm internal diameter, 
1.5 mm OD) glass capillaries with internal filaments were pulled to the desired 
resistance (4-9 mOhm) using a Sutter p95 electrode puller.  Data are sampled 
directly from the low-pass filtered (5 kHz) output of the patch amplifiers using 
LabVIEW 8.2 (National Instruments Inc.). The sampling rate is fixed at 10 kHz with a 
resolution of 16 bits per sample. Data acquisition and analysis software were written 
in LabVIEW 8.2 by Timothy O’Leary (O'Leary et al., ; O'Leary, 2008).  Recordings 
are analysed off-line. 
Concentrations of drugs used are given in Table 2. 8. 
 
Table 2. 7 Solutions used for electrophysiological recordings 
Standard Cesium based Concentration (mM)
K-gluconate 130 - CaCl2 2.5
KCl 10 - MgCl2 1.3
Cs-gluconate - 130 Glucose 10
CsCl - 10 NaCl 150
HEPES 10 10 KCl 3
EGTA 0.1 0.1 HEPES 10
Glucose 10 10 Glycine 0.05
Na phosphocreatine 10 10
Mg ATP 4 4
Mg GTP 0.5 0.5
Internal Recording Solution External Recording Solution
Concentration (mM)
The pH is adjusted to 7.3 using KOH (4M); osmolarity is 290-
300 mOsm.
The pH is adjusted to 7.3 using NaOH
(4M); osmolarity is 310-320 mOsm.







TTX (Tetrodotoxin citrate) 500 nM
PTX (Picrotoxin) 50 µM
CNQX  (6-cyano-7-nitroquinoxaline-2,3-dione) 5 µM
APV  (d-2-amino-5-phosphonopentanoate) 50 µM
NMDA (N-methyl-D-aspartic acid) 100 µM
AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate) 50 µM
Bic (Bicuculline) 50 µM









AMPA mEPSCs were isolated electrophysiologically by blocking neurotransmitter 
receptors other than AMPA receptors and preventing action potential driven 
neurotransmitter release.  The cell’s transmembrane potential was voltage clamped 
at -70mV.  At -70mV the voltage sensitive NMDA receptor is blocked.  The 
extracellular recording solution was supplemented with tetrodotoxin (TTX) picrotoxin 
(Ptx) and magnesium chloride (Mg2Cl, 1.3 mM).  TTX binds to the pore of voltage 
gated, fast action sodium channels and prevents action potentials, thus blocking 
action potential driven neurotransmitter release.   Ptx was used to block GABAergic 
events. Magnesium is used to ensure the NMDA receptor’s voltage gated 
magnesium block is available.   Access resistance was monitored between 
recordings and recordings were abandoned if the access resistance was unstable or 
above 28MΩ.  Recordings with fluctuations in the baseline or a large amount of 
noise (greater than 4 pA RMS) are excluded.   
 
mEPSC analysis 
Typically, at least three two minute recordings were made from each cell, depending 
on mEPSC frequency.   At least 300 events were analysed per cell.  mEPSC 




cell.  The mEPSC frequency was calculated by averaging the inter event intervals 
(ms), then obtaining the reciprocal value (Hz).  The mean mEPSC amplitude (pA) 
and frequency (Hz) from each neuron was then averaged to give a value for the 
entire population.  
 
Figure 2. 4 shows the method of analysing an mEPSC.  mEPSCs are detected by 
setting an amplitude threshold relative to a baseline which is perturbed only by 
events with a characteristic duration greater than 2 ms, a value that is comparable to 
the rise-time of mEPSCs. An event amplitude threshold is set at 5 pA above this 
baseline, which is twice the typical RMS noise that is measured in these recordings.  
The process for analysing individual events is as follows. Event amplitudes are 
calculated relative to a 15 ms baseline preceding the event, risetimes are calculated 
as the time taken for the event to reach 90% of its maximum value after exceeding 
10% of its maximum, and decay time-constants are estimated by fitting a single 
exponential curve to the decaying phase of the event. Each of these parameters is 
fitted automatically and adjusted by hand if the initial fit is unsatisfactory.  Events 
that are separated by an interval of less than 15 ms are excluded from the analysis; 
this imposes a cut-off on the maximum event frequency and inter-event-interval 
(IEI). Fluctuations in the current which are isolated as events but do not resemble 
mEPSCs are excluded from the analysis.  
To calculate mean values, the individual fitted traces are aligned to the time of the 
half-maximal value during the rising phase.  
 






























Figure 2. 4 mEPSC measurement 
mEPSC event amplitudes, 10-90% rise-time and exponential decay time-constants 
are calculated automatically  but are monitored and can be hand-fitted if necessary. 
 
 
Whole Cell Currents 
Cells are voltage clamped at -70mV.  The external recording solution for eliciting 
AMPA currents includes AMPA at the saturating concentration of 50 µM, MgCl2 and  
the NMDA receptor antagonist APV (Table 2. 8).   This AMPA cocktail is bath 
applied until the inward current reaches a plateau, then washed out until the 
baseline holding current is restored before a repeat application is performed to 
ensure a stable response.  The extracellular recording solution containing Mg2+ is 
then replaced with Mg2+ free recording solution to remove the NMDA receptor’s Mg2+ 




reaches a plateau, then washed out until the baseline holding current is restored 
before a repeat application is performed to ensure a stable response.  The NMDA 
receptor co-agonist Glycine is also included, as is the AMPA receptor antagonist 
CNQX.   All solutions contain TTX to prevent action potential mediated influx of 
current, and Ptx to block GABAergic receptors. 
Whole cell currents are quantified by averaging the trace values in an area of the 
stable plateau phase of the current.  Coverslips were used for a maximum of two 
sets of agonist application to avoid desensitisation of AMPA and NMDA receptors. 
 
Capacitance measurements 
Cell capacitance was measured in two ways.  Whole cell capacitance neutralisation 
was performed using the amplifier.  The series resistance and whole cell 
capacitance  were altered together to achieve neutralisation of the capacitance 
transient (N. B. Standen, 1987).   The value of the capacitance was then read from 
the whole cell capacitance dial.  However a neuron is not single electrical 
compartment and doesn’t behave like a single capacitor in parallel with a resistor so 
neutralistion is always an approximation.  A more accurate way to measure the 
capacitance is to measure the charge transferred following a voltage step of a 
known size and this is implemented with the software.  Similar values were 
obtained, however the later method was used as it is believed to be more accurate. 
 
Measurement of neuronal soma upper surface area 
Single fluorescent images of fixed GFP transfected cells were captured with a x40 
lens.  All pixels were within the dynamic range.  Soma were outlined using the 
‘region of interest’ tool in ImageJ.  The resulting area measurements equates to an 
approximate 2D measurement of the area of the upper surface of the 3D cell bodies. 
 
Transfection of neurons for electrophysiology 
Neurons were transfected in the same manner as for morphological analysis 




to optimise conditions for electrophysiological recording.   See Appendix One for the 
optimisation of transfection protocol for electrophysiological recordings and the 
confirmation of cotransfection resulting in coexpression.  The optimised transfection 
conditions were ; 0.3 µg DNA/ 1ul Lipofectamine 2000 per well of a 24 well plate.  
0.1 µg eGFP was used with 0.2 µg of a SynGAP construct or an empty vector.  
Recordings were made from 16 to 36hrs from the time the complexes were added to 
the cells. 
 
Classification of ‘silent’ cells 
Neurons were included for classification as silent or non silent cells if they met 
following criteria.  Recordings with low noise (<3.5 RMS) and low holding current (<-
150pA).  A minimum recording length of 2 minutes where no mEPSCs were 
apparent was required for a cell to be classified as silent. 
 No minimum recording length was necessary to designate a cell has non silent, the 
appearance of obvious mEPSCs was sufficient.  Cells with high RMS noise but with 
mEPSCs obvious above the noise were not included in this analysis.   
 
Spontaneous and stimulated activity 
Neurons were voltage clamped at -70mV, all recordings were performed in the 
presence of Mg2+.  Spontaneous activity was recorded for at least 5 min before the 
bath application of bicucculine and 4-AP (Bic/4-AP).  Bic/4AP was perfused on for 
30s while stimulated activity was recorded continuously for 5 min, Bic/4AP was 
perfused on again after 3 min for 30s.  CNQX was used to block AMPA receptors. 
 
Statistics  
All statistical analyses were performed in GraphPad Prism 5.  T-tests are students 
unpaired t-test unless otherwise specified.  Bar graphs display the mean +/- 





The D’Agostino-Pearson test is used to test for normality.  The D'Agostino-Pearson 
normality test performed by Prism is the ‘omnibus K2’.  It first computes the 
skewness and kurtosis to quantify how far from Gaussian the distribution is in terms 
of asymmetry and shape. It then calculates how far each of these values differs from 
the value expected with a Gaussian distribution, and computes a single P value from 
the sum of these discrepancies.  The distribution of the mEPSC frequencies within 
conditions is not normal (D’Agostino and Pearson normality test, p<0.05 for all 
groups except SynGAP A-alpha-1 (Figure 5. 15, Figure 5. 16) thus the data should 
not be analysed by one way ANOVA.  However the non-parametric version of one 
way ANOVA, the Kruskal Willis test, assumes that the shapes of the distributions 
are identical which is not the case.  I have presented the results both using one way 
ANOVA and transformed the data to normalise the distributions. 
 
Chi square (population) and Chi square test for expected vs observed values were 
performed on the online calculator at graphpad.com.  Dunnett’s post hoc test 
compares all groups to the control group.  Bonferroni planned comparison test 
compares all groups to the control group, but is not corrected for multiple 
comparisons.   
 
 
2.6 Methods of Appendix 1 
Calculation of co-transfection efficiency 
Co-transfection efficiency was calculated to determine if transfection with two 
separate plasmids resulted in the same neurons expressing both plasmid products.  
Two plasmids encoding fluorophores (eGFP-N1 and mCherry-N1) were used to 
allow visual assessment of co-transfection.  7 ratios of eGFP to mCherry (from 0.25 
– 4) were used to optimise co-transfection rates.  3 coverslips per condition were 
transfected and all fluorescent cells in 5-8 fields of view per coverslip were noted as 
being red, green or both using a x 40 objective.  The filter cube used for visualisation 
of mCherry fluorescence filters between 515-560 nm.  These wavelengths are 




Calculation of transfection efficiency 
Transfection efficiency was calculated by counting all eGFP expressing neurons and 
DAPI stained healthy appearing nuclei using a x 20 objective with graticule.  3 
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3 Chapter Three: Molecular Biology 
 
3.1 Introduction 
This chapter is concerned with the structure of the SynGAP gene, as well as its 
transcription and translation.  As described in the main introduction SynGAP is a 
complex gene, with N-terminal variation arising from multiple transcription start sites 
and C-terminal variation arising from alternative splicing.  I will give a brief 
introduction to the mechanisms that give rise to such complexity, and how they may 
be regulated, before more specifically addressing the work performed in this 
chapter. 
 
More than half of human genes (at least 53%) have alternative promoters (Kimura et 
al., 2006).  To initiate and modulate transcription, factors interact with chromatin and 
DNA sequence features in regulatory regions surrounding the transcription start site 
of a gene. In this region, factors of the transcription machinery interact directly with 
DNA sequence motifs to ensure the proper recruitment of RNA polymerase II and 
transcription of the pre-mRNA.   
 
From the moment a gene is transcribed, it undergoes a series of post-transcriptional 
regulatory modifications in the nucleus and cytoplasm until its final deployment as a 
functional protein. Initially, a message is subjected to extensive structural regulation 
through alternative splicing, which is capable of greatly expanding the protein 
repertoire by generating, in some cases, thousands of functionally distinct isoforms 
from 
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a single gene locus. Then the mature mRNA is packaging into neuronal transport 
granules and potentially recognised by RNA-binding proteins and/or microRNAs 
which are capable of restricting protein synthesis to selective locations and under 
specific input conditions.  The tight regulation of spatial and temporal deployment is 
well adapted to the extreme morphological requirements of the neuron.  The 
expression profiles of splice isoforms are modified during development and to 
response to changes in neuronal activity (Ule et al., 2005; Li et al., 2007). 
 
Insights into the importance of splicing in the development of the complexity of an 
organism comes from comparative genomics.  Among unicellular eukaryotes, 
alternative splicing seems to be relatively rare: only three genes of the budding 
yeast Saccharomyces cerevisiae are reported to be alternatively spliced; alternative 
splicing is observed also in a more distant fission yeast Schizosaccharomyces 
pombe and in the malaria parasite Plasmodium falciparum.  The estimated fraction 
of alternatively spliced Arabidopsis genes ranges from 10− 20% and remains 
consistently lower than that of animal genes (Artamonova & Gelfand, 2007). 
 
Surprisingly, splicing events are often less conserved than the total level of 
conservation between two species.  About one quarter of human alternatively 
spliced transcripts are not present in the orthologous mouse gene products, and 
about half of alternatively spliced genes have species-specific isoforms (Nurtdinov et 
al., 2003). 
 
3.1.1 Types of pre-mRNA alternative splicing 
There are various types of alternative splicing categorised depending on the nature 
of the alternative sequence.  Entire exons may be present or absent, an alternative 
splice site may be chosen at the beginning or end of an existing exon, or an intronic 
sequence may be retained in the mature mRNA.  Alternative promoters that initiate 
transcription at different exons which are spliced onto common exons is also 
included as a splicing mechanism.  These types of splicing are illustrated in Figure 
3.1.  In all cases the alternative regions may be in-frame or out of frame.  In-frame 
regions lead to the inclusion or exclusion of amino acids without changing the 
sequence of the remainder of the protein.  Out of frame alternative sequence leads 
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to a frameshift in the open reading frame (ORF) which completely changes all 
subsequent protein sequence.                      





b Alternative 3’ splice site  selection
c Alternative 5’ splice site selection
d Intron retention
e Alternative promoters




Figure 3.1  Types of alternative splicing 
Exon skipping (a), the inclusion or exclusion of a ‘cassette’ exon, represents the most 
common type of alternative splicing (Sultan et al., 2008).  Exon skipping accounts for 40% of 
alternative splicing events in higher eukaryotes. Through the use of alternative 3' (b) or 5' (c) 
splice sites exons can be extended or shortened in length (19% and 8% of splicing events, 
respectively).  The excision of an intron can be suppressed, to leave the intronic sequence in 
the mature mRNA (d, < 5% of splicing events). Transcriptional initiation at different 
promoters generates alternative 5'-terminal exons that can be joined to a common 3' exon 
downstream (e).  Similarly, alternative 3' exons, with alternative polyadenylation sites, can be 
joined to a common upstream exon (not shown).  Sometimes paired cassette exons show 
mutually exclusive splicing, where one exon or the other is included, but not both (not 
shown).  Introns are represented by the horizontal line and lines exon connecting represent 
splicing options.   




3.1.2 Regulated alternative splicing 
Splicing is carried out by the spliceosome, a massive structure in which five small 
nuclear ribonucleoprotein particles (snRNPs) and a large number of auxiliary 
proteins cooperate to accurately recognize the splice sites and catalyse the splicing 
reaction.  The decision as to which exon is removed and which exon is included 
involves RNA sequence elements and protein regulators.  Splicing decisions can be 
profoundly influenced by the strength of the individual 5’ and 3’ splice sites and by 
auxiliary RNA sequences that tune splice site strength via enhancement or silencing 
mechanisms.  Protein regulators are a combination of tissue and developmental 
stage specific and ubiquitously expressed RNA binding factors which influence 
splicesome assembly  (Black, 2003).  Additionally, there has been accumulating 
evidence showing that RNA transcription can be coupled to splicing regulation 
(Batsche et al., 2006; Moldon et al., 2008; Chen & Manley, 2009).  The coupling of 
promoter related machinery with splicing machinery is of particular interest in the 
study of SynGAP because it may determine the linkage between N and C-termini.   
 
3.1.3 Regulated alternative promoter usage 
Many different promoter expression and splicing patterns are induced during 
neuronal development, presumably as a result of changes in the expression of 
splicing regulators and transcription factors.  Use of alternative promoters enables 
diversification of transcriptional regulation within a single locus and thereby plays a 
significant role in the control of gene expression in various cell lineages, tissue types 
and developmental stages. 
It appears that the transcription of alternative SynGAP N termini are under the 
control of distinct promoters as they are differentially regulated in development and 
in an activity dependent manner (Figure 1. 5).  
 
It is well established that new gene transcription is necessary for the long term 
storage of memory (Bailey et al., 1996).  The first wave of gene transcription to 
occur after stimulation is called immediate early gene transcription.  It is mediated by 
the host of transcription factors and accessory proteins that are the ultimate 
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effectors of such signalling pathways as ERK/MAPK, eg CREB (Abraham et al., 
1993).  Further changes in gene transcription are mediated by the immediate early 
gene products and it is likely that SynGAP falls into this category as the changes in 
SynGAP mRNA levels are only apparent after 4 hours, but not 1 hour, of stimulation 
(Mark Barnett, personal communication).   
 
To the best of our knowledge SynGAP is the only example of synaptic activity 
dependent differential regulation of alternative promoter usage within a gene 7 
   
 
3.1.4 Neuronal regulation of alternative splicing  
Alternative splicing is especially common in the nervous system and as such it is 
expected that many more regulatory elements and proteins are involved compared 
to other tissue types (Li et al., 2007).  Several trans-acting splicing regulators that 
direct neuron-specific splicing have been identified, including Nova-1/2, Hu proteins 
and Fox-1/2 (Ule et al., 2005; Underwood et al., 2005; Zhu et al., 2006).  There are 
numerous examples of changes in alternative splicing of ion channels, receptors 
and synaptic signalling proteins at different development stages and in adaptive 
changes associated with neuronal excitability and synaptic efficacy (Lipscombe, 
2005; Wu et al., 2010).  
 
Particularly relevant examples that demonstrate how different splice forms can have 
different activities include the SynGAP-related RasGAP neurofibromatosis type I 
(NF1) which when spliced to exclude exon 23a shows 10 times greater ability to 
down-regulate Ras signalling than the isoform that includes exon 23a (Barron et al., 
                                               
7
 The synaptic scaffolding protein Homer is referenced in the literature as being an example 
of activity dependent alternative promoter usage.  However, the activity dependent regulation 
of Homer actually appears to be alternative splicing rather than alternative promoter or TSS. 
Xiao B, Tu JC & Worley PF. (2000). Homer: a link between neural activity and glutamate 
receptor function. Curr Opin Neurobiol 10, 370-374. 
, Tappe A & Kuner R. (2006). Regulation of motor performance and striatal function by 
synaptic scaffolding proteins of the Homer1 family. Proc Natl Acad Sci U S A 103, 774-
779..Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL & Worley PF. 
(1997). Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 
386, 284-288. 
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2010).  The N-terminally extended splice variant of Rap1 GAPII, contains a motif 
which mediates its interaction with heterotrimeric G proteins and results in the 
activation of its GAP activity (Mochizuki et al., 1999).  Finally, in postsynaptic 
membranes a splice variant of the synapse-associated protein-97 (SAP-97) recruits 
AMPA receptors to and enlarges cortical spines.  Overexpression of an alternative 
form that lacks a single exon has no effect.  SAP-97 splicing therefore represents a 
mechanism to up and downregulate the efficacy of glutamatergic synapses (Waites 
et al., 2009) 
The regulation of splicing by cell excitation. 
Some splicing events can be controlled dynamically in mature excitable cells.  
Splicing switches are common in ion channels, neurotransmitter receptors and 
proteins that are involved in calcium signalling or the control of membrane 
physiology. Many of these splicing events are themselves altered by cell excitation 
or by treatments that stimulate calcium signalling pathways.  Exons in calcium-
ATPase, SNAP25, NMDAR1, the large-conductance, calcium- and voltage-gated 
potassium channels (BK channels) and other transcripts are repressed by shifting 
cells into high-potassium media. In many cases, inhibiting L-type calcium channels 
blocks this repression, indicating that a calcium signalling pathway is required, but 
other pathways can also be involved (Lipscombe, 2005) 
 
The case of activity induced changes in the NMDA receptor subunit NR1 splicing is 
particularly noteworthy.  Neuronal activity promotes the choice of splice site that 
leads to one C-terminal tail (C2), while blockade of activity leads to the translation of 
a different tail (C2’) that accelerates the transport of the receptor to the plasma 
membrane (Zukin & Bennett, 1995; Mu et al., 2003).  Indeed some sequence motifs 
essential for depolarisation and CaMKIV-dependent splicing of NR1 have been 
identified (An & Grabowski, 2007; Lee et al., 2007). 
 
Neuronal activity has also been shown to promote alternative mRNA processing 
(alternative polyadenylation) specifically of the immediate early gene targets of the 
transcription factor MEF2, leading to the production of truncated mRNAs that may 
have different functions than their full length counterparts (Flavell et al., 2008). 
 
Chapter Three   
 
96 
It would be illuminating to know if 3’ alternative splicing of SynGAP, like its 5’ 
alternative promoter usage, is also subject to activity dependent regulation. 
 
3.1.5 Aims of this chapter 
The main objective of this thesis is to determine if these N and C-terminal variants of 
SynGAP have any influence on its function.  The experiments performed in this 
chapter were primarily geared toward equipping ourselves with the tools required to 
perform the assays of the remainder of the thesis.  In order to perform these 
morphological and functional experiments physical clones of SynGAP were needed.  
Here, I will describe the cloning and construction of the SynGAP variants that are 
used throughout this thesis.  During the process of cloning a number of novel 
transcripts were found that add further complexity to the transcriptional, and 
possibly, translational profile of SynGAP.  The cloning experiments which led to the 
discovery of new transcripts were not an attempt at a comprehensive 
characterisation of SynGAP transcriptional variation and as such are not exhaustive.  
In instances where the discovery of a new variant had implications for the planned 
functional assays additional investigations were performed. 
 
Additionally, as I have outlined in the main introduction, SynGAP contains a number 
of domains that may mediate localisation independent of synapse specific 
mechanisms.  In order to investigate if SynGAP displayed any recognisable pattern 
of subcellular localisation that could be attributed to these domains or give an 
indication of a possible function of the N and C-termini I examined localisation in a 
non-neuronal cell line.   
  





3.2.1 Overview of Results 
 
The SynGAP protein, and all its isoforms, are highly conserved between human, rat 
and mouse.  Multiple isoforms of SynGAP are expressed endogenously. 
 
Two full length SynGAP cDNA clones were isolated from a plasmid library screen; 
these were SynGAP E-alpha-1 and SynGAP A-alpha-2.  The full length SynGAP E-
alpha-1 clone has a shorter 3’ UTR than the SynGAP A-alpha-2 clone, which is 
extended due to a retained intron.  The two clones share the same polyadenylation 
signal. 
 
Further cloning of the 3’ end of SynGAP revealed that there is no absolute 
correlation between length of 3’ UTR and the isoform coding status of an mRNA 
transcript.    
 
A SynGAP B clone with a novel 4 bp insertion that is predicted to result in premature 
truncation of translation was isolated. 
 
Full length open reading frames (ORFs) of SynGAP A-alpha-1, B-alpha-1, C-alpha-1 
and A-alpha-2, B-alpha-2, C-alpha-2 were constructed and expressed successfully, 
at the predicted molecular weights in a heterologous cell line, HEK293. 
 
In HEK 293 cells overexpressed SynGAP was apparent as hollow spheroid bodies 
of varying size and unknown provenance.  Spheroid bodies were also sometimes 
present in the soma of neurons overexpressing SynGAP. 
 
3.2.2 SynGAP is conserved among species 
Multiple alignment of SynGAP sequences between species indicated that it is highly 
conserved among species (Figure 3. 2).  Between human and the rodents, rat and 
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mouse, there is 99% homology on the protein level and 92% homology on the gene 
level (see NCBI HomoloGene 84739 for additional comparisons).   There are no 
amino acid substitutions between rodents and human in the PH, C2, GAP or proline 
rich domains.  The alternatively spliced protein regions are also present unchanged 
in the rodents and human.  (The sequences shown in Figure 3. 2 are the isoforms 
present in the curated protein database UniProt which is not an exhaustive list for 
each species.)  
 
The association between N and C-termini shown here is not indicative of true 
linkage as most sequences have been compiled from overlapping clones.  The 
exceptions to this are the two clones isolated in this thesis, SynGAP E-alpha-1 and 
A-alpha-2.  The other rodent full length SynGAP clone described, SynGAP C-alpha-
1, was isolated by Kim et al. (1998) but the GenBank sequence has since been 
replace by a sequence coding for SynGAP C-alpha-2 and this is the sequence that 
appears here.  Full length SynGAP A-alpha-1 has been found in the human 
(accession number AK307888.1).  Bioinformatic analysis of the unique peptide 
regions reveals no predicted conserved domains or motif sequences apart from the 
PDZ binding domain at very C terminus of SynGAP alpha-1 (NCBI conserved 









Figure 3. 2 A multiple alignment of SynGAP protein isoforms from human, rat and 
mouse 
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Figure 3.2 A multiple alignment of SynGAP protein isoforms from human, rat and 
mouse 
All SynGAP protein sequences present in the UniProt database are aligned against the 
protein translation of the two clones, SynGAP E-alpha-1 (Mouse 1) and SynGAP A-alpha-2 
(Mouse 2) pulled from the library.  The alignment at the N and C-termini has been 
manipulated for clarity and coloured according to isoform.  The N-termini are; A (grey), B 
(blue), E (green) and C (no colour, a truncation) and the C-termini are; alpha-1 (orange), 
alpha-2 (dark blue), beta (light green) and gamma (purple).  Only one sequence per species 
is shown in the central common section.  Full homology is indicated by the solid blue 
colouring, differences are indicated by light blue (> 60 % homology) and white (< 40 % 
homology).   Protein domains are highlighted in the scale bar above the sequence.  
Homology scoring is based on the Blossum62 substitution matrix.  The accesion numbers 
are Q96PV0 (human) and Q9QUH6 (rat). 
 
 
3.2.3 Endogenous SynGAP expression 
Western blot analysis of endogenous SynGAP reveals a triplet band around 130 
kDa indicating that indeed multiple SynGAP isoforms are expressed (Figure 3. 3).  
The lower two bands, but not the upper band, of the triplet also appear when the blot 
is probed with antibodies specific to SynGAP alpha-1 and beta.    Mass 
spectrometry data indicates that SynGAPs A, B, alpha-1, alpha-2, and beta can all 
be found in the PSD (Komiyama, N, personal communication).  SynGAP C cannot 
be specifically detected as it is a truncated protein with no unique sequence. 

























Figure 3. 3 Western blot of endogenous SynGAP probed with antibodies against 
SynGAP alpha-1, beta and a common region (pan). 
Mouse cortex homogenate was stained with antibodies against a region common to all 
isoforms (pan SynGAP), SynGAP alpha-1 and SynGAP beta.  Protein bearing nitrocellulose 
lanes were cut in half and each half incubated with pan SynGAP and the C-terminal specific 
antibody.  The middle panel shows the same blot imaged using a higher intensity laser 
setting to effectively increase the exposure and allow the discrimination of the lower band in 
SynGAP beta.  Blots were also probed with anti beta actin to confirm that the two halves of 
each lane were aligned correctly.   
 
 
3.2.4 Cloning SynGAP 
In order to study the function of different SynGAP isoforms the coding sequences 
needed to be cloned.  A range of different approaches were tried in order to isolate 
full length SynGAP clones.  These included; 
 
• Full length PCR of SynGAP from cDNA derived from tissue failed repeatedly 
despite multiple attempts using a variety of primer pairs and locations.  The 
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optimisation of the thermocycling conditions, quality of cDNA template and 
specialised Taq polymerases similarly failed to produce positive results.   
• A lambda zap phage library (mouse brain large insert cDNA library, 
Clontech) was screened for SynGAP with negative results and later found to 
entirely lack SynGAP sequence.   
• A cDNA plasmid library was screened by conventional PCR and a magnet 
bound probe system (GeneTrapper, Invitrogen), both of these approaches 
were unsuccessful.  However the plasmid library was positive for SynGAP 
sequences and was successfully screened by the colony hybridisation 
technique. 
 
3.2.5 The isolation of two full length SynGAP clones 
Two full length SynGAP clones were isolated from the plasmid library colony 
hybridisation screen.  Briefly, this involved probing a library of plasmids that 
contained cDNA fragments from a mouse brain.  Large numbers of E.coli were 
exposed to relatively low numbers of plasmid such that each colony transfected 
contained only one plasmid clone.  Plates of bacterial colonies were then screened 
with a radioactive DNA probe derived from a portion of SynGAP which is present in 
all isoforms (pan SynGAP) and a SynGAP A specific region.  Two bacterial regions 
that were positive for SynGAP signal were isolated further by sequential plating and 
single colony PCR until a pure clonal population was derived.  Sequencing of the 
clones revealed them to be SynGAP E-alpha-1 (pan SynGAP probe) and SynGAP 
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Figure 3. 4 A schematic diagram of the exonic structure of two clones, SynGAP A-
alpha-2 and SynGAP E-alpha-1 isolated from a plasmid library screen. 
The exonic structure of two clones, SynGAP E-alpha-1 (upper) and SynGAP A-alpha-2 
(lower) is illustrated by boxes, intronic DNA is illustrated by a horizontal line.  Translation 
initiation codons (right angle arrows) and termination codons (straight arrows) are shown.  
Shaded boxes indicate translated sequence, unshaded boxes indicate untranslated regions.   
C-terminal alternatively present sequence is highlighted (dashed line).  For reference protein 
domains are indicated by light grey lines.  Diagram is not to scale 
 
 
SynGAP E-alpha-1 (Figure 3.1, upper) consisted of 4171 nucleotides with a coding 
sequence of 3657 nucleotides.  SynGAP E is an undescribed N-terminal isoform 
which contains 12 unique amino acids before splicing into the exon common to 
SynGAPs A and B.  Although SynGAP E is not present in the literature or online 
databases the unique E fragment has been cloned previously in our laboratory 
(personal communication, Mark Barnett).  The C terminus of this clone contains only 
one G at the G insert position, therefore is translated as SynGAP alpha-1. The clone 
is also positive for the 6 bp insert (valine lysine coding).  Translation of this clone 
would give rise to a protein of 1219 amino acids with a predicted molecular weigh of 
134 kDa. 
 
SynGAP A-alpha-2 (Figure 3. 4, lower) consisted of 5921 nucleotides, with a coding 
sequence of 3969 nucleotides.  This clone a longer ‘A’ N terminus (downstream Met, 
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beginning MSYAP) and has two Gs at the G insert position therefore is translated as 
SynGAP alpha-2.  This clone does not contain the VK insert.  Translation of this 
clone would give rise to a protein of 1323 amino acids with a predicted molecular 
weigh of 146 kDa. 
 
The two clones differed in length of the 3’ untranslated region (UTR).  The UTR of 
SynGAP A-alpha-2 was 1761 bp long from its stop codon to the polyadenylation 
signal and was an uninterrupted continuation of the same exon.  The clone was 
polyadenylated 16 bp after a canonical polyadenylation signal (aataaa).  SynGAP E-
alpha-1 had a shorter 3’UTR (454 bp after the alpha-1 stop codon, 350 bp after the 
alpha-2 stop codon) but shared the same final 116 bases, including the 
polyadenylation signal, with SynGAP A-alpha-2.   Therefore there was alternatively 
spliced 3’ UTR exon of 1414 bp that was present in the A-alpha-2  clone but absent 
in the E-alpha-1  clone.  The same long UTR, with the same polyadenylation signal 
is present in human SYNGAP (accession number of compiled sequence 
NM_006772).  The splice junctions of the short UTR do not fit the normal consensus 
splice sequence of 3’ end of intron:GU, 5’ of intron; AG, instead the sequence is 3’ 
end of intron, AG, 5’ of intron; AC.  
 
3.2.6 Association between UTR and isoform 
SynGAP alpha-1 and alpha-2 mRNA transcripts differ by only one bp which 
hampers differential detection.  If the long UTR were always associated with 
SynGAP alpha-2 transcripts and the short UTR with SynGAP alpha-1 transcripts the 
probing for these regions would facilitate differential detection.  Additionally, an 
isoform coding/UTR linkage would inform the choice of clones to use for the 
functional studies.  UTRs often contain regulatory sequences that determine the 
stability, localisation and translation of an mRNA transcript (Wilkie et al., 2003).  If 
there was a clear association between ORF and UTR it would be appropriate to use 
a clone with the endogenous UTR for expression.  However, if no linkage was 
apparent the consistent use of clones with different UTRs to express different 
isoforms could introduce experimental artefacts.       
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In order to establish if there was an association between UTR and isoform coding 
additional regions of the 3’ end of SynGAP were cloned by PCR amplification of 
cDNA.  In this group of clones there is no absolute association between the length of 
the UTR and the isoform coding status of a transcript (Figure 3. 5).  The presence of 
one or two guanines (at position 324, Figure 3. 5) determines the translation of 
alpha-1 or alpha-2 however both cases appear in clones that have long and short 
UTRs.   
 
Transcripts containing the SynGAP beta specifying 13 bp insert were also cloned.  
Each of these three clones had a long UTR but we cannot conclude that SynGAP 
beta transcripts with short UTRs do not exist.  
 
A short 3’ UTR identical to that of the original full length SynGAP E-alpha-1 (ie the 
same exon-exon boundaries) was not found again.  Instead a number of different 
shorter UTRs were present (190 – 320 bp shorter than that of SynGAP E-alpha-1).  
Three of these clones code for SynGAP alpha-1 and have a 5’ splice junction that is 
upstream of the SynGAP alpha-2 stop codon.  If this very short UTR (134 or 137 bp 
from the alpha-1 stop codon) were present in an alpha-2 clone it would lead to the 
translation of a truncated protein with a few unique amino acids, but there is no 
evidence to suggest that such a transcript does exist.  An additional two short UTR 
transcripts (alpha-2 coding) were found, both of the 5’ splice junctions are 
downstream of the stop codon.  There was also variation in the position of the 3’ 
splice junction of the short UTRs (-19 to +10 bp from the 3’ splice site of SynGAP E-
alpha-1)(Rogozin et al., 2005).    The splice junctions of these UTRs also do not fit 
the consensus splice junction sequence. 
 
In summary, there is no association between SynGAP alpha-1/alpha-2 coding status 
and the length of the 3’ UTR.   





Figure 3. 5 An alignment of the 3’ end of SynGAP cDNA transcripts 
Legend overleaf 
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Figure 3.5 An alignment of the 3’ end of SynGAP cDNA transcripts 
A multiple alignment of the 3’ end of SynGAP including clones derived by PCR from cDNA 
(clones 1-22) and the two clones isolated from the library screen, SynGAP A-alpha-2 and 
SynGAP E-alpha-1 (bottom two lines).   Highlighted are alternatively present inserts, the 6 bp 
VK insert (orange, TGA AGG), the 13 bp beta insert (green, CCC GTC CCT TCA G) and the 
alpha-1/alpha-2 determinant (red, G/GG/GGTG).  Stop codons for beta, alpha-1 and alpha-2 
are shown by coloured arrows.  Splice junctions in the UTR are indicated by teal highlighting.   
The sequence is abridged for brevity (boxed region 740 – 2020 is omitted).   Horizontal 
arrows indicate primer positions. The polyadenylation signal (aataaa) is boxed in red. 
 
 
3.2.7 Construction of a range of SynGAP variants 
A range of SynGAP variants were constructed from the two clones described above.  
Initially SynGAP A-alpha-1 was constructed by cutting the N terminus from the 
SynGAP E-alpha-1 clone and replacing it with the N terminus that had been cut from 
the SynGAP A-alpha-2 clone.  Despite multiple attempts SynGAP E failed to ligate 
to the alpha-2 3’ region.  Coding sequence for the N-termini was not isolated from 
the library, SynGAPs B and C, was cloned by PCR from cDNA derived from mouse 
brain.  By PCR restriction enzyme cleavage sites were added to these SynGAP B 
and C fragments which facilitated their replacement of SynGAP A in full length 
SynGAP alpha-1 and alpha-2 constructs. 
 
 As I found that there was no strict association between C-terminal isoform coding 
and the length of 3’ UTR I felt it was necessary to remove the different length UTRs 
from SynGAP alpha-1 and alpha-2 in order to avoid any potential confounding 
effects, for example, on expression level.  Due to a lack of suitable restriction 
enzyme cleavage sites within the UTR the coding regions of all 6 clones were 
amplified by PCR.  Restriction enzyme cleavage sites were added to the primers to 
facilitate the subcloning of the genes into a different expression vector, also under 
the control of the CMV promoter. Subcloning into the eGFP-C1 vector, to create 
SynGAP fusion proteins, was done in parallel with subcloning into the same vector 
from which GFP had been removed (henceforth the CMV backbone).  Despite 
apparently successful confirmation digests and sequencing, the eGFP fusion 
Chapter Three   
 
108 
proteins did not express SynGAP protein (data not shown).  Untagged SynGAP 
proteins did express correctly (Figure 3. 8). 
 
3.2.8 SynGAP B-shift 
During the cloning of SynGAP B fragments a novel form of SynGAP was found 
(Figure 3. 6).  This B isoform is identical to the normal B coding region except for the 
addition of 4 base pairs at the 3’ end of the second B specific exon.   These four 
base pairs lead to a frameshift in the open reading frame which terminates in a 
premature stop codon.  This 92 amino acid fragment would include 53 novel 
residues not present in canonical SynGAPs We termed this putative truncated 
fragment SynGAP B-shift.  Two clones encoding SynGAP B-shift were found from 
two separate experiments. We do not know if this fragment is expressed as there 
are no antibodies against any region within the peptide. However, the entire length 
of the coding region for SynGAP B-shift is 5’ of the insertion site of the deletion 
cassette in the knock out animal used in this thesis.  It is conceivable therefore that 
SynGAP B-shift may be expressed in the SynGAP -/- mouse.  SynGAP B-shift (B 
with the 4bp insertion with the alpha-1 3’ end) was subcloned in the same manner 
as the other full length clones described above. 




M   G   L   R   P   P   T   P   T   P   S   G   G   S 
ATG GGC TTA AGG CCT CCC ACC CCG ACC CCG TCA GGG GGC TCC
G   S   G   S   L   P   P   P   S   H   R   Q   P   L 
GGC TCA GGT TCC TTG CCC CCT CCT TCC CAC CGC CAG CCT CTC
R   R   R   C   S   S   C   C   F   P   G   G   R   I 
CGC CGC CGC TGC TCT TCT TGC TGC TTT CCG GGG G GTAG A ATA
P   L   G   S   L   E   E   E   E   C   P   R   G   E 
CCA CTT GGG TCG CTC GAG GAG GAA GAG TGT CCC AGG GGG GAA
T   V   Q   H   G   G   R   P   R   C   A   L   P   A 
ACA GTA CAG CAT GGA GGC CGC CCC CGC TGC GCC CTT CCG GCC
L   A   R   L   P   E   P   E   A   K   K   L   Y   Q 
CTC GCA AGG CTT CCT GAG CCG GAG GCT AAA AAG CTC TAT CAA
T   Y   K   V   T   T   Q   T   *




Figure 3. 6  Truncation of SynGAP B by a 4bp insertion 
The nucleotide sequence, from the initiation codon, of SynGAP B with a novel 4bp insertion 
(highlighted in red).  The canonical SynGAP B amino acid sequence is highlighted in blue 
until the frameshift which results in non-canonical SynGAP B sequence (highlighted in grey).  




3.2.9 An updated view of the exonic structure of the SynGAP 
gene 
An updated view of the exonic structure of the SynGAP gene including the data 
presented here is given in Figure 3. 7.  The alternatively spliced 3’ UTR region is 
indicated.  The position of the 4bp insertion which could give rise to SynGAP B-shift 
is also shown.  An additional isoform that contains the first A specific exon but lacks 
next two A specific exons, including the A translation start codon, is shown as 
SynGAP F.  SynGAP F was found by PCR during attempts to clone full length 
SynGAP.  This isoform contains an open reading frame that begins at the next 
methionine downstream from the second (canonical) A start codon and would be 
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translated as slightly truncated version of this protein (7 amino acids shorter than the 
SynGAP A clone pulled from the library screen). 
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Figure 3. 7  An updated schematic diagram of the exonic structure of the SynGAP gene. 
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Figure 3. 7 An updated schematic diagram of the exonic structure of the SynGAP 
gene. 
The full exonic structure of the SynGAP gene is given in the upper panel with new variants of 
SynGAP transcript in the lower panel. This figure complements Fig x in the introductions 
which includes all previously described SynGAP variants.  3’ regions are included to illustrate 
alternative UTR splicing. Exons are illustrated by boxes (shaded indicates translated regions, 
unshaded indicates untranslated regions) and intronic DNA is illustrated by a horizontal line. 
Isoform specific UTR is indicated by a lower case letter within the box.  Alternatively present 
sequence is highlighted with dashed lines.  Where divergence occurs at the same locus the 
different possible outcomes are shown above and below the midline.  Diagram is not to 
scale. 
 
3.2.10 Confirmation of expression of SynGAP isoforms in 
transfected cells 
In order to confirm that the constructed SynGAP isoforms had been built correctly 
and were capable of being expressed I transfected cells of a heterologous line (HEK 
293) with equal amounts of SynGAP plasmid DNA. Enhanced green fluorescent 
protein (eGFP) was used as a cotransfection marker. Cell lysates were analysed by 
western blot using an antibody against the central domain of SynGAP that 
recognises all canonical isoforms (pan SynGAP) (Figure 3. 8).  HEK 293 cells do not 
express endogenous SynGAP protein as was confirmed by the lack of signal from 
cells expressing eGFP only.  All isoforms yielded strong signal at the approximate 
predicted molecular weight (~135 kDa, expected molecular weights are given in the 
figure legend).  Differences between the weights of the isoforms were also evident; 
SynGAP alpha-2 isoforms were consistently heavier than the alpha-1 isoforms of the 
same N-terminal.  N-terminal differences were also apparent, SynGAP A appeared 
slightly heavier than B while both were considerable heavier than C.  This indicated 
that all isoforms were expressed as expected.  SynGAP B-shift was also transfected 




















































Figure 3. 8 Transfected SynGAP isoforms are expressed at the expected 
molecular weights in HEK 293 cells 
A western blot of HEK 293 cells transfected with eGFP and various SynGAP isoforms 
probed with an antibody that recognises all forms of SynGAP (pan SynGAP), beta actin and 
eGFP.  The expected molecular weights are; SynGAP A-alpha-1, 142 kDa, 1309 aa; 
SynGAP A-alpha-2, 146 kDa, 1323 aa; SynGAP B-alpha-1, 137 kDa, 1248 aa; SynGAP B-





Expression levels of the isoforms, relative to beta actin and eGFP, were also 
calculated by fluorescence densitometry.  No statistically significant differences were 
found by one way ANOVA, data not shown (n = 3).  The appearance of bands at 
lower molecular weights is likely to be due to SynGAP degradation products rather 
than non-specific binding of the antibody (no bands appear when GFP only is 





Overexpressed SynGAP forms spheroid bodies 
In neurons SynGAP is localised mainly at the synapse where its interaction with a 
number of PSD proteins is thought to be mediated by its C terminus.  In order to 
examine the localisation determination of the protein domains of SynGAP, excluding 
its interaction with the PSD, I transfected cells of a non-neuronal line (HEK 293) with 
SynGAP.  HEK 293 cells do not express endogenous SynGAP or synaptic proteins 
(data not shown) thus the localisation of SynGAP in this context may be determined 
by protein/membrane interactions not specific to neurons.  Surprisingly SynGAP 
forms cytoplasmic spheroid bodies when overexpressed in HEK 293 cells  
Figure 3. 9, d - f).  These bodies are remarkably sphere like and occur in different 
sizes throughout a given cell.  They appear to consist of a membrane vesicle the 
inside of which is hollow.  These bodies can also be seen as round or ring like 
deformations on the surface of cells when viewed by differential interference 
microscopy (DiC) (Figure 3.9, g-i).  Spheroid bodies can also occur in the soma, but 
not the dendrites, of neurons when SynGAP is overexpressed (Figure 3.9, a-c).  
They are not apparent in GFP only expressing cells (not shown). 
 
In order to determine what the spheroid bodies were I coexpressed SynGAP with a 
number of subcellular markers.  The spheroid bodies did not express markers of the 
endoplasmic reticulum, golgi apparatus or lysosome (Figure 3. 10, a-f).  A marker of 
the stress related proteolytic organelle, the autophagosome, was expressed 
throughout the cytoplasm, as would be expected for an unstressed cell.  There was 
some indication that this marker was slightly enriched within spheroid bodies but this 
was not clear (Figure 3. 10, g,h).  SynGAP can regulate turnover of the actin 
cytoskeleton in neurons and another synaptic GAP, SPAR, has been shown to 
reorganise the actin cytoskeleton in heterologous cells (Pak et al., 2001; Carlisle et 
al., 2008).   However the expression of SynGAP did not have any obvious effect on 








Figure 3. 9 SynGAP forms spheroid bodies when overexpressed in cells 
When SynGAP is overexpressed in cells (SynGAP -/- neurons, a-c, and HEK 293, d-i) and 
detected by immunocytochemistry it appears as spheroid bodies in the somatic cytosol.  D,e 
and f show the spheroid bodies of one HEK cell, outlined by a dotted line in the z projection 
(d) and a single optical slice (e) and volume rendered in (f).  Differential interference 
microscopy (DiC) allows the visualisation of the features on the surface of cells where the 





Figure 3. 10 SynGAP spheroid bodies do not colocalise with markers of 
endoplasmic reticulum, Golgi apparatus, endosome, autophagosome or F-actin. 
An example of the localisation of each marker in the absence of SynGAP is shown in the left 
most panel (a, c, e, g, i).  Cells coexpressing SynGAP and markers for endoplasmic 
reticulum (b, ER), Golgi apparatus (d), endosome (f), autophagosome (h) and actin (j) are 
shown on the right.  The nucleus (DAPI) is also shown with the Golgi apparatus in (c) to 
highlight its perinuclear localisation.  The scale bar for a - g is 5 µm and for h - j is 15 µm.  




The initial aim of the work of this chapter was to clone and construct SynGAP 
variants for expression.  This was accomplished and during this process novel 
SynGAP transcripts were found and an unexpected pattern of localisation was 
encountered when SynGAP was expressed in a heterologous cell line.   
 
The identification of an alternatively spliced transcript does not prove that it is 
functionally relevant. Besides its abundance relative to other products from the 
gene, one indication of the functional significance of an mRNA variant is 
evolutionary conservation.  Many important splicing changes are highly conserved 
across mammals or vertebrate species.  The presence of all the previously 
described isoforms8 in human and the mouse and rat indicates that they may have 
some functional role (Figure 3. 2).   The presence of a transcript also does not 
guarantee its translation or stability however the finding of all the unique peptide 
sequences at the synapse confirms their existence in protein form.    
 
Is SynGAP unusual in its complexity? 
There are many reports of extraordinarily complex alternative splicing; the classic  
spectacular example used to illustrate this are the DSCAMs (Drosophila 
melanogaster gene Down syndrome cell adhesion molecules), which can generate 
38,016 distinct mRNA isoforms, a number far in excess of the total number of genes 
(~14,500) in the organism (Schmucker et al., 2000).  DSCAMs are thought to 
provide the molecular basis of axonal pathfinding self-avoidance and the innervation 
of non overlapping synaptic fields (Hattori et al., 2008).  The KCNMA1 pre-mRNA 
contains multiple alternative 5’ splice sites, alternative 3’ splice sites and sequence 
corresponding to cassette exons. Together, these allow more than 500 mRNA 
isoforms to be synthesized from a single pre-mRNA (Nilsen & Graveley)  A less 
terrifying, and more familiar, example of complexity comes in the form of Kalirin, a 
brain specific Rho GEF that has at least 3 alternative promoters and 3 alternatively 
spliced 3’ termini.  It is known that all possible exonal combination of mRNA are 
present (McPherson et al., 2002, 2004).   
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Consensus estimates of alternative splicing frequency in the human genome have 
rapidly expanded from an estimate of 5% of genes in the mid-1990s.  Now, new 
high-throughput sequencing technology has revealed that > 90% of human genes 
undergo alternative splicing  — a much higher percentage than anticipated (Wang et 
al., 2008).  As elucidation of alternative splicing events continues apace perhaps it 
will become apparent that the level of complexity of SynGAP is, rather than being 
unusual, the norm. 
 
cis connectivity of exons (or which N-terminus with which C-terminus 
?) 
The cloning of two full length cDNA clones in this thesis brings to four the number of 
known linkages between SynGAP N- and C-termini.  To reiterate, these are 
SynGAP A-alpha-2 and E-alpha-1 (this thesis, mouse), C-alpha-1 (Kim et al., 1998) 
and A-alpha-1 (accession number AK307888.1, human).   
 
Questions arise that are not addressed experimentally in this thesis but inform the 
interpretation of the data that is presented here.  Is there specificity in the linkage of 
N- and C-termini, or like Kalirin, can all N-termini be coupled to all C-termini?  How 
can we determine what N-termini are linked to what C-termini?  How might such 
associations be mediated?  Does the linkage between N- and C-termini matter?  I 
will discuss these questions in reverse order. 
 
Does the linkage between N and C-termini matter?  Presumably it does. The 
differential regulation of 5’ variants combined with the proven functional relevance of 
the C-termini indicates that the different ends of the protein do have roles to play.   
The appearance of three discrete bands on a Western blot when endogenous 
SynGAP is probed by a common antibody suggests there are certain isoforms that 
are predominantly expressed.  However, it is impossible to predict which isoforms 
these bands correspond because the molecular weights of the different potential 
isoforms are too close to be resolved.  Additionally, SynGAP can be extensively 
phosphorylated (Dosemeci & Jaffe, ; Oh et al., 2004) and may be subject to other 




How might such linkage be mediated?  As mentioned in the introduction there has 
been accumulating evidence showing that RNA transcription can be coupled to 
splicing regulation (Batsche et al., 2006; Moldon et al., 2008; Chen & Manley, 2009), 
references 18-22 in Chen).  Two models have been proposed to explain this 
coupling.   
For transcription to initiate at a particular site on genomic DNA a host of transcription 
factors and accessory proteins need to mediate the recruitment of RNA polymerase 
II.  The first model is known as the recruitment model, in which the transcription 
machinery, RNA polymerase II (RNApol II) and the transcription factors, interact 
either directly or indirectly with splicing factors and alter the efficacy of splicing.   For 
example PGC1, a transcription co-activator that is recruited to target genes by 
specific transcription factors, can modulate alternative splicing by interacting with 
other splicing factors and the elongating form of RNAPol II (Monsalve et al., 2000)  
Importantly, the ability of PGC-1 to function in RNA processing appears to require its 
prior entry into a transcriptional initiation complex.  
 
The second, kinetic model posits that the regulation of alternative splicing depends 
not only on the interaction of splicing protein factors with splicing regulatory 
elements in the pre-mRNA, but also on the rate and pausing of transcriptional 
elongation (Chen & Manley, 2009).  In this model the rate of elongation influences 
the time window within which the splicing machinery has to assemble.  In support of 
this model a slowly elongating RNAPol II was found to greatly enhance the inclusion 
of an alternate exon with weak splice sites (de la Mata et al., 2003).  The rate of 
elongation can itself be determined in part by the rate of initiation which is influenced 
by the strength of the promoter thus linking 5’ initiation events to more downstream 
splicing choices (Epshtein & Nudler, 2003).   
 
Therefore it could be possible that alternative promoters could lead to different 
splicing patterns  (Kornblihtt, 2005).  Interestingly some authors have observed that 
genes with alternative promoters tend to demonstrate more alternative splicing 
compared to genes with a single promoter, and genes with more alternative 
promoters tend to have more alternative splicing variants. Furthermore transcripts 
from different alternative promoters tend to splice differently (Xin et al., 2008).  An 
association between the use of different transcription start sites with the inclusion of 
specific cassette exons has also been established bioinformatically (Chern et al., 
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2008).  It is possible that internal splicing variants are the consequence of important 
changes in pre-mRNA secondary structure resulting from different first exon 
sequences.  Whether such mechanisms could have an effect over considerable 
distances is unclear (in the case of SynGAP up to 6 kb in the mature mRNA).   
Furthermore, most of the evidence regarding the link between transcription and 
splicing regards cassette exons.  It remains to be seen what happens with 
alternative splice site choice, especially of only a few base pairs difference as is the 
case with SynGAP, in vivo. 
 
How then can we determine which N-termini are linked to which C-termini?   
Exhaustive screening and cloning from full length cDNA libraries would inform us of 
exon combinations that do exist.  However, partly due to potential PCR bias, such a 
technique is not quantitative and we could not make any conclusions regarding 
abundance.  More importantly we could not conclude that because a certain 
combination was not cloned that it does not exist.  Furthermore, the disadvantages 
of costliness and time intensiveness should not be overlooked if quantitatively 
reliable data is not a potential outcome.  
 
High throughput second generation sequencing has massively increased our 
knowledge of the complexity of the transcriptome, but due to the short nature of the 
sequencing reads produced cannot inform us of the long range connectivity between 
exons (Sultan et al., 2008).  Sequencing reads of second generation sequencing are 
generally very short (35-100 bp) where conventional Sanger di-deoxy sequencing 
reads give a maximum of about 800bp.  Clearly reads of this length are no use in 
determining linkage of sequences separated by thousands of bases. 
 
The new technology of paired end reads, which produces short reads from both 
ends of a long fragment of DNA, could potentially provide the type of information we 
require.  Currently the focus in the development of this technology is on genome 
sequencing, specifically in determining long-range positional information, de novo 
assembly and structural variations such as chromosomal rearrangements and copy 
number variations.  RNA paired end tag (RNA-PET) libraries have been constructed 
from full length cDNA libraries; these consist of the first few bases of a transcript 
linked to the last few bases.  This technology is ideal for demarcating the first exon 
(transcription start site) in combination with the last (polyadenylation site), however it 
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cannot yield sequence from the interior of the transcript that we require (Fullwood et 
al., 2009). 
 
A less direct strategy would be to attempt to assess if the regulation, in response to 
synaptic activity and in development, of specific 3’ ends mirrors that of the 5’ ends.  
If this was the case we could infer connectivity, but this would not be conclusive 
evidence.  Difficulties again arise regarding the difficulty of detection of 1 and 2 bp 
changes, even 13 bp is challenging.  Lately a SynGAP alpha-2 antibody has 
become available so the proteins levels of SynGAPs alpha-1, alpha-2 and beta 
could be correlated with the transcript levels of SynGAPs A, B, C and E.  Again, this 
is not ideal as transcript levels do not necessarily correlate with protein expression. 
 
Immunoprecipitation using isoform specific antibodies followed by mass 
spectrometric analysis would allow the identification of linkage between isoforms 
with unique peptide sequence (i.e. not SynGAP C).  Clearly, the generation of 
antibodies specific to all the unique peptide sequences would be enormously useful. 
 
The choice of isoforms for further study 
As we do not know if there is specificity in the linkage of N and C-termini the choice 
of isoforms for use in the functional experiments of this thesis was determined by a 
number of factors.  The previously demonstrated importance of the C-terminal 
alpha-1 tail guaranteed its inclusion and the differential regulation of SynGAPs A, B 
and C merited further study.  SynGAP alpha-2 was used as a C-terminal tail whose 
synaptic function had not been studied, and which we isolated form the library 
screen.  SynGAP E was not carried forwards for functional study as it does not 
exhibit differential regulation in development and in response to synaptic regulation.  
Additionally the number of isoforms needed to be limited for practical time 
considerations.  The remaining isoforms may be  studied in future. 
 
UTR            
The discovery of two alternately spliced sections of 3’ UTR in the initial library 
screen derived clones posed some questions and offered some hope of a potential 




UTR, especially 3’ UTR, is heavily involved in mediating the trafficking, stability and 
translation of mRNAs.  This can be mediated by non mutually exclusive cis 
regulatory elements, that is sequence determined structural features like secondary 
structure, and trans acting elements in the form of proteins or miRNAs that bind to 
those regions (Wilkie et al., 2003).   Thus, alternative UTRs could provide a 
mechanism of differential regulation of different isoforms.  Isoform specific regulation 
could only be the case if there was an absolute linkage between ORF and UTR.  
This question was partially addressed experimentally and it appears that there is not 
a definite correlation between isoform coding and the length of 3’ UTR (Figure 3. 5).   
The purpose in further analysing the 3’ end was not to comprehensively screen for 
all possible UTRs but rather to resolve a specific question that had bearing on the 
future expression of SynGAP.   The experiment performed was not exhaustive and 
merely tells us some of the combinations of alternative splicing.  Additionally the 
data set has to be biased, due to the choice of certain primer pairs, as well as PCR 
and cloning bias.  The use of an oligo-dT reverse primer would go some way to 
rectifying the primer induced bias. 
 
The finding of a range of different splice sites within the 3’ UTR is puzzling but, given 
the extensive variability of 3’ end of SynGAP, not entirely unexpected.  The splice 
junctions do not observe the consensus splice site recognition sequences, 
particularly the especially conserved AG dinucleotide at the 3’ splice site (GT/AG) 
(Ast, 2004; Rogozin et al., 2005).   These type of alternatively spliced non 
conventional transcripts at the 3’ end of SynGAP have been cloned previously in our 
lab (Mark Barnett, Patrick Stoney, personal communication).  The presence of non-
conventional splicing junctions in the SynGAP E-alpha-1 clone isolated from the 
library screen indicates that these types of clones are not necessarily an artefact 
somehow introduced by PCR.  There are reports in the literature of non-
conventional alternative splicing. The unfolded protein response mediates the non 
spliceosomal splicing of a limited number of genes (Ma & Hendershot, 2001) and 
there is a second spliceosome that mediates a different type of non-conventional 
splicing of a rare class of introns more common in metazoan (Patel & Steitz, 2003).  
However the SynGAP transcripts do not contain the consensus sequences or splice 
junctions described for either of this two mechanisms.  This aspect of the SynGAP 




SynGAP B-shift  
The isolation of a number of clones with a novel 4 bp insertion at the start/end of a 
SynGAP B specific exon adds to SynGAP’s repertoire of alternative splice site 
selection variants.  This one, if translated, would give rise to a truncated peptide. It is 
possible that a truncated SynGAP peptide could have some functional role.  While 
we have no evidence translation occurs, a concern that the transcript could be 
present in the SynGAP -/- mouse used in this thesis prompted the further study of 
what we term SynGAP B-shift.  This experiment is described in Chapter Four. 
 
Another possibility is that SynGAP B-shift transcript may be degraded in a regulatory 
mechanism known as nonsense mediated decay (NMD).  NMD is a recently 
discovered surveillance mechanism against transcripts that contain exon−exon 
junctions downstream of a termination codon (Lejeune & Maquat, 2005).  NMD is 
thought to have evolved to select mRNAs with an intact reading frame from a pool of 
splice combinations generated by the splicing machinery.  Indeed, a large-scale 
computational study demonstrated that as much as one-third of mRNA transcripts 
may be subject to NMD.  Combined with the ‘noisy splicing’ view, which supposes 
that splicing is inherently noisy and spurious transcripts are common, it is suggested 
that RUST (regulated unproductive splicing and translation) is one of the major 
regulatory mechanisms for establishing the right level of gene expression (Green et 
al., 2003)(Lewis et al., 2003; Zhang et al., 2009).  If this view is correct SynGAP B-
shift could be one of many transcripts destined for degradation. 
 
Spheroid bodies 
The appearance of spherical bodies enriched in SynGAP in transfected HEK cells is 
surprising ( 
Figure 3. 9). Morphologically the bodies do not appear to be like any normal cellular 
organelle.  This is supported by patterns of expression patterns of a number of 
organellar markers (Figure 3. 10).   Clearly these bodies are an artefact of 
overexpression as they are not present in wild type neurons probed with an antibody 





The first point to take from this localisation is that the PH and C2 domains were not 
sufficient to mediated translocation to the plasma membrane.  It is possible that the 
protein might translocate if the cells were stimulated to release intracellular stores of 
Ca, as in the case of CAPRI and RASAL (Liu et al., 2005).  SynGAP also had no 
effect on the actin cytoskeleton of the cells despite a previously demonstrated role in 
the neuronal regulation of the actin depolymerising protein cofilin (Carlisle et al., 
2008).  One could postulate that other synaptic proteins are required to mediate this 
activity, or that, again stimulation is required.   
 
The spheroid bodies appear to be hollow membranous vesicles, perhaps implicating 
the potentially membrane interacting PH and C2 domains (although these normally 
associate with plasma membranes).  Incubation with FM dyes would allow the 
assessment of whether or not these inclusions arise from the plasma membrane 
(Cochilla et al., 1999).  The C2 domain has been demonstrated to have a role in 
membrane bending (see main introduction, p46).  Membrane bending proteins 
usually bend membranes to a specific geometry and it is unlikely that the large 
variety in vesicle seen here would be caused.  
 
Fairly equal distribution of bodies throughout the soma and the apparent health of 
associated nuclei suggests that they are not fragmenting Golgi apparatus ( 
Figure 3. 9, d-f,).  The Golgi marker used, which does not co-localise with the 
spheroid bodies, is for the trans-medial Golgi and thus will not be expressed in all 
Golgi compartments (Figure 3. 10, c,d).  Therefore, it might be useful to use 
additional Golgi markers to conclusively exclude the possibility of fragmented Golgi.  
When stressed mitochondria can swell, or balloon, into more rounded structures 
than their normal elongated shape (Rintoul et al., 2003).  Although the extreme 
spherical nature of the SynGAP bodies combined with the variability in size, 
including very large structures, indicates that they are not stressed mitochondria, I 
cannot exclude this definitively until I co-stain with a mitochondrial marker.   
 
The spheroid bodies are reminiscent of the enlarged endosomes caused by 
expression of a constitutively active forms of Rab5 and RabD (Roberts et al., 2000; 
Li & Liang, 2001; Harris & Cardelli, 2002).  Rab is considered to be a rather local 
switch that controls specific membrane fusion events during endocytosis (Tall et al., 
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2001; Ng & Tang, 2008).  The enlarged vesicles in these cells are due to excessive 
early endosomal fusion.  The endosomal marker used in Figure 3. 10 (e,f) is RhoB 
which is restricted to the late, degradative pathway and does not co-localise with 
early endosomal markers (Wherlock et al., 2004).  For this reason we would not 
expect RhoB to mark these spheroid bodies if they were enlarged early endosomes.  
A more comprehensive experiment would make use of an expanded range of 
endosomal markers such as EEA1 or fluorescent-labelled transferrin to saturate the 
early and recycling endocytic compartments, CD63 for late endosomes and LAMP-1 
for late endosomes/lysosomes.  
 
 
In addition to the multiple studies that indicate an ability of SynGAP to regulate Ras 
and Rap, one study has demonstrated an in vitro Rab5 GAP activity of the isolated 
GAP domain of SynGAP (Tomoda et al., 2004).  If SynGAP is deactivating Rab in 
these cells the presence of enlarged endosomes is even more surprising.  The Rab 
mutants mentioned above are constitutively active but the presence of SynGAP 
should mediate the inactivation of Rab5 (inactive mutants of Rab5 do not cause 
enlarged endosomes).   
 
To continue speculating, it is worth noting that one major pathway for controlling the 
abundance of synaptic AMPA receptors is local endocytic recycling.  Activity-
dependent translocation of recycling endosomes (REs) into spines is required to 
supply a mobilizable pool of AMPA receptors to synapses during long-term synaptic 
plasticity (Ehlers, 2000; Park et al., 2006).  It has been shown that Rab5 activation 
drives the specific internalization of synaptic AMPA receptors in a clathrin-
dependent manner and that this activity is required for NMDA receptor dependent 
LTD. (Brown et al., 2005).  If SynGAP has a role in regulating Rab mediated 
endosomal trafficking this may be the mechanism by which it exerts its effect on 
altered AMPA receptor trafficking. 
 
To summarise, SynGAP is a highly conserved protein of high molecular complexity.  
A number of differenti isoforms are expressed endogenously, as is evident by 
Western Blot analysis, but the precise identity of the combinations of N and C 
termini are not known.  We have cloned two full length isoforms (SynGAP A-alpha-2 
and E-alpha-1) and used these to construct a range of isoforms (A, B, C combined 
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with alpha-1 and alpha-2) to be used in the assays in the remainder of this thesis.  
Additionally, we have shown that there are many different lengths of SynGAP 3’ 
UTR exist but that there is no absolute linkage between UTR identity and C terminus 
coding ability.  The potential existence of a truncated SynGAP, SynGAP B shift, was 
examined and discussed, as was the appearance of anamolous SynGAP enriched 










This chapter is concerned with the morphological implications of altering SynGAP 
expression.  SynGAP is found in abundance at excitatory synapses, which are 
located primarily on small protrusions called dendritic spines.  The main objective of 
this chapter was to first examine the effect of the removal of all SynGAP isoforms on 
dendritic spine morphology.  Second, to determine if spine morphology would be 
differentially affected by the overexpression of particular isoforms of SynGAP. 
 
Dendritic spine morphology is tightly regulated as it plays a major role in the 
functional development and plasticity of synapses.  Spines are thought to provide 
biochemical as well as electrical signalling compartmentalisation and are present in 
many shapes and sizes (Nimchinsky et al., 2004; Noguchi et al., 2005).  Broadly 
spines can be categorised as; mushroom, a protrusion with a clearly defined neck 
supporting a larger head; stubby, a short protrusion lacking neck/head definition; 
and thin, a thinner protrusion again lacking neck/head definition (Peters & 
Kaiserman-Abramof, 1970).  Longer thin protrusions are classified as filopodia which 
are probably the precursors to spines (Vaughn, 1989; Fiala et al., 1998).  Greater 
diversity is conferred by variations in spine head size and shape, from spherical, 
oval and cup to irregularly shaped heads.  Spine necks can be thin or thick, bent or 
straight, branch or unbranched.  Spines are highly dynamic structures which can 
shift shape over the course of seconds to minutes (Dailey & Smith, 1996; Fischer et 
al., 1998; Dunaevsky et al., 1999). 
 
The dynamic nature of spines is key to their functional role in plasticity and 
development (Bonhoeffer & Yuste, 2002; Holtmaat & Svoboda, 2009).  The most 
mobile protrusions are the filopodia which seem to continually extend and retract, 
before becoming more stable when they partner with a presynaptic terminal to form 
a synapse.  Mushroom spines are the most stable form of protrusion, and although 
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some are present only transiently, they can persist for months and potentially the 
lifetime of an animal (Grutzendler et al., 2002; Trachtenberg et al., 2002; Zuo et al., 
2005).  There is a strong correlation between the strength of a synapse and the 
spine head size, thought to be due to the high levels of AMPA receptors found in the 
PSD of larger spines (Matsuzaki et al., 2001; Kasai et al., 2003).   LTP and 
experience dependant plasticity can induce the formation of new spines and the 
transition of thin spines to mushroom type.  The reverse is true for LTD (Nagerl et 
al., 2004; Okamoto et al., 2004; Hofer et al., 2009).  Interestingly the correlation of 
spine structure with function is not clear cut and can be decorrelated in many cases 
(Ehrlich & Malinow, 2004; Kopec et al., 2007; Wang et al., 2007).  Wang et al. 
demonstrate several conditions in which spine size is unrelated to trafficking of 
AMPA receptors and that NMDAR-LTD and spine shrinkage diverge in the 
downstream signalling events, and can occur independently of each other. 
 
As mentioned, spines are regulated by multiple parallel pathways that seem to 
converge on two mechanistic cellular processes; the trafficking of post synaptic 
proteins and the regulation of actin dynamics.  Larger spines contain greater 
amounts of PSD proteins and the insertion of additional plasma membrane with the 
fusion of trafficking endosomes also contributes to the increase in size (Harris & 
Stevens, 1988; Park et al., 2006).  With an eye to SynGAP it is worth noting that 
many small G proteins, and their regulators, have been implicated in spine 
morphology regulation.  Rap1, Rap2, Rnd1, Rac, Cdc42 and especially Rho and 
Ras have all been found to alter spine morphology or density (Pak et al., 2001; 
Ishikawa et al., 2003; Xie et al., 2005; Xie et al., 2007).  Actin polymerisation and 
depolymerisation plays a major part of the physical mechanism by which spines 
change shape and can be regulated by the Rho/Rac/Cdc42 family of G proteins 
(Fischer et al., 1998).    
 
Altered actin regulatory networks have been observed in a SynGAP -/- mouse 
(Carlisle et al., 2008).  Vasquez et al.  (2004) find an enlargement of spine heads in 
SynGAP -/-  hippocampal neurons at day in vitro (DIV) 14, cultured in the absence of 
FBS.  They also find an increase in spine density.  Hippocampi of adult SynGAP +/- 
animals also have the same prematurely developed spine heads (Carlisle et al., 
2008).  Rumbaugh et al. (2006) do not directly examine spine morphology, but find 
an increase in ‘synapse cluster size’, but not density.  The impact of the 
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overexpression of different SynGAP isoforms on spine morphology has not been 
assessed.  Expression of SynGAP A-alpha-1 in SynGAP -/- neurons is sufficient to 
rescue the enlarged spine head phenotype observed by Vazquez et al.  Mutation of 
the PDZ binding domain removes the ability of SynGAP A-alpha-1 to rescue the 
spine phenotype while a GAP domain mutant retains the ability to rescue some 
elements of the phenotype, namely premature synaptic clustering of PSD-95.  
These findings suggest that SynGAP and its various domains influence spine 
formation by distinct but overlapping mechanisms.   Here I will further this work by 
describing the SynGAP -/- spine phenotype which had not yet been examined in this 
mouse model, and address for the first time the effects and dendritic localisation of 






Part One:   




Morphological analysis of dendritic protrusions of wild type cells overexpressing 





4.2.1 Overview of Results 
 
Part One: Morphological analysis of dendritic protrusions of wild type and 
SynGAP -/- neurons. 
 
It is possible to maintain viable SynGAP -/- neurons in culture and, by transfecting 
them with enhanced green fluorescence protein (eGFP), visualise their morphology.  
 
In both cortical and hippocampal cultures, mean dendritic protrusion length and 
width is unchanged in SynGAP -/- compared to wild type neurons.  Dendritic 
protrusion density is mostly unchanged, however there is a significant increase in 
protrusion density in SynGAP -/- cortical neurons at DIV 10.  
 
Despite a lack of difference in the means there are changes in the distributions of 
measurements; there is a shift toward shorter spines in SynGAP -/- cortical and 
hippocampal neurons.  This difference is not observed in hippocampal neurons 
when they are cultured in the absence of FBS. 
 
In the presence of FBS, the distributions of protrusion widths in SynGAP -/- cortical 
neurons, but not hippocamapal neurons, is shifted toward thinner heads (cultured 
with FBS).  When hippocampal neurons are cultured without FBS the distribution is 
shifted in the other direction, toward thicker heads. 
 
Insights into protrusion development in culture include the observation that, 
compared to hippocampal neurons, the protrusions of cortical cells are very sparse 
at DIV 10 but treble in density by DIV14.  While the protrusion density of 
hippocampal cells stays constant over this time period the width of the protrusion 
heads does increase. 
 
The main effect of the removal of FBS from the culture protocol is a decrease in 






Part Two: Morphology of neurons overexpressing various SynGAP 
isoforms. 
 
Overexpression of SynGAP isoforms A-alpha-1, B-alpha-1 or A-alpha-2 in wild type 
neurons does not affect the mean protrusion length, width or density of dendritic 
protrusion. 
 
All isoforms have the same effect on the distribution of protrusion lengths; a shift 
toward shorter protrusions.   In contrast, the effect of isoforms on the distribution of 
protrusion widths diverges; overexpression of SynGAPs A and B-alpha-1 cause a 
decrease in prevalence of the thinnest and the widest heads while SynGAP A-alpha-
2 has no effect. 
   
There is divergence in the dendritic localisation patterns of overexpressed SynGAPs 











4.2.2 Part One:  Morphological analysis of dendritic 
protrusions of wild type and SynGAP -/- neurons. 
 
Viable neurons can be maintained in culture 
The experimental system of this thesis is dissociated neuronal culture.  The 
hippocampus or cortex is dissected from 17.5 day old embryos (E17.5) derived from 
timed matings.  The tissue is enzymatically treated and mechanically dissociated.  
Viable neurons are counted in a haemocytometer and plated at high density (1500 
cells/mm2) or low density (200 cells/mm2).  See Methods (p51) for additional details.  
Upon plating very few cell bodies had short appendages but most neurons had 
grown visible neurites the day after plating.  One week after plating a network of 
neurons was easily recognisable.  A glial layer was visible through breaks in the 
network when the neurons were cultured in the presence of foetal bovine serum 
(FBS).   
 
4.2.3 Neuronal morphology can be visualised by filling cells with 
green fluorescent protein 
Neurons were transfected with enhanced green fluorescent protein (eGFP) using a 
proprietary liposome based system (Lipofectamine 2000, Invitrogen).  For the 
purposes of morphological analysis neurons were transfected at DIV 9 or DIV13, 
then fixed with paraformaldehyde on the subsequent day.  16 hours after 
transfection was sufficient time to allow the development of bright, fully filled green 
fluorescent neurons.  The first signs of green appeared from as little as 4 hours after 
transfection.  The transfection rate was approximately 1-2% (see Appendix 1).  A 
wide range of neuronal morphologies were visible in both hippocampal and cortical 
cultures.  Figure 4. 1 (upper panel) shows a typical field of view of a hippocampal 
culture.  A classical pyramidal neuron and some bipolar neurons are indicated.  
Multipolar neurons were also observed.  The cell bodies of untransfected neurons 
are visible due to autofluorescence.  Only neurons of pyramidal type morphology 
were analysed in order to limit experimental variability.  Pyramidal neurons are 
typified by a pyramid or triangular shaped soma, a prominent main dendrite 
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resembling the in situ apical dendrite and shorter basal dendrites arising from the 
cell body, or often the tips of the cell body.  Some examples of pyramidal type 
neurons are shown in Figure 4. 1 (bottom panel).   
 
Dendritic spines are visible on eGFP expressing cultured neurons 
Protrusions from dendritic shafts were visible on eGFP expressing cultured neurons 
from at least DIV 9 (Figure 4. 2).  The protrusions ranged in morphology from long 
filopodia and short thin protrusions to protrusions with a clear thin neck with a thicker 
head that could be classified as mushroom spines.  Short stubby spines were also 
evident.  Bifurcating protrusions of the long thin and mushroom type also occured.  
 Imaging and analysing dendritic spines 
In order to obtain high definition images amenable to analysis confocal microscopy 
was used to capture sections of dendrites bearing spines.  The length and head 
width of protrusions up to a certain length (8 µm) were measured manually I do not 
refer to the protrusions as spines because long filopodia are also included under this 
criterion.  I cannot discount the possibility that some of the longer protrusions may 






Figure 4. 1 eGFP expressing cultured neurons display different morphologies 
 
Shown is a representative field of view of a DIV 10 hippocampal culture transfected at DIV 9 
with eGFP (upper panel).  A pyramidal type neuron is indicated by the white arrow.  Bipolar 
neurons are indicated by yellow arrows.  The autofluorescing cell bodies of untransfected 
neurons are visible (Red arrow). In order to capture the dendrites effectively the cell body 
most be overexposed, the white colour here indicates that this region is outside of the 
dynamic range of the image.  Examples of pyramidal type neurons in a hippocampal culture 





Figure 4. 2 Dendritic protrusions are visible on GFP filled neurons 
 
A pyramidal type neuron (a) and a representative stretch of dendrite (b) are shown in the 
upper panel.  Various examples of the type of dendritic protrusions observed on GFP 
expressing pyramidal type neurons in culture are shown in the bottom panel (c-o).  These 
spines could be classified as mushroom (c, d, k, l), short (e, f, g) long or filopodia (h, I, m–o) 
and bifurcating (j).  The examples shown here are z projections of deconvolved image stacks 




Viable SynGAP -/- neurons can be maintained in culture 
SynGAP -/- mice die a few days after birth, P2-7,(Komiyama et al., 2002; Kim et al., 
2003; Vazquez et al., 2004) but SynGAP -/- neurons can be maintained in culture.  
SynGAP -/- embryos and cultured neurons were grossly morphologically identical to 
wild type litter mate controls.  There was no difference in cell density between 
mature SynGAP -/- and wild type cultures.  Equivalent numbers of cells with healthy 
appearing nuclei were found indicating that there is not a difference in propensity 
toward cell death (Figure 4. 3). 
 
 



















Figure 4. 3 Cell density and survival in SynGAP -/- and wild type cultures 
 
There is no difference in total nuclei density in wild type and SynGAP 
-/-
 low density 
hippocampal cultures at DIV 10.  Nuclei were stained with Topro 3.  All nuclei, irrespective of 
morphology, were counted to yield a total nuclei density.  The proportion of healthy 
appearing nuclei is unchanged in the SynGAP 
-/-
 cultures.  This data indicates a 40% survival 
rate to DIV 10 at this density.  Data are from three wild type and three SynGAP 
-/-
 embryos 
from two separate cultures.  Data are mean +/- SEM. 
 
 
4.2.4 Dendritic protrusion morphology in SynGAP -/- neurons 
I examined dendritic protrusion morphology and density in SynGAP -/- neurons from 
cortical and hippocampal cultures at different time points.  There was no difference 
in mean dendritic protrusion length, width or density between SynGAP -/- cortical or 
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hippocampal neurons at DIV 10 or 14 (Figure 4. 4 and Figure 4. 5, two way ANOVA, 
post hoc Bonferonni t-tests).  The only trend towards a difference was the apparent 
increase in protrusion density in cortical SynGAP -/- neurons (0.33 +/- 0.03 
protrusions/µm) compared to wild type (0.22 +/- 0.03 protrusions/µm) (Figure 4. 4, 
g).  If this data is examined in isolation an individual student’s t-test indicates a 
statistically significant difference, p = 0.02.  
 
Nevertheless it appears that cortical and hippocampal protrusions develop 
differently.  In cortical neurons protrusion density increased with development in 
both wild type type (0.22 +/- 0.03 protrusions/µm at DIV 10 to 0.58 +/- 0.2 
protrusions/µm at DIV 14) and SynGAP -/- neurons  (0.33 +/- 0.03 protrusions/µm at 
DIV 10 to 0.69 +/- 0.07 protrusions/µm at DIV 14, two way ANOVA, p<0.001, post 
hoc Bonferroni t-test, all p < 0.001) (Figure 4. 4, g).   On the other hand density was 
unchanged with time in hippocampal neurons (Figure 4. 5, g) but protrusion width 
increased as the neurons aged (Figure 4. 5,d).  Again this is equally true for wild 
type (width of 0.31 +/- 0.01 µm at DIV 10 to 0.42 +/- 0.03 µm at DIV 14) and 
SynGAP -/- neurons (width of 0.32 +/- 0.01 µm at DIV 10 to 0.41 +/- 0.01 µm at DIV 
14, two way ANOVA, p<0.0001, post hoc Bonferroni t-test, all p<0.001).   
 
Analysis of the distributions of all the protrusions lengths and widths analysed 
revealed some significant changes between wild type and knock out.  (The D value 
indicates the maximum difference between the two cumulative frequency histograms 
(not shown here)).  In SynGAP -/- cortical neurons there was a slight shift towards 
shorter, thinner protrusions which is more marked at DIV 10 than DIV 14 (two 
sample Kolomogorov-Smirnov test, all p < 0.05, width; DIV 10 D = 0.25, DIV 14 D = 
0.08, length; DIV 10 D = 0.22, DIV 14 D = 0.11) (Figure 4. 4, b, c, e, f).   The 
distribution of protrusion widths in SynGAP -/- hippocampal neurons was unaffected 
(Figure 4. 5, e,f) but again the distribution of lengths was shifted slightly toward more 
shorter protrusions (Figure 4. 5, b,c).  Again the magnitude of the difference was 
greater at the younger age (two sample Kolomogorov-Smirnov test, both p < 0.05, 
DIV 10 D = 0.14, DIV 14 D = 0.07).    
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Figure 4. 4 Dendritic protrusions in wild type and SynGAP -/- cortical neurons 
Mean dendritic protrusion length, width and density from wild type and SynGAP 
-/-
  cultured 
cortical cells at DIV 10 and DIV 14 are shown in the left most panels (a, d, g, DIV 10; WT n = 
5, SynGAP 
-/-
 n = 8, DIV14; WT n = 10, SynGAP 
-/-
 = 6).  Data from individual cells are 
indicated in the scatter plot.  Spine density increases with development (g) in the wild type 
and knock out (two way ANOVA, p < 0.001; wild type, DIV 10 =  0.22 +/- 0.06 spines/µm to 
DIV 14 = 0.58 +/- 0.2 spines/µm,  p < 0.001***; SynGAP 
-/-
 , DIV 10 = 0.33 +/- 0.08 
spines/µm to DIV 14 = 0.69 +/- 0.17 spines/µm,  p < 0.001***, post hoc Bonferroni t-tests).  A 
student’s t-test indicates an increase in spine density in the knock out compared to wild type 
at DIV 10, (p = 0.02*, grey connecting line).  Frequency histograms of the lengths (b, c) and 
widths (e, f) of all dendritic protrusions are shown on the right (DIV 10; WT n = 143, SynGAP 
-/-
 n = 359, DIV 14; WT n = 1059, SynGAP 
-/-
 n = 999, two sample Kolomogorov-Smirnov test, 
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all p ≤ 0.05). The p and D values of two sample Kolmogorov-Smirnov tests are inlaid in the 
graphs.  Representative sections of dendrite appear in (h).  Scale bar is 2 µm.  Data are from 
5 wild type and 5 SynGAP 
-/-
 embryos from 2 separate cultures.  
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Figure 4. 5 Dendritic protrusions in wild type and SynGAP -/- hippocampal neurons 
 
Mean dendritic protrusion length, width and density from wild type and SynGAP 
-/-
  cultured 
hippocampal cells at DIV 10 and DIV 14 are shown in the left most panels (a, d, g, DIV 10; 
WT n = 10, SynGAP 
-/-
 n = 12, DIV14; WT n = 6, SynGAP 
-/-
 = 10).  Data from individual cells 
is indicated in the scatter plot.  Spine width increases with development (d) in wild type and 
knock out cells (two way ANOVA, p < 0.001,  wild type, DIV 10 =  0.31 +/- 0.04 µm to DIV 14 
= 0.42 +/- 0.07 µm,  p < 0.001***; SynGAP 
-/-
 , DIV 10 = 0.32 +/- 0.03 µm to DIV 14 = 0.41 +/- 
0.04 µm,  p < 0.001***, post hoc Bonferroni t-tests).  Frequency histograms of the lengths (b, 
c) and widths (e, f) of all dendritic protrusions are shown on the right (DIV 10; WT n = 1125, 
SynGAP 
-/-
 n = 1291, DIV 14; WT n = 834, SynGAP 
-/-
 n = 1351). The p and D values of two 
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sample Kolmogorov-Smirnov tests are inlaid in the graphs.  Representative sections of 
dendrite appear in (h).  Scale bar is 2 µm.  Data are from 6 wild type and 6 SynGAP 
-/-
 






































Previous work that found an increase in dendritic spine width in SynGAP -/- neurons 
was performed on cultures grown in the absence of foetal bovine serum (FBS) 
(Vazquez et al., 2004).  The results I have described up to now are derived from 
cultures maintained in the presence of FBS.  In order to determine if the presence of 
FBS has an effect on protrusion morphology or density I cultured wild type and 
SynGAP -/- hippocampal neurons without FBS.  I found no difference in mean 
protrusion morphology or density between wild type and knock out with this 
treatment (Figure 4. 6, a, d, g).  However the absence of FBS did effect spine 
development.   Both wild type and SynGAP -/- neurons cultured in the absence of 
FBS had a shorter mean protrusion length compared to equivalent neurons cultured 
with FBS  (two way ANOVA, p<0.0001; wild type + FBS, 1.63 +/- 0.17 µm   
compared to wild type - FBS, 1.09 +/- 0.05 µm, post hoc Bonferroni t-test, p<0.001; 
SynGAP -/- + FBS, 1.51 +/- 0.06 µm compared to SynGAP -/- - FBS, 1.15 +/- 0.11 
µm, post hoc Bonferonni t-test, p<0.05) (Figure 4. 6, a).  This change was also 
apparent in the different distributions of protrusion length (two sample Kolomogorov-
Smirnov test, both p < 0.001, wild type D = 0.28, SynGAP -/-  D = 0.22) (Figure 4. 6, 
b, c).  
 
In the absence of FBS the distribution of wild type widths was unchanged compared 
to the +FBS condition (Figure 4. 6, e), however the distribution of SynGAP -/- widths 
was slightly different between the two cases (SynGAP -/- ; +/- FBS, widths, D = 0.14, 
p < 0.001) (Figure 4. 6, f).  The shift of the SynGAP -/- distribution was toward slightly 
wider protrusion heads.  This change is borne out when wild type and SynGAP -/- 
width distributions (-FBS) are compared directly (-FBS; wild type v SynGAP -/-, 
widths, D = 0.11, p < 0.001) (Figure 4. 7).  
 
In order to assess if any given sub type of spine was affected by the removal of 
SynGAP, eg long and thin, or short and thick, I calculated the correlation between 
protrusion length and width.  There is no correlation between protrusion length and 
width within any of the populations of protrusions analysed (data not shown, 
Pearson’s correlation coefficients).  There was no apparent differences in the scatter 













































































































































































































































































Figure 4. 6 Dendritic protrusions in wild type and SynGAP -/- hippocampal neurons 
cultured in the presence and absence of foetal bovine serum (FBS) 
 
Mean dendritic protrusion length, width and density from wild type and SynGAP 
-/-
  cultured 
hippocampal cells at DIV 14 are shown in the left most panels (a, d, g,  + FBS; WT n = 6, 
SynGAP 
-/-
 n = 10, - FBS; WT n = 12, SynGAP 
-/-
 = 9).  Data from individual cells is indicated 
in the scatter plot.  Protrusion lengths (a) of wild type and knock out neurons is decreased in 
the absence of FBS cells (two way ANOVA, p < 0.001, wild type, + FBS = 1.63 +/- 0.41 µm 
to –FBS = 1.1 +/- 0.17 µm,  p < 0.001***; SynGAP 
-/-
 , + FBS = 1.51 +/- 18 µm to –FBS = 
1.15 +/- 0.34 µm,  p < 0.001*, post hoc Bonferroni t-tests).  Frequency histograms of the 
lengths (b, c) and widths (e, f) of all dendritic protrusions are shown on the right (+ FBS; WT 
n = 834, SynGAP 
-/-
 n = 1351, - FBS; WT n = 1081, SynGAP 
-/-
 n = 906). The p and D values 
of two sample Kolmogorov-Smirnov tests are inlaid in the graphs. Representative sections of 
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dendrite appear in (h).  Scale bar is 2 µm. Data are from 5 wild type and 5 SynGAP 
-/-
 
embryos from 3 separate cultures. Note that the data for the + FBS condition here is the 
same as shown in figure 4.6. 
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Figure 4. 7 Direct comparison of the distributions of wild type and SynGAP -/- dendritic 
protrusion length and width in neurons cultured in the absence of FBS 
  
Frequency histograms of dendritic protrusions measurements from wild type and SynGAP 
-/-
 
hippocampal neurons at DIV 14.  All data was derived from neurons cultured in the absence 
of FBS ( WT n = 1081, SynGAP 
-/-
 n = 906).  The p and D values of two sample Kolmogorov-
Smirnov tests are inlaid in the graphs. 
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4.2.5 Part Two: Morphological analysis of dendritic protrusions 
of wild type cortical cells overexpressing various SynGAP 
isoforms. 
 
4.2.6 Dendritic protrusion morphology in wild type neurons 
overexpressing SynGAP isoforms 
A range of SynGAP isoforms, SynGAP A-alpha-1, SynGAP B-alpha-1, SynGAP A-
alpha-2 were expressed in wild type cortical cells to assess their effect on the 
morphology and density of dendritic protrusions.  SynGAP was co transfected with 
GFP to allow the identification of cells expressing SynGAP.  See Appendix 1 for the 
optimisation of the co-transfection protocol and confirmation of co-expression of 
GFP and SynGAP.  None of the isoforms had any effect on protrusion density, mean 













































Figure 4. 8 Dendritic protrusions in wild type cortical cells transfected with 
various SynGAP isoforms. 
Dendritic protrusions length, width and density were analysed on neurons transfected with 
GFP only or GFP and the SynGAP isoform indicated.  The population mean is displayed 
(GFP only, n = 14, SynGAP A-alpha-1, n = 11, SynGAP B-alpha-1, n = 6, SynGAP A-alpha-
1, n = 12) as well as each individual cell (the mean is indicated by a horizontal line).  Data 
are from 3 separate cultures. 
 
148 
To examine this data in greater detail frequency histograms are shown in Figure 4. 9 
illustrating the distribution of all protrusion lengths and widths in SynGAP expressing 
cells compared to the control distribution.  Comparison of the distributions exposed 
statistically significant but small differences (small based on the D value which 
illustrates the maximum distance between cumulative histograms).  There was a 
shift toward shorter spines with overexpression of all the isoforms (two sample 
Kolomogorov-Smirnov test, all p < 0.05).  When the distributions were categorised 
based on the quartile values of the control population this shift was apparent in the 
expansion of the ‘shortest protrusion’ category (Figure 4. 9, bottom panel).  
 
Moreover, expression of different isoforms had a differential effect on the distribution 
of protrusion widths; SynGAP A-alpha-2 (Figure 4. 9, e) had no effect but expression 
of SynGAPs A and B-alpha-1 both result in an increase in the kurtosis of the 
distribution (Figure 4. 9, a, c) (two sample Kolomogorov-Smirnov test, both p < 0.05, 
kurtosis values; control = 2.44, SynGAP A-alpha-1 = 3.55 , SynGAP B-alpha-1 = 
4.04, SynGAP A-alpha-2 =  2.44).  Kurtosis quantifies whether the shape of the data 
distribution matches the Gaussian distribution. A Gaussian distribution has a 
kurtosis of 0.  A flatter distribution has a negative kurtosis, and a more peaked 
distribution has a positive kurtosis.  These values  indicate a shift away from the 
smallest and largest lengths and an expansion of the medial categories (Figure 4. 9, 
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Figure 4. 9 Frequency histograms of dendritic protrusion length and width from 
wild type cortical neurons transfected with various SynGAP isoforms. 
Frequency histograms of the lengths and widths of all dendritic protrusions of cortical 
neurons transfected with SynGAP isoforms (coloured line) are overlaid on the histogram for 
GFP only control cells (filled grey area).  (control, n = 1019, SynGAP A-alpha-1, n = 875, 
SynGAP B-alpha-1, n = 489, SynGAP A-alpha-2, n = 990).   The p and D values of two 
sample Kolmogorov-Smirnov tests are inlaid in the graphs.  Protrusion widths and lengths 
are classified into four categories (legend) based on the quartiles of the control populations 
(illustrated by the broken orange line) (bottom panel).  Data are from three separate cultures.   
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4.2.7 Localisation of overexpressed SynGAP isoforms 
It is known that endogenous SynGAP is localised to the post synaptic compartment 
(Chen et al., 1998; Li et al., 2001; Barnett et al., 2006).  We wanted to know if the 
overexpressed SynGAP molecules were present in dendrites and able to reach the 
synapse, and if the isoforms were differentially localised.  Due to the lack of 
availability of isoform specific antibodies the isoforms were expressed in SynGAP -/- 
neurons thereby allowing detection with one SynGAP antibody that recognises a 
central domain common to all isoforms.  Examples of dendritic stretches 
overexpressing SynGAPs A, B and C alpha-1 and alpha-2 are shown in Figure 4. 
10.  The dendritic localisation of the all isoforms is clearly not identical.  It appears 
that both SynGAP A isoforms (alpha-1 and alpha-2) (Figure 4. 10, a-d) had strong 
punctate localisation with minimal diffuse signal in the dendritic shaft, this 
distribution was similar to that of SynGAP B-alpha-1 (Figure 4. 10, e,f).  The puncta 
were localised both in spines and on the dendritic shaft.  While puncta were 
distinguishable in dendrites expressing SynGAP C-alpha-1 there was much more 
uniform staining along the dendritic shaft and in protrusions (Figure 4. 10, I, j).  The 
almost uniform stain observed upon expression of SynGAPs B and C-alpha-2 was 
very similar to that of the GFP expression (Figure 4. 10, g, h, k, l). 
 
4.2.8 Expression levels of SynGAP isforms 
Overexpressed proteins can mislocalise due to saturation of trafficking mechanisms 
or binding partners.  The same quantities of SynGAP DNA are transfected for each 
isoform but it is not necessarily the case that all SynGAP isoforms will be expressed 
equally.  Although all isoforms are under a very strong promoter (CMV) it is still 
possible that their expression level and/or turnover may be differentially regulated.  
Differential expression levels could be an explanation for differential function or 
localisation.  Overexpressed SynGAP was undetectable by western blotting of 
lysates of transfected SynGAP -/- neurons, presumably due to the extremely low 
transfection rate. Therefore I quantified the protein expression level of 
overexpressed SynGAP isoforms by semi-quantitative fluorescence microscopy 
(Figure 4. 11).  The use of one antibody facilitated this approach as the confounding 
effect of different binding affinities should be minimal.  The expression level of 
SynGAP B-alpha-1 was higher than that of all other isoforms.  This is the case for 
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the expression level relative to eGFP (one way ANOVA, p < 0.01, see figure legend 
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 neurons transfected with various SynGAP isoforms were probed with an antibody 
against all SynGAP isoforms.  Examples of dendritic sections from two different neurons are 
shown for each isoform.  The GFP filled segment (green) and the antibody probed segment 
(red) are shown above the overlaid images. These images were acquired by confocal 







































Figure 4. 11 Quantification of the protein expression levels of various SynGAP 




Dendritic protein expression levels of various SynGAP isoforms were quantified by semi-
quantitative confocal microscopy.  SynGAP isoforms were expressed in SynGAP 
-/-
 neurons 
and detected by immunocytochemistry with an antibody against all SynGAP isoforms.  The 
fluorescence signal from SynGAP is expressed as a ratio against GFP fluorescence.  One 
way ANOVA with post-hoc Tukey t-tests indicate statistical significance only between 
SynGAP B-alpha-1 and the other isoforms.  Asterisks above the bars signify statistical 
significance between the isoform indicated and SynGAP B-alpha-1 (one way ANOVA, p = 
0.02, pairwise post-hoc Tukey t-tests, p < 0.05*, p < 0.01**, p < 0.005***).  Data are from four 






The aim of this chapter was to examine the role of SynGAP in dendritic protrusion 
development by two methods, removal of all SynGAPs and the overexpression of 
specific isoforms of SynGAP.  The main result of this chapter is the inability to 
repeat the previously published effect of the ablation of SynGAP expression 
(Vazquez et al., 2004).  Namely, I failed to reproduce the results of enlarged, 
prematurely developed dendritic spines on pyramidal neurons in SynGAP -/- 
cultures.  Despite examining dendritic protrusions at different DIV and in cultures 
derived from regions with the highest expression level of SynGAP, the hippocampus 
and cortex, the phenotype was not observed (Kim et al., 1998; Barnett et al., 2006) 
(Figure 4. 5 and Figure 4. 4).  Manipulation of the protocol to closely adhere to the 
experimental procedure used in the previous publication (removal of FBS) did not 
alter this finding (Figure 4. 6).  However, subtle and varied changes were observed 
in the distributions of spine morphology among tissue types and ages, indicating that 
SynGAP’s regulatory role may be more nuanced than previously thought.  
 
Is the culture system behaving as expected? 
Before discussing the particulars of this data regarding SynGAP the first issue to be 
addressed is whether the experimental system is behaving as expected.  Generally 
the morphology of the neurons grown were similar to those described by many other 
groups (Kriegstein & Dichter, 1983; Ishikawa et al., 2003; Vazquez et al., 2004).  
Neurons which exhibited signs of stress, specifically dendritic blebbing, were 
excluded from the analysis.  Mirroring the in vivo development of filopodia and 
spines the first protrusions of cultured neurons begin to appear around DIV 7 or 8.  
The densities of protrusion found here are very much in agreement with other 
preparations.  Although protrusion density is generally found to be much lower in 
culture (slice and dissociated) than in the brain there is remarkable consistency 
between culture preparations.  To illustrate; Pak et al (2001) and Ishikawa et al. 
(2006) find a density of 0.5 spines/µm in dissociated rat hippocampal neurons 
cultured with serum and without serum reµspectively.  Collin et al. (1997) describe 
rat hippocampal slice cultures with a density of 0.6 spine/µm.  Another culture 
method, the Banker method, where neurons grow in the presence of, but not in 
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contact with, a layer of glial feeder cells, again yields a density of 0.5 spine/ µm for 
hippocampal neurons (Boyer et al., 1998).  Other groups find lower spine densities, 
even in apparently very similar culture conditions; Papa et al. (1995) describe 
protrusion densities of 0.2 spines/µm in hippocampal culture with serum and 
Vazquez et al.  (2004) show this same density but in cultures without serum.  All the 
protrusion densities described in this thesis were within this range, 0.2 – 0.6 spines/ 
µm.  Protrusion density on cultured cortical neurons also falls within a similar range 
within this time window (0.2 – 0.8 spines/µm), and again encompasses the data 
reported here (Hayashi & Shirao, 1999; Penzes et al., 2003). 
 
It is more difficult to determine if protrusion morphology is found to be consistent 
between labs and preparations as there is often disparity in the method of analysis.   
The dimensions of spines are often not measured but instead assigned to the 
classical mushroom, thin, stubby and filopodia categories.  The criteria for 
classification can vary between investigating groups and even between 
experimenters if it is done manually or semi-manually.  Clearly a classification 
method obscures what is in reality a continuum of spine variety into artificially 
discrete groupings; at what arbitrary length does a thin spine become a filopodium? 
This system is convenient and useful in certain cases, it is probably most suited to 
older cultures and brains where a greater proportion of protrusions are likely to fit 
into these categories.  The relatively immature cultures examined here would be 
grossly misrepresented by the classification of their protrusions.   
 
Divergence in methodology remains even when dendritic spine head is measured; 
for example, the finding of enlarged spine heads in SynGAP -/- neurons was 
established by Vazquez et al. by measuring the width of the bounding rectangle, a 
method which likely underestimates differences as bends in filopodia increase their 
recorded width.  Often protrusion measurements are given in terms of volume or 
surface area (Harris & Kater, 1994; Xie et al., 2007).  Direct measurement of the 
widest point of a protrusion head taken from a z projection of a stack of confocal 
images, the method used in this thesis, is also common.   Despite differences in 
method of measurement my data fits within the range of 0.5 – 1.5 µm which is often 
reported for the mean spine head widths of cultured neurons (Pak et al., 2001; 
Ishikawa et al., 2003).  Additionally the distribution of protrusion lengths that I see is 
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remarkably similar to that previously described, in slice and dissociated culture, at 
the same approximate age (Dailey & Smith, 1996; Boyer et al., 1998) 
 
Insights into protrusion development from control cells  
Although secondary to the examination of SynGAP loss on protrusion development 
the data presented in this chapter give insight into the programme of protrusion 
developmental in hippocampal and cortical cultures, as well as the effect of the 
presence of FBS.   
Compared to hippocampal neurons the protrusions of cortical cells were very sparse 
at DIV 10 but treble in density by DIV14.  While the density of hippocampal cells 
stayed constant over this time period the width of the protrusion heads did increase 
(Figure 4. 4 and Figure 4. 5).  What is perhaps most surprising was the similarity 
between neurons cultured with and without FBS (Figure 4. 6 and Figure 4. 7).  The 
only difference being a decrease in protrusion length in the absence of FBS. (Figure 
4. 6, a)  Given the documented importance of glia in synapse and spine 
development (discussed later), in addition to direct trophic effects of the serum itself, 
I would have expected a greater effect.  The decrease in protrusion length could be 
attributed to a loss of trophic factor or a shift away from immaturity indicated by the 
longest, filopodia like spines.     
 
Subtle changes in the SynGAP -/-  distributions of protrusion length and 
width  
It is abundantly clear that a phenotype of greatly exaggerated spine development 
was not present in these experiments but I did find subtle differences between the 
wild type and SynGAP -/- distributions of protrusion width and length in certain 
circumstances.  In cortical neurons the distribution of protrusion widths was shifted 
slightly toward thinner spines, a change opposite to that which would be expected 
given previous work (Figure 4. 4, e, f).  Surprisingly the distributions of protrusions 
lengths are shifted slightly toward shorter protrusions in both hippocampal and 
cortical neurons (Figure 4. 4, Figure 4. 5, Figure 4. 6, all b, c).   
 
Protrusion length is not such a widely examined metric in the study of spine 
development, the spine head width is a more reliable measure of spine stability and 
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maturity.  Long protrusions can often be classified as filopodia, which normally do 
not bear mature synapses, and so can be interpreted as an indicator of immaturity.   
These early protrusions, characterised by shorter lifetimes and high motility, are 
thought to transition to mature spines (Dailey & Smith, 1996; Lendvai et al., 2000; 
Portera-Cailliau et al., 2003).  Therefore the shift away from longer protrusions in 
SynGAP -/- neurons could be interpreted as premature maturation, which is 
consistent with previous work.  I have observed ‘long’ protrusions, up to ~ 4 µm, 
supporting mature appearing mushroom type heads of ~1 µm in width (eg  Figure 4. 
2, c) so this interpretation should be made with caution.  An additional confound to 
this interpretation is the finding that in adult hippocampi of SynGAP +/- mice spines 
appear to be elongated, as well as increased in head volume (Carlisle et al., 2008). 
 
The influence of serum on neuronal cultures 
The work described above (Figure 4. 4 and Figure 4. 5) was performed on cultures 
maintained in the presence of FBS and, as mentioned, experiments showing the 
exaggerated spine development in cultured SynGAP -/- neurons were grown in the 
absence of FBS.  Historically serum has been essential for the maintenance of 
healthy neuronal cultures as it provides a raft of identified and unidentified growth 
promoting factors (Sasaki et al., 1998).  However serum is chemically undefined and 
varies from batch to batch so introduces several variables that should otherwise be 
tightly controlled.  In recent years much effort has gone into the development of 
serum free tissue culture systems.  A strong impetus for this change is concern 
regarding safety and contamination when the end product is used in human 
therapeutics.  Serum free medium also provide advantages in the research setting 
as it provides a more defined, controlled cell culture environment.  Serum free 
neuronal culture is made possible by commercially available supplements (eg. B27) 
that support long term neuronal survival, but crucially, do not allow glial proliferation.  
Therefore there is a key difference between neurons cultured in the presence and 
absence of FBS, namely, the levels of glial cells.  When culturing with FBS glial 
proliferation is terminated after four days (by the addition of a cell cycle inhibitor, 
cytosine -D-arabinofuranoside (AraC)) by which time a confluent base layer of glial 
cells has formed.  In the absence of FBS, some glial cells are present but they do 
not proliferate.   We should consider then what effect glial cells might have on 




The influence of glia on synapses and spines 
Far from being passive support cells which ‘glue’ the brain together it has emerged 
that glia play a major part in regulating the neuronal environment and are crucial for 
processes such as synaptic plasticity and synaptogenesis (reviewed by (Allen & 
Barres, 2005).  Astrocytes (a class of glial cell) can respond to neurotransmitters 
and release neuroactive molecules which control synapse formation (Cornell-Bell et 
al., 1990; Ullian et al., 2004; Christopherson et al., 2005), regulate presynaptic 
function (Mauch et al., 2001) and modulate the response of the postsynaptic neuron 
to neurotransmitters (Stellwagen & Malenka, 2006).  The notion of the tripartite 
synapse, composed of presynaptic and postsynaptic neuronal compartments 
ensheathed by a responsive and active astrocytic projection illustrates the intimate 
nature of glial involvement in synaptic function (Perea et al., 2009).   
It would not be surprising then if the presence or absence of glia could have 
dramatic effects on protrusion development.  Astrocytic processes can have a direct 
role in the shaping of dendritic spine morphology via ephrin/eph signalling and 
stable astrocytic contacts are found at stable spines (Murai et al., 2003; Stellwagen 
& Malenka, 2006).  Astrocytically released molecules (TNFalpha and ATP) have 
been shown to have a direct impact on synaptic AMPA receptor content (Beattie et 
al., 2002; Gordon et al., 2005).  This release seems to be important for the 
maintenance of synapses and synaptic scaling, and if reduced one could envisage 
how compensatory regulatory mechanisms might involve SynGAP, leading to 
dysregulation in the knockout.   To look at it another way, with a high complement of 
glial cells (+FBS) the regulation of synaptic AMPA receptor content or spine shape 
might be more robust than in the case of a low complement of glial cells (-FBS). 
  
Interestingly I did find a shift towards wider spines in the distribution of SynGAP -/- 
protrusions, agreeing with the results of Vazquez et al., when the neurons are 
cultured without FBS (Figure 4. 7), indicating that different pathways to spine 
development might be activated in the presence and absence of serum.  However 
there were no differences in mean protrusion width, length or density (Figure 4. 6, a, 




What do changes in distribution mean? 
Despite some indications of a shift away from immaturity in the form of reduced 
spine lengths the expected phenotype of greatly enlarged spine heads was not 
found here.  When cultured without FBS protrusion widths in SynGAP -/- neurons are 
slightly increased but magnitude is not as great as that described by Vazquez et al..   
Indeed, the opposite result, an indication of thinner protrusion heads, is found in 
SynGAP -/- neurons from the cortex.  All these differences are statistically significant 
based on the comparison of the distributions of the entire population of 
measurements.  Do these differences have any functional significance?   
 
It is difficult to know how to interpret such changes.  It is possible that the trend 
toward thinner spines in cortical neurons wouldn’t be recapitulated if the experiment 
was performed in the absence of FBS, and so this result is not directly comparable 
the finding of a shift toward increased width in hippocampal cell (+FBS).  
Nevertheless it is perhaps simplistic to expect that a large outright change in spines 
would occur, even if it has been shown before, given our hypothesis of SynGAP as 
a multifunctional molecule which regulates opposing pathways.  It is very possible 
that all the changes in distribution observed are real and indicative of elements of 
SynGAP function that are exposed given the precise set of experimental 
circumstances.  We do not know which isoforms are expressed where.  It is unlikely 
the intracellular milieu of cortical cells is identical to that of hippocampal cells and 
therefore unlikely that they will be affected in exactly the same way by the removal 
of all the SynGAP isoforms.  Therefore, if we truly accept our hypothesis of SynGAP 
as a bidirectional switch then the lack of a clear change in either direction becomes 
a likely outcome.  The magnitude of these changes may be too small to be seen in 
the mean given the number of neurons examined here.   
 
Increased protrusion density in SynGAP -/- cortical neurons at DIV 10 
I found an increase in protrusion density in SynGAP -/- cortical neurons at DIV 10, 
but not at DIV 14 (Figure 4. 4) and not in any hippocampal neurons (Figure 4. 5).  
Potential reasons for discrepancies between my findings and previously published 
work will be addressed below and the variety in tissue type and age have been 
mentioned above.  Here I will consider two potential mechanisms by which an 
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increase in protrusion density might occur namely exaggerated stabilisation or 
impeded stabilisation. 
 
Deletion of SynGAP could lead to an exaggeration of stabilisation whereby more 
protrusions are stabilised than normal.  These ‘stabilisation’ mechanisms could be 
further sub-divided into two categories, depending on the mechanism of spine 
stabilisation.  First, structural stabilisation could be the primary event; changes in the 
actin dynamics lead to the creation of a larger spine, perhaps with more scaffolding 
molecules, which can accommodate a larger synapse.  Second, that the insertion of 
the functional moieties, in this case AMPA receptors, into the membrane with the 
concomitant insertion of additional membrane is the primary mechanism of 
stabilisation.  It is most likely that these two mechanisms, both affected by SynGAP, 
are complementarily and co-ordinately regulated (Rumbaugh et al., 2006; Carlisle et 
al., 2008).   Where an increase in spine density occurs with an increase in spine 
head size (cultured SynGAP -/- and in vivo SynGAP +/- neurons) the proposed 
mechanism is of increased stabilisation, both via AMPA receptor insertion and 
altered actin dynamics.    
 
Alternatively, if ablation of SynGAP prevents protrusions from being stabilised then 
perhaps the neuron will put forth additional protrusions in an attempt to compensate 
for the lack of input; this could give rise to an increase in density of immature, 
possibly filopodial processes, similar to the phenotype observed in Fragile X 
syndrome (Cruz-Martin et al.).  Because I saw a slight shift toward thinner spine 
heads this latter mechanism, lack of stabilisation, provides a more parsimonious 
model for the increase in protrusion density than the former. 
 
 
Enhanced Ras activity can increase spine number (Goldin & Segal, 2003; Gartner et 
al., 2005) so this premature increase in density fits with the schema of SynGAP 
functioning mainly as a RasGAP.  Interestingly the Ras induced increase in density 
does not necessarily involve changes in the profile of large spines.  Indeed 
stimulations that enhance Ras mediated MAPK activity increase the density of 
protrusions primarily through the addition of new filopodia, rather than the 
stabilisation of protrusions already present (Wu et al., 2001).  Thus, the deletion of 
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SynGAP could remove the negative regulation of Ras leading to the addition of new 
thin spines 
 
However, this effect did not penetrate all cases examined here and was not 
recapitulated in a particular setting in which it was observed before.  An increase in 
spine density has been shown in DIV 14 SynGAP -/- hippocampal neurons however 
by DIV 21 there was no longer a difference between wild type and knock out 
densities (Vazquez et al., 2004). Therefore we could conclude that SynGAP 
RasGAP function is not entirely dominant but that it is sensitive to the precise 
neuronal conditions.  Furthermore, SynGAP can act on both Rap1, the 
overexpression of which can have no effect on spines, and Rap2, which can induce 
a decrease in spine density (Krapivinsky et al., 2004; Fu et al., 2007).  Interestingly 
both molecules decrease AMPA receptor mediated mEPSC amplitude and 
frequency (Zhu et al., 2002; Huang et al., 2004).  This shows that SynGAP can 
regulate a pathway in which structure and function may be decorrelated, suggesting 
that the lack of a structural phenotype is not necessary predictive of the lack of a 
functional role. 
   
Why is the morphological phenotype in this SynGAP -/- mouse different 
to the published phenotype? 
We must consider what experimental factors might be causing the disparity in 
phenotype between the work presented here and previously published work.   
Despite efforts towards aligning the experimental protocols obvious differences 
remain in the form of the knock out mouse models. 
 
There are three different SynGAP -/- mice models in existence.   The mouse 
generated by (Vazquez et al., 2004) which I term the Kennedy mouse, the mouse 
used in this thesis (Komiyama et al., 2002) which I term the Grant mouse, and the 
mouse generated by (Kim et al., 2003) which I term the Huganir mouse.  The names 
refer to the principal investigator of the labs which generated the mice.   
 
When we speak about the differences between mouse models there are two main 
aspects to be considered.   Firstly the genetic background strain of the mouse that 
carries the knock out allele, and secondly the knock out allele itself.  In the case of 
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SynGAP both the background strain and the transgenic allele are different in all 
three knock out models. 
 
Mouse genetic background 
It is clear that phenotypes can differ wildly between inbred strains of mice.  There 
are thousands of inter breed phenotypic differences categorised in the Jackson 
Laboratories Mouse Phenome Database (http://phenome.jax.org)  ranging from 
disease susceptibility, aging, obesity, neurosensory disorders to behaviour and 
learning/memory ability.  For example, BTBR T+tf/J has a severe defect in corpus 
collosum development and exhibits extreme behavioral phenotypes. JF1/Ms has 
congenital eye abnormalities and has remarkably high percent body fat; and B6.Cg-
Ay/J exhibits severe obesity-related phenotypes (Grubb et al., 2009).  Even 
substrains develop differences; a range of different fear responses are observed 
between the C57BL6/J and C57BL/6N substrains (Stiedl et al., 1999).   
 
Unfortunately there is variety in the background on which SynGAP -/- alleles are 
maintained.  The Kennedy and Huganir mice were maintained on C57Bl6 (Kim et 
al., 2003; Vazquez et al., 2004) but lately have been crossed with an unspecified 
129 substrain or 129 sv/ev respectively due to breeding problems on the pure 
background (Carlisle et al., 2008; Guo et al., 2009).  Original experiments on the 
Grant mouse were performed when it was on an F2 MF1 background and since then 
it has been backcrossed partially onto C57Bl6/J/ola/HSD.  
 
It is well known that differences in background strain can alter the phenotype of a 
genetic manipulation (Eisener-Dorman et al., 2009).  Each strain has unique 
background alleles that may interact with and modify the expression of a mutation or 
transgene, as well as the expression of proteins that can compensate for the action 
of the deleted gene.  Many examples of background-unique modifier genes have 
been shown. They may influence gene expression by suppressing or enhancing it, 
altering DNA transcription rates or mRNA stability, and inducing epigenetic effects, 
such as DNA methylation.  Recently Mineur et al. (2002) and Ivanco and Greenough 
(2002) have described opposite effects of a null mutation in the Fmr1 gene, 
reporting an increase in the size of the hippocampal intra- and infrapyramidal mossy 
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fiber terminal field when the mutation was on an FVB background, but a decrease 
when the mutation was on a C57BL6/J background. 
 
The technology for generating experimental transgenic mice of one background can 
lead to the insertion of unpredictable amounts of DNA from an entirely different 
background strain.  For example, the targeting constructs used for the generation of 
all the SynGAP deletions, as is standard practice, were derived from and injected 
into ES cells of various 129 lines (Magin et al., 1992).  Despite backcrossing onto 
other backgrounds it is likely that some 129 genetic material remains due to close 
linkage with the knock out locus, and it is possible that unlinked 129 loci also exist  
(reviewed in (Ridgway et al., 2007).   This ‘flanking gene effect’ has been shown to 
confound phenotypic analysis where a flanking gene, rather than the ablation itself, 
has been found to be responsible for the observed phenotypic effect (Cool et al., ; 
Kanagawa et al., 2000).  More generally, the expression levels of genes surrounding 
a transgenic locus are often found to be different to those from an undisrupted 
chromosome.  In this flanking gene model, the flanking DNA (from ES cells) 
contains polymorphisms that alter gene expression relative to the genetic 
background of the backcrossed mice (Valor & Grant, 2007).    
 
The effect of the deletion of SynGAP therefore may be quite different depending on 
the true genetic background of the experimental mice. 
 
The knock out allele 
Secondly, while an absence of SynGAP protein, using western blots probed with 
antibodies against the central domain, has been shown in all cases it is worth 
discussing that the genetic manipulation differs between the three mouse models.  
The point of insertion of the deletion cassette into the gene may be a factor in the 
variability of phenotype.  Of the three genetic manipulations the model used in this 
thesis, the Grant mouse, has the most downstream insertion point.  The Grant 
cassette excises the C2 domain and part of the GAP domain, whereas the Huganir 
cassette deletes from the middle of the more upstream PH domain, and the 
Kennedy deletion begins two exons upstream of the PH domain (Komiyama et al., 
2002; Kim et al., 2003; Vazquez et al., 2004).  The Grant mouse deletion cassette 
consists of a HA epitope tag followed by stop codons, an internal ribosome entry 
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site, the gene for beta galactosidase and a poly adenylation signal before an MC1 
neo polyA cassette.   Thus a stabilised bicistronic transcript consisting of the first 
few SynGAP exons followed by the lacZ coding region exists.  The Kennedy and 
Huganir mice rely on the removal of all translation starts sites and the frameshift 
effect of the deletion, given expected splicing events, to result in a premature stop 
codon.   
 
It is pure conjecture to suggest that these differences might affect phenotype but 
there are cases where the use of cryptic start sites can lead the translation of 
truncated proteins of unpredictable function.  In addition, it is possible that as yet 
unidentified isoforms of SynGAP exist and are expressed, for example, in western 
blots of tissue from the Huganir mouse a protein smear is detected about 10kDa 
lower than the position SynGAP would appear.  I will discuss in Chapter Five (p187) 
the possible expression in our mouse of a truncated N-terminal peptide with some 
unique amino acid sequence, described in Chapter Three (p108) as SynGAP B-shift 
.  
Although some differences may exist the phenotypes of the three mouse models are 
grossly similar in terms of deficits in synaptic plasticity and they all die postnatally . 
 
Compensation 
I mentioned above that differences in background may lead to differential 
compensation for the absence of an important molecule.  It is notable that in yeast, 
central metabolic pathways appear to have more alternatives than other pathways 
(Maltsev et al., 2005).  It has been found in an analysis of transcriptional and signal 
transduction networks that parallel pathways connecting a regulator to a regulated 
molecule are not, as is commonly perceived, rare but are actually quite common 
(Wagner & Wright, 2007).  Paralagous genetic redundancy is often cited as a 
mechanism to account for lack of a knockout phenotype and there are a number of 
genes with high homology to SynGAP.  For example, SynGAP is closely related to 
nGAP, DAB2IP and neurofibromin (NF1) and it is possible that these molecules 
could compensate for the action of SynGAP.  Alternatively compensation could 
occur at any other point in the signalling pathway. 
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Overexpression of SynGAP isoforms 
Overexpression of a range of SynGAP isoforms saw, as in the case of the knock 
out, no changes in mean protrusion length, width or density (Figure 4. 8).  Also like 
the knock out changes in the distribution of the data were observed.  There was a 
shift toward shorter spines irrespective of which isoform was overexpressed (Figure 
4. 9).  A shift toward shorter spines was also found when all SynGAP isoforms were 
knocked out, perhaps suggesting that the fine control exerted by endogenous 
SynGAP is required for normal protrusion outgrowth.  However the isoforms’ effects 
on the distribution of widths were not uniform.  Given previous work on the 
overexpression of SynGAP alpha-1 showing a reduction of synapse strength one 
might expect to see a decrease in spine width.  However, both SynGAPs with the 
alpha-1 C-terminal tail caused a change in protrusion width that involved a shift 
away from the thinnest and widest protrusions and an expansion of ‘medium’ widths. 
(Figure 4. 9, g)  One could suggest that this pattern could reflect an impairment of 
the SynGAP alpha-1 expressing spine to dynamically regulate its shape.  Or, if the 
thinnest spines bear silent synapses this change could be reflected 
electrophysiologically by a loss of the largest synapses.  By contrast, SynGAP A-
alpha-2 had no effect on protrusion widths (Figure 4. 9, e, g).  The lack of effect of 
SynGAP A-alpha-2 acts as an internal control for this experiment, indicating that the 
effects of SynGAP alpha-1 are due to its function rather than a non-specific effect of 
overexpression.  Mutation of the SynGAP alpha-1 PDZ binding domain destroyed its 
ability to rescue the enlarged mushroom heads (Vazquez et al., 2004) and 
enhanced synaptic transmission (Rumbaugh et al., 2006) of the knock out 
phenotype.  Therefore it is not surprising that SynGAP alpha-2 (which lacks the PDZ 
binding domain) does not affect spine shape.   
Localisation of overexpressed SynGAP isoforms 
Having shown that SynGAP A-alpha-2 does not effect spine shape, while SynGAP 
alpha-1 does have an effect, if was important to determine if overexpressed 
SynGAP A-alpha-2 was in fact present in spines.  We know from mass spectrometry 
analysis that SynGAPs A, B, alpha-1 and alpha-2 are all present in the PSD (Seth 
Grant, personal communication).  (Mass spectrometry data regarding SynGAP C is 
unobtainable as it, being a truncated protein, does not have any unique peptide 
sequences that can be identified.)  Unfortunately overexpressed proteins can be 
mislocalised, due to their high levels of expression trafficking and scaffolding 
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molecules can be saturated.   Therefore it is crucial to know if all the overexpressed 
SynGAP isoforms used in this thesis can be localised to synapses in order to 
interpret experiments which involve examination of synaptic function (Chapter 5).  In 
addition, differential localisation in itself indicates different roles for different 
isoforms.  
 
The dendritic expression patterns of overexpressed SynGAP provide some 
noteworthy and surprising findings.  The fact that SynGAP A-alpha-2 appears as 
competent as SynGAP A-alpha-1 in achieving punctate, apparently synaptic, 
expression in spines and on the dendritic shaft indicates a number of things (Figure 
4. 10, a, d).  First, SynGAP A-alpha-2’s lack of effect on protrusion width is not due 
its absence in spines.  Second, comparison with SynGAPs B and C-alpha-2 (Figure 
4. 10, g, h, k, l) , which display almost uniform distribution patterns, suggests that 
the ‘A’ unique peptide sequence may have an independent role in determining 
synaptic localisation.  This is the first indication of a role for an alternatively spliced 
N-terminal portion of SynGAP.  Further evidence for a role of the N terminus in 
determining synaptic localisation comes from a comparison between SynGAP 
alpha-1s with different N termini.  SynGAPs A and B –alpha-1 show high degrees of 
punctate expression with little diffuse dendritic stain but SynGAP C-alpha-1, 
although displaying some degree of punctate expression, has much more uniform 
expression on the dendritic shaft (Figure 4. 10, I, j).  These differences imply that the 
localisation may be a result of the combination of N and C-termini and not entirely 
determined by one end or the other.  One can envisage how this combinatorial 
schema could allow for very fine control of the positioning of SynGAP and potentially 
the alteration of functional outcomes. 
 
Finally, for the overexpression experiment outlined in this chapter and those 
described in Chapter 5, it is essential to rule out the possibility that any differential 
effects of the expression of SynGAP isoforms are not due solely to differences in 
their relative protein expression levels.  Quantification of the dendritic expression 
levels of SynGAP isoforms by confocal microscopy indicates that one isoform, 
SynGAP B-alpha-1 is expressed to a greater degree than all the other isoforms 
(Figure 4. 11).  This should be kept in mind when interpreting experiments involving 
its expression.  SynGAPs A and B-alpha-1 both had similar effects on spine width, 
despite different expression levels, which implies that the alpha-1 effect is a specific 
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one.  SynGAP A-alpha-2 is expressed at a comparable level to SynGAP A-alpha-1, 
again indicating that the effect of SynGAP alpha-1 is specific. 
 
To summarise, the previously published phenotype of enlarged dendritic spines in 
SynGAP -/-  cultured neurons is not recapitulated here; some differences are 
apparent but they are not consistent amoung tissue types, developmental stages 
etc.  The meaning of these changes, as well as possible causes for the lack of clear 
phenotype are discussed.  Overexpression of different SynGAP isoforms have no 
effect on mean dendritic spine morphology or density despite displaying different 
patterns of localisation. 
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This chapter is concerned with the functional implications of altering SynGAP 
expression.  As SynGAP is thought to regulate AMPA receptor trafficking I have 
examined AMPA receptor mediated currents in a range different manipulations of 
SynGAP expression.  Namely, I have studied AMPA receptor function in SynGAP -/- 
neurons, wild type neurons overexpressing various SynGAP isoforms, and SynGAP 
-/- neurons transfected with various SynGAP isoforms.   The chapter is divided into 
three parts to reflect these three manipulations. 
 
The central metric used is the examination of AMPA receptor mediated miniature 
post synaptic currents, known as mEPSCs or colloquially ‘minis’.  mEPSCs are 
currents recorded from a neuron when all action potentials are blocked in the neural 
network.  The lack of activity in the network ensures that all the currents recorded 
from the neuron are caused by spontaneous quantal neurotransmitter release from 
presynaptic neurons.  Synaptic vesicles are released from presynaptic termini in an 
infrequent and stochastic fashion so each postsynaptic current is the result of one 
packet of neurotransmitter binding to the post synaptic receptors.  mEPSCs 
therefore give us information about the AMPA receptor content specifically at the 
synapse. 
 
Simplistically, the amplitude of an AMPA mEPSC is determined by the number of 
AMPA receptors at a given synapse.  This truism holds up if the neurotransmitter 
content of synaptic vesicles is truly quantal.   The concept of quantal vesicular 
release has been the subject of great debate in recent years with studies indicating 
that  glutamate concentration within a synaptic vesicle may be a source of quantal 
size variation (Bekkers & Stevens, 1995; McAllister & Stevens, 2000; Wu et al., 
2007).  The strength of quantal transmission is consequently determined both 
presynaptically, through the magnitude of neurotransmitter release, and 
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postsynaptically, by the number and properties of the receptors available for 
activation.   
 
When single synapses are studied it is found that the median recorded size of 
mEPSCs is highly correlated with the current evoked by a saturating dose of 
glutamate (Liu et al., 1999).  This evidence suggests that, while we may not be able 
to calculate the absolute number of receptors at a synapse from mEPSC data, 
mEPSCs are still a useful too for comparing synaptic strength between treatments.  
This is especially true given the transfection conditions used in this thesis which 
ensure that only the post synaptic cell has been affected by overexpression.   
 
Classically, it is considered that changes in the frequency of mPSCs reflect a 
modification in the probability of the presynaptic transmitter release ((Del Castillo & 
Katz, 1954; Malgaroli & Tsien, 1992).  However, mEPSC frequency can also be 
determined by the number of synapses present and is influenced by the strength of 
synapses, which determines whether or not an mEPSC will be above the detection 
threshold.  It is likely that the synaptic currents generated at a significant proportion 
of synapses may not be detectable due to the low AMPA receptor content and that 
these synapses may be exposed electrophysiologically when additional AMPA 
receptors are added (Nusser et al., 1998). 
 
 
Previous work on SynGAP has demonstrated that in its absence mEPSCs are 
increased in frequency.  An increase in amplitude has been shown by one group, 
but another group sees no change (Vazquez et al., 2004; Rumbaugh et al., 2006).  
As one would expect, overexpression of SynGAP alpha-1 isoforms result in a 
decrease in mEPSC amplitude and frequency.  When the PDZ binding domain of 
SynGAP alpha- 1 is disrupted the decrease in mEPSC frequency and amplitude are 
no longer apparent (Krapivinsky et al., 2004; Rumbaugh et al., 2006).  There has 
been no work published on the function of other C-termini and the N-termini are 
never mentioned.  This chapter addresses this gap in the literature. 




Part One Electrophysiological properties of wild type and SynGAP -/- neurons. 
 
 
Part Two Electrophysiological properties of wild type neurons overexpressing 
various SynGAP isoforms. 
 
 
Part Three Electrophysiological properties of SynGAP -/-  neurons 
overexpressing various SynGAP isoforms. 
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5.2.1 Overview of Results 
 
Part One: Electrophysiological properties of wild type and SynGAP -/- neurons. 
Miniature excitatory postsynaptic currents (mEPSC) are revealed in whole cell patch 
clamp recordings of cultured neurons in the presence of tetrodotoxin (TTX).   
 
There is no difference in mEPSC amplitude or frequency between wild type and 
SynGAP -/- neurons in high density cortical, hippocampal and low density 
hippocampal cells. 
 
Whole cell NMDA and AMPA currents are unchanged in SynGAP -/- hippocampal 
cells but because capacitance is higher in the SynGAP -/-  neurons the NMDA 
current density is lower.  The AMPA/NMDA current density ratio remains 
unchanged. 
 
Despite the difference in capacitance measurement of cell soma size in fixed 
cultures does not indicate a difference in soma size between wild type and SynGAP 
-/- neurons. 
 
Part Two: Electrophysiological properties of wild type neurons 
overexpressing various SynGAP isoforms. 
 
A large proportion of wild type neurons overexpressing SynGAP isoforms with the 
alpha-1 C-terminus were found to entirely lack mEPSCs.  The extent of silencing 
was determined by which N-terminus was present.  The percentage of neurons 
categorised as silent is as follows: GFP (10.5%), SynGAP A-alpha-1 (72.6%), 
SynGAP B-alpha-1 (45%) and SynGAP C-alpha-1 (44.7%). 
 
Overexpression of SynGAP isoforms with the alpha-2 C-terminus did not cause 
silencing of mEPSCs.  The percentage of neurons categorised as silent is as 
follows: GFP (10.5%), SynGAP A-alpha-2 (14.3%), SynGAP B-alpha-2 (0%) and 
SynGAP C-alpha-1 (5%). 
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In the SynGAP expressing neurons that did have mEPSCs there was no difference 
in their amplitude compared GFP expressing control cells.   
In the minority of SynGAP A-alpha-1 cells that did have mEPSCs the frequency was 
lower than control cells.  
 
When all cells (silent and non-silent) were included in analysis the mEPSC 
amplitude and frequency of neurons overexpressing SynGAP alpha-1 isoforms was 
decreased.  The expression of SynGAP B-alpha-2 and C-alpha-2 caused an 
increase in mEPSC amplitude and frequency.  SynGAP A-alpha-2 had no effect on 
mEPSC amplitude or frequency. 
 
Silent cells expressing SynGAP alpha-1 did not have reduced total cell surface 
expression of AMPA receptors.  They have synaptic AMPA receptors and are 
innervated by functional presynaptic termini as they respond normally to action 
potential mediated input. 
 
Part Three: Electrophysiological properties of SynGAP -/- neurons 
overexpressing various SynGAP isoforms. 
 
As was the case with wild type neurons a large proportion of SynGAP -/- neurons 
overexpressing SynGAP isoforms with the alpha-1 C-terminus were found to lack 
mEPSCs.  The extent of silencing was determined by which N-terminus was 
present.  The percentage of neurons categorised as silent is as follows: GFP (20%), 
SynGAP A-alpha-1 (80%), SynGAP B-alpha-1 (100%) and SynGAP C-alpha-1 
(55%). 
 
Again, similar to the case in wild type neurons, overexpression of SynGAP A-alpha-
2 in SynGAP -/- cells did not cause silencing of mEPSCs (0% silent). 
 
In SynGAP -/- cells there was no difference in mEPSC amplitude or, in contrast to 
the scenario in wild type neurons, frequency between control cells and non-silent 
SynGAP expressing cells. 
 
Like the case in wild type neruons, when all cells (silent and non-silent) are included 
in the analysis mEPSC frequency and amplitude of SynGAP A-alpha-1 expressing 
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neurons is decreased, but that of SynGAP A-alpha-2 expressing neurons is 
unchanged. 
 
Expression of SynGAP A-alpha-1 in SynGAP -/- cells did not rescue the increase in 
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5.2.2 Part One: Electrophysiological properties of wild type and 
SynGAP -/- neurons. 
 
5.2.3 Spontaneous miniature excitatory postsynaptic currents 
(mEPSCs) 
Whole cell patch clamp recordings were performed on cultured neurons between 
DIV 9 and 14.  Spontaneous currents are evident when a neuron is voltage clamped 
at -70mV (Figure 5. 1).  The currents can be divided into two types; large currents, 
which are often organised into bursts, and small currents which are evident between 
the bursts.  Application of tetrodotoxin (TTX, 1 µM) and picrotoxin (PTX, 50 µM) 
abolishes the large amplitude events but leaves small amplitude events known as 
miniature excitatory postsynaptic currents (mEPSCs).  The AMPA receptor 
antagonist CNQX blocks all mEPSCs.  Some mEPSCs of a representative neuron 
are shown in (Figure 5. 1).  Examining mEPSCs on the most expanded time base 
reveals their characteristic fast risetime (~0.5 - 1 ms) and decay time constant (~ 4 - 
8 ms).  Events with amplitudes larger than 5 pA were analysed by measuring their 
peak amplitude, 10-90% risetime, decay time constant and frequency, as described 
in Methods (p82) 300 events were analysed per neuron.   
 
Data produced from the analysis of the representative neuron is shown in  
Figure 5. 2.  The mean and median mEPSC was created by aligning all the 
analysed events at the half maximal time point of the rising phases.  As is well 
established in the field   frequency histograms of all the analysed parameters reveal 
positively skewed distributions (Bekkers et al., 1990; McBain & Dingledine, 1992; 
Wyllie et al., 1994).  These non Gaussian distributions are maintained when a large 
population of mEPSCs is examined (5783 events from 19 cells in the case of Figure 
5. 3, a-d).     
 
A concern when recording in the whole cell configuration is the effectiveness of the 
voltage clamp over distance, the space clamp. Miniature synaptic events that are 
located at great distances from the cell soma can be filtered and will appear to have 
longer rise times, smaller amplitudes, and longer decays (Rall, 1969). There is no 
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correlation between mEPSC amplitude and risetime, or amplitude and decay time 
constant in the population examined here (Figure 5. 3, e,f).  This data suggests that 
the large variation in mEPSC amplitudes is not due to differential filtering of events 
arising at different locations on the dendritic tree. 
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Figure 5. 1 mEPSCs are revealed in the presence of TTX and abolished by CNQX 
An example voltage clamp recording of a DIV 10 cortical neuron held at the transmembrane 
potential of -70 mV. Large spontaneous inward currents are apparent in the absence of any 
drugs (a). These large currents are eliminated upon addition of 1µM TTX and reveal small 
amplitude spontaneous inward currents known as mEPSCs (b, mEPSCs shown with 
expanding time bases). mEPSCs are abolished by the addition of the AMPA receptor 
antagonist CNQX (5 µM) (c).   
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Figure 5. 2 mEPSC characteristics of an individual representative neuron. 
 
306 mEPSC events were recorded and analysed from one hippocampal neuron at DIV 10.  
(a) The mean and median mEPSC waveforms are calculated by horizontally aligning all 
mEPSCs at their half maximal risetime.  Frequency distributions for mEPSC amplitude (b, 
mean = 24.89 pA, median = 22.12 pA), 10 – 90 % risetime (c, mean = 0.87 ms, median = 
0.69 ms), decay time constant (d, mean = 3.14 ms, median = 2.83 ms) and inter event 
interval (e, mean = 1014 ms, median = 605 ms) are shown with mean (grey solid line) and 
median (red broken line) values highlighted.  The mEPSC frequency of this cell (the 
reciprocal of the mean inter event interval) is 0.98 Hz. 
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Figure 5. 3 mEPSC characteristics of a population of neurons. 
 
At least 300 events per cell were recorded and analysed from 19 hippocampal cells.  All 
5783 events were pooled to create frequency distributions for mEPSC amplitude (a, mean = 
23.91 pA, median = 18.04 pA), 10 – 90 % risetime (c, mean = 1.31 ms, median = 0.98 ms), 
decay time constant (c, mean = 5.69 ms, median = 3.99 ms) and inter event interval (d, 
mean = 305 ms, median = 150 ms).  The mean (grey solid line) and median (red broken line) 
values are highlighted.  There is no significant correlation between decay time constant and 
amplitude (e), or between the risetime and amplitude (f) in this population of mEPSCs (R
2
 = 
0.05 in both cases, Pearson’s correlation co-efficient, shown with a linear regression fit). 
Data are from 3 separate cultures. 
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5.2.4 Mean mEPSCs in SynGAP -/- neurons 
Wild type and SynGAP -/- neurons cultured from the cortex and hippocampus were 
examined at DIV 9 to DIV 14 (Figure 5. 4) Cells were plated at a reasonably high 
plating density (1500 neurons / mm2).  The mean mEPSC amplitudes of each cell 
were averaged to yield a population mean.   
 
Previous work has shown an increase in mEPSC amplitude and frequency in 
SynGAP -/- cultures (Vazquez et al., 2004; Rumbaugh et al., 2006).  However 
contrary to expectation mean mEPSC amplitudes and frequencies are unchanged in 
SynGAP -/- neurons under the various experimental conditions described below.   
Mean mEPSC amplitudes and frequencies are unchanged in SynGAP -/- cortical 
cells at different DIV (two way ANOVA,Figure 5. 4).  Mean mEPSC amplitudes and 
frequencies are unchanged between wild type and SynGAP -/- hippocampal cells at 
different DIV (two way ANOVA, Figure 5. 5).  However SynGAP -/- mEPSC 
frequency (+/- SEM) is increased from 4.74 +/- 0.86 Hz at DIV 9-10 to 12.53 +/- 4.16 
Hz at DIV 13-14, (two way ANOVA, p<0.05, post hoc Bonferroni test, p<0.05) 
whereas wild type mEPSC frequency is not (Figure 5. 5,c,d)  
 
When Vazquez et al. showed an increase in SynGAP -/-  mEPSC amplitude and 
frequency they used neurons cultured at the sparser plating density of 200 
cells/mm2.  In order to assess if plating density had an effect on the presence of the 
mEPSC phenotype hippocampal cells were cultured at the reduced plating density 
of 200 neurons/mm2.  Mean mEPSC amplitudes and frequencies are unchanged in 
SynGAP -/- sparsely cultured hippocampal cells at different DIV (two way 
ANOVA,Figure 5. 5)  
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Mean mEPSC amplitudes and frequencies from wild type and SynGAP 
-/-
  cultured cortical 
cells at DIV 9-11 and DIV 13-14,  (b, d, DIV 9 - 11; WT n = 11, SynGAP 
-/-
 n = 19, DIV 13 - 
14; WT n = 12, SynGAP 
-/-
 = 13), and each individual cell at each time point from wild type 
and SynGAP 
-/-
 cells (a,c, the mean is indicated by a horizontal line).  Data are from three 
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Mean mEPSC amplitudes and frequencies from wild type and SynGAP 
-/-
  hippocampal cells 
cultured at high (1500 neurons/mm
2
) and low (200 neurons/mm
2
) densities recorded at DIV 9 
- 10 and DIV 13 - 14.  The left panels (a,c) show each individual cell recorded at each time 
point from wild type and SynGAP 
-/-
 cells  (high density; DIV 9 - 10; WT n = 16, SynGAP 
-/-
 n 
= 24, DIV 13 - 14; WT n = 5, SynGAP 
-/-
 = 6, low density; DIV 10; WT n = 5, SynGAP 
-/-
 n = 5, 
DIV 14; WT n = 8, SynGAP 
-/-
 = 7 ), (the mean is indicated by a horizontal line).  The right 
panel (b,d) shows mean +/- SEM.  SynGAP 
-/-
 mEPSC frequency is increased from DIV 9 - 
10 (4.74 +/- 0.86 Hz) to DIV 13 - 14 (12.53 +/- 4.16 Hz) when cultured at a high density (two 
way ANOVA, p<0.05, post hoc Bonferroni test, p < 0.05*).  However wild type mEPSC 
frequency is increased from DIV 9 – 10 (1.48 +/- 0.98 Hz) to DIV 13 – 14 (8.65 +/- 3.12 Hz) 
when cultured at a low density (two way ANOVA, p < 0.01, post hoc Bonferroni test, p < 
0.05*).    Data are from five separate cultures. 
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5.2.5 mEPSC amplitude distributions in SynGAP -/- neurons 
While the mean mEPSC amplitudes of a population of cells may remain constant the 
distribution of the individual mEPSC amplitudes may change.  For example, a 
positive skew in the distribution could be masked by an increase in the maximal 
values, or an increase or decrease in a particular subset of events.  The entire 
pooled distribution of mEPSC amplitudes is shown as frequency distribution 
histograms in Figure 5. 6. 
 
As is expected neither wild type nor SynGAP -/- mEPSCs populations display a 
normal distribution at any age or in any cell type (D'Agostino-Pearson normality test,  
all p<0.0001) but there is little difference between the histogram profiles of wild type 
and SynGAP -/- mEPSCs.   The maxiumum amplitude mEPSC achieved by each 
individual cell was extracted to examine if this subset of the largest synapses was 
affected by the absence of SynGAP.  However there is no difference between wild 
type and SynGAP -/- in the maximal amplitude mEPSCs (Figure 5. 7. 
 
5.2.6 mEPSC amplitude and frequency covariance 
To assess if amplitude and frequency co-vary, and if this relationship is the same in 
wild type and SynGAP -/- neurons, I plotted the mean amplitude against the 
frequency for each individual cell (data not shown).  There is no statistically 
significant correlation between amplitude and frequency in cortical or high density 
hippocampal cells (Pearson’s correlation calculation).  However in hippocampal cells 
cultured at a low density (200 neurons/mm2) a weak correlation is apparent in 
SynGAP -/- cells at DIV 10 (WT r2 = 0.53, p > 0.05, n = 5, SynGAP -/-  r2  = 0.61, p < 
0.05, n = 8) and a stronger correlation in both wild type and SynGAP -/-  cells at DIV 
14; (WT r2 = 0.92, p < 0.01, n = 8, SynGAP -/- r2 = 0.76, p < 0.05, n = 7). 
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Figure 5. 6 Frequency histograms of mEPSC amplitudes from wild type and 
SynGAP 
-/-
 cortical, hippocampal and sparsely cultured hippocampal cells. 
 
Frequency histograms of amplitudes of all mEPSCs recorded from cortical neurons at DIV 9-
11 (a, WT n = 2718, SynGAP 
-/-
 n = 5207) and DIV 13-14 (b, WT n = 3355 , SynGAP 
-/-
 n = 
3951).  Frequency histograms of amplitudes of all mEPSCs recorded from hippocampal 
neurons at DIV 9-10 (c, WT n = 2978, SynGAP 
-/-
 n = 5126) and DIV 13-14 (d, WT n = 1468, 
SynGAP 
-/-
 n = 1686).  Frequency histograms of amplitudes of all mEPSCs recorded from 
sparsely cultured hippocampal neurons at DIV 10 (e, WT n = 1061, SynGAP 
-/-
 n = 1781) and 
DIV 14 (f, WT n = 1531, SynGAP 
-/-
 n = 2115).  Data are from three, three and two separate 
cultures respectively.  None of the distributions follow a normal distribution (D'Agostino-
Pearson normality test, all p < 0.0001) 
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Figure 5. 7 Maximum mEPSC amplitudes per cell in wild type and SynGAP 
-/-
 
cortical, hippocampal and sparsely cultured hippocampal cells. 
 
The maximum amplitude mEPSC of each cell from wild type and SynGAP 
-/-
  cortical cells at 
DIV 9-11 and DIV 13-14 (a, b, DIV 9 - 11; WT n = 10, SynGAP 
-/-
 n = 19, DIV14; WT n = 12, 
SynGAP 
-/-
 = 14), wild type and SynGAP 
-/-
  hippocampal cells at DIV 9 - 10 and DIV 13 - 14 
from high density (1500 neurons/mm
2
) and low density (200 neurons/mm
2
) cultures,  (c,d, 
high density; DIV 9 - 10; WT n = 16, SynGAP 
-/-
 n = 24, DIV13 - 14; WT n = 5, SynGAP 
-/-
 = 
6,  low density; DIV 10; WT n = 5, SynGAP 
-/-
 n = 5, DIV14; WT n = 8, SynGAP 
-/-
 = 7).  Each 
individual cell’s maximal amplitude is displayed in the adjacent scatter plot. Data are from 
three, three and two separate cultures respectively and are displayed as mean +/- SEM in 
b,d. 
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5.2.7 Whole cell currents  
Examining AMPA mEPSCs gives us information about AMPA receptor content at 
the synapse (with some caveats, to be discussed later).  It appears that this aspect 
of cellular function is largely unchanged in SynGAP -/- neurons under the 
experimental conditions described here.   
 
To obtain information about total receptor cell surface expression, synaptic  
and extra synaptic, saturating concentrations of AMPA (50µM) and NMDA (100 
50µM) were bath applied to elicit activation of all available AMPA and NMDA 
receptors.  An example recording is shown in Figure 5. 8 (a).  The agonist is applied 
until the inward current reaches a plateau, then washed out before reapplication to 
ensure a stable response.  The plateau current amplitude (pA) is normalised to the 
measured capacitance of the cell (pico Farads, pF) to yield a current density 
measurement (pA/pF).  Because total membrane capacitance is directly proportional 
to the membrane surface area the current density measurement is independent of 
cell size. 
 
Whole cell currents in SynGAP -/- neurons 
NMDA and AMPA whole cell currents are not different between wild type and 
SynGAP -/- hippocampal cells (t-test, p > 0.05), however the mean cell capacitance 
(+/- SEM) is increased from -50.5 +/- 4.5 pF in wild type cells to -73 +/- 5.2 pF in 
SynGAP -/- neurons (t-test, p < 0.01) (Figure 5. 8, a,b).  This suggests the SynGAP -/- 
neurons are larger.  As a result of the difference in cell capacitance the NMDA 
receptor current density is decreased from -18.6 +/- 1.9 pA/pF in wild type cells to -
12.8 +/- 0.8 pA/pF in SynGAP -/- neurons (t-test, p < 0.01) (Figure 5. 8, d).  The 
apparent decrease in AMPA receptor current density is not statistically significant (t-
test, p = 0.083).  Once the ratio of AMPA receptor current density to NMDA receptor 
current density is obtained, there again is no statistically significant difference 
between wild type and SynGAP -/- neurons (Figure 5. 8, e).   
 
 















































































































Representative recording of whole cell AMPA and NMDA currents from a hippocampal cell 
(a). Whole cell currents from wild type (n = 6) and SynGAP 
-/-
 hippocampal cells (n = 9) 
recorded at DIV 10 - 11 (b).  Capacitance is reduced in SynGAP 
-/-
  cells (c), (WT = 50.1 +/- 
4.5 pF, SynGAP 
-/-
 = 73 +/- 5.2 pF, t-test, p < 0.01**).  NMDA and AMPA current density 
(pA/pF) are calculated by normalising whole cell currents (pA) to capacitance (pF) (d). 
(NMDA receptor current density; WT = -18.6 +/- 1.9 pA/pF, SynGAP 
-/-
 = -12.8 +/- 0.8 pA/pF, 
t-test, p < 0.01**; AMPA receptor current density; WT = -9.1 +/- 1.9 pA/pF, SynGAP 
-/-
 = -5.9 
+/- 0.65 pA/pF, t-test, p = 0.083).    The ratio of AMPA receptor current density to NMDA 
receptor current density (e).  Data are from one culture only, and are displayed as mean +/- 
SEM.  Statistics are one way ANOVA followed by post hoc Tukey t-test. 
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Soma size and neurite projection in SynGAP -/- neurons 
To further investigate the unexpected increase in capacitance in SynGAP -/- neurons 
I measured the area of neuronal cell bodies in fixed GFP transfected wild type and 
SynGAP -/- hippocampal neurons from separate cultures (Figure 5. 9, a).  This 
measurement showed no difference in soma area between wild type and SynGAP -/- 
neurons at DIV 4-5 or DIV 10.  In the younger neurons I counted the number of 
neurites projecting from the soma (Figure 5. 9, b, c).  There is no difference between 
wild type and SynGAP -/- neurons in the number of projecting neurites (Figure 5. 9, 





















































Soma size was measured in GFP expressing wild type and SynGAP 
-/-
  hippocampal cells by 
outlining the cell body in a single epifluorescence image taken with a x40 objective (a).  
Cultures were fixed at DIV 5 and 10.  The major neurites projecting from the soma were 
counted in DIV 5 cultures. (b). (c) Example image processed in ImageJ, red dots indicate the 
neurites counted, yellow outline and white dots indicate the area measured.  Data are from 2 
DIV 5 and two DIV 10 cultures, n = 30 neurons per condition in all cases.  Scale bar is 10µm 
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5.2.8 Action potentials in SynGAP -/- neurons 
In current clamp SynGAP-/- neurons are observed to fire action potentials in a 
manner that is indistinguishable from wild type controls (data not shown).  They fire 
action potentials spontaneously and in response to stimulation of the culture with 
bicuculine and 4 amino-pyridine.   
 
5.2.9 The expression of a putative truncated form of SynGAP B 
During the cloning of SynGAP B fragments a novel form of SynGAP was found (see 
Chapter Three, p108).  This SynGAP contains a four base pair insertion at the end 
of the last SynGAP B specific exon.  These four base pairs constitute a frameshift 
mutation which, if translated, would lead to premature truncation.  This 92 amino 
acid fragment includes 53 novel residues not present in full length SynGAPs and 
would not be recognised by any available SynGAP antibody.  We do not know if this 
fragment, which we refer to as SynGAP B-shift, is expressed.  However, the entire 
length of the coding region for SynGAP B-shift is 5’ of the insertion site of the 
deletion cassette in the knock out animal used in this thesis.  It is conceivable 
therefore that SynGAP B-shift may be expressed in the SynGAP -/- mouse.  
As we do not know what effect, if any, the putative peptide may have on neurons, I 
assessed mEPSC amplitude and frequency in cells overexpressing SynGAP B-shift.  
There is no change from control levels in mEPSC amplitude or frequency when 













































Figure 5. 10 mEPSC amplitude and frequency in wild type cells overexpressing 
SynGAP B-shift. 
 
mEPSC amplitude means (a) recorded from wild type hippocampal neurons transfected with 
GFP only (n = 8) and SynGAP B-shift (n = 9).  Mean mEPSC frequencies are shown in (b).  
Individual cell values (amplitude mean and frequency) are displayed in the adjacent scatter 
plots, horizontal lines indicate the population mean.  Data were recorded at DIV 9 - 11 and 
are from two transfections from two cultures.                                            
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5.2.10 Part Two: Electrophysiological properties of wild 
type neurons overexpressing various SynGAP isoforms. 
 
5.2.11 Expression of SynGAP isoforms 
A range of SynGAP isoforms were expressed in wild type hippocampal cells to 
assess their effect on the electrophysiology of the neuron.  Three N-termini (A, B 
and C) were combined with two C-termini (alpha-1 and alpha-2), resulting in six 
distinct isoforms; SynGAP A-alpha-1, SynGAP B-alpha-1, SynGAP C-alpha-1, 
SynGAP A-alpha-2, SynGAP B-alpha-2 and SynGAP C-alpha-2.  SynGAP was co 
transfected with GFP to allow the identification of cells expressing SynGAP.  See 
Appendix 1 for the optimisation of the co-transfection protocol and confirmation of 
co-expression of GFP and SynGAP.  The transfection rate obtained is approximately 
0.5 - 1% of neurons (Appendix Figure 7. 1 Co-expression and transfection 
efficiency controls).  When a transfected cell is patched it is likely that only that post 
synaptic cell is affected by SynGAP overexpression.  I have never visually observed 
autaptic synapses.  All recordings were performed between DIV 9-11, the day after 
transfection (16 to 36 hrs after the transfection complexes were added to the cells).   
 
Great difficulty was experienced in obtaining good electrophysiological recordings 
from transfected cells.  Transfection conditions were optimised to improve the 
quality of recordings (Appendix 1). 
 
5.2.12 An observation: ‘Silent’ cells 
The primary observation I made when I began recording from neurons 
overexpressing SynGAP was that a large portion of the neurons transfected with 
isoforms ending in the C-terminal variant alpha-1 completely lacked AMPA 
mEPSCs.  Therefore I categorised neurons depending on whether they had any 
mEPSCs or not.  I term the neurons lacking any mEPSCs as ‘silent’ (Figure 5. 11)9. 
                                               
9
 Use of the term ‘silent cell’ should not be confused with the term ‘silent synapse’.  A silent 
synapse is defined as a synapse where an EPSC is absent at the resting membrane 
potential, but becomes apparent when the cell is depolarised ie silent synapses have an 
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A low noise recording of a minimum length of 2 minutes where no mEPSCs were 
apparent was required for a cell to be classified as silent.  No minimum recording 
length was necessary to designate a cell as non-silent, the appearance of obvious 
mEPSCs was sufficient.  Recording with high levels of noise but with mEPSCs 
distinguishable above the background noise were not included in this analysis. 
 
5.2.13 Silence in SynGAP transfected cells 
Neurons overexpressing SynGAP with an alpha-1 C-terminus were most likely to be 
silent, and within that group the extent of the silencing was determined by which N-
terminus was present  (Figure 5. 11)  
 
When expressing only GFP silence was observed in 10.5% of neurons.  When 
expressing SynGAP A-alpha-1 72.5% of neurons recorded from were silent.  This 
figure dropped to 45 and 44.7% silence in neurons expressing SynGAP B-alpha-1 
and SynGAP C-alpha-1 respectively.  If we take the data for GFP only expressing 
neurons to represent the level of silence we would expect to see in neurons a Chi 
square test for expected versus observed values can be performed.  All SynGAP 
alpha 1 isoforms are statistically significantly different from control (all p < 0.0001).  
In contrast, the expression of SynGAP alpha-2 isoforms does not increase the 
likelihood of a neuron being silent.  When SynGAP A-alpha-2 and SynGAP C-alpha-
2 were expressed 14.3% and 5% respectively of cells were silent (both p = 0.09, Chi 
square test).  However, no neurons expressing SynGAP B-alpha-2 were silent, this 
is different to control (p = 0.0009, Chi square test). 
 
                                                                                                                                     
NMDA receptor mediated response but no AMPA receptor mediated response (Kerchner et 
al., 2008; Liao et al., 1995; Isaac et al., 1995; Discussed later, 5.3.10).  









76 62 63 31 38 20n :
A B C A B C



















Figure 5. 11 Presence or absence of mEPSCs in wild type neurons transfected with 
various SynGAP isoforms. 
 
Hippocampal neurons were categorised as either having mEPSCs (upper portion of the bar) 
or not (silent, lower portion of the bar).  Data is displayed as a percentage of cells recorded 
from for each construct.  The percentage of neurons categorised as silent is as follows:  GFP 
only = 10.5%, SynGAP A-alpha-1 = 72.6%, p < 0.0001, SynGAP B-alpha-1 = 45%, p < 
0.0001, SynGAP C-alpha-1 = 44.7%, p < 0.0001, SynGAP A-alpha-2 = 14.3%, p = 0.09, 
SynGAP B-alpha-2 = 0%, p = 0.0009, SynGAP C-alpha-2 = 5%, p = 0.09.   The p value is 
from a Chi square test for expected v observed with GFP values are taken as the expected 
values.  Population Chi square test, p < 0.0001.  Data are from approximately 32 separate 
transfections from 16 separate cultures.  The total number of cells is displayed above each 
bar.  The C-terminal isoform alpha-1 is illustrated in the orange palette and alpha-2 is 
illustrated in the blue palette.  The N-terminal to which they are connected is illustrated by 
the depth of colour; darkest colour for A, middle colour for B and lightest colour for C. 
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I took two approaches to examine the effect of SynGAP overexpression on 
mEPSCs; the first involves analysing only the cells in which mEPSCs were present; 
the second involves including a representative value for each silent cell to allow all 
cells to be included in the analyses. 
 
5.2.14 Approach One: Exclusion of silent cells in mEPSC 
amplitude and frequency analysis: 
mEPSC amplitudes in non-silent SynGAP transfected cells 
The non-silent cells presented in the previous figure (Figure 5. 11) were analysed for 
mEPSC amplitude and frequency.  Mean mEPSC amplitudes are shown in Figure 
3.12.  One-way ANOVA indicates all the data was not sampled from groups with the 
same mean, p < 0.0001.  However despite the differences in silencing post-hoc 
Tukey t-tests indicate that there are statistically significant differences in mean 
mEPSC amplitudes only between alpha-1 isoforms and alpha-2 isoforms, but not 
between control and SynGAP transfected cells.  Table (b) in Figure 5. 12 includes 
the p values for all the pairwise comparisons. 
 
To reframe the experimental question to ask specifically if the expression of 
SynGAP alters mEPSC amplitude from control level, rather than between two 
SynGAPs, two additional post hoc tests were performed.  The Dunnett’s post hoc 
test compares all experimental groups to the control group only.  The Bonferroni test 
was applied to compare each group with control.  No SynGAP isoform was 
statistically significantly different from the GFP control in either test.  A single 
students t-test of control against SynGAP A-alpha-1 does reach statistical 
significance (p < 0.01). 
 
Bartlett’s test for equal variances was performed on the data set and concluded that 
the variances differ significantly (p = 0.015).  This variable spread of data can be 
seen when the mean mEPSC amplitude for each cell is displayed in a scatter plot 
(Figure 5. 12, a).   
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Using a cell’s median mEPSC amplitude to calculate the population 
mean 
If data are sampled from a Gaussian distribution then the mean and median will 
have very similar values, but if the distribution is skewed the values can differ a lot.  I 
have already shown (Figure 5. 2 and Figure 5. 3) how the population of mEPSC 
amplitudes are not a normally distributed population.  In order to asses if using a 
cell’s median mEPSC amplitude to calculate the population mean gives a different 
result I repeated the above analyses.  While the median mEPSC amplitudes are 
generally smaller than the mean the overall profile of the statistics remains very 
similar.  The median values, results of the ANOVA, post hoc Tukey t-tests and 
Dunnett’s tests are given in Table B of Figure 5. 12. 




















































22.32  +/- 
1.42
19.01   +/- 
1.06
Post hoc 
Dunnett's  test ns * ns ns ns ns ns ns ns ns ns *
ns ns ns ns ns ns ns ns ns ns ns ns
- - ns ns ns ns ns ns ** ** ** ***
- - ns ns ns ns * * * **
- - ns ns ns ns * *
Post hoc Tukey t-test - - ns ns ns ns




















Figure 5. 12 mEPSC amplitudes from non-silent wild type neurons transfected with 
various SynGAP isoforms. 
 
mEPSCs were recorded from hippocampal neurons transfected with GFP only or GFP and 
the SynGAP isoform indicated.  (a) The mean (or the median, values shown in table (b) only) 
mEPSC amplitude was calculated for each cell.  The mean (or the median) was then 
averaged to give a mean for the entire population.  Cell means are shown in scatter plots 
next to the population mean bar.  Statistical analyses yield slightly different results for the 
population means calculated from cell means or medians, (b).. Displayed are the p values 
from the post hoc Tukey and Dunnett’s t-test performed on values calculated from the mean 
(shaded box) or median (unshaded box),  p < 0.05*, p < 0.01 **, p < 0.001 ***.  A students t-
test of control vs SynGAP A-alpha-1 gives a p-value = 0.007.  The n numbers are; GFP, n = 
27, SynGAP A-alpha-1, n = 11, SynGAP B-alpha-1, n = 10, SynGAP C-alpha-1, n = 17, 
SynGAP A-alpha-2, n = 23, SynGAP B-alpha-2 n = 21, SynGAP C-alpha-2, n = 15.  Data are 
from 13 transfections from 9 separate cultures and are shown as mean +/- SEM. 
a 
b 
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mEPSC amplitude distributions in cells transfected with SynGAP 
isoforms 
To closer inspect the effect of SynGAP isoforms on mEPSCs I have plotted the 
frequency distribution of all events recorded from non-silent transfected cells (Figure 
5. 13).  Visual appraisal of the histograms gives rise to the impression that the 
SynGAP A-alpha-1 and B-alpha-1 distributions contain more small amplitude events 
than control, whereas SynGAP B-alpha-2 and C-alpha-2 distributions have less 
small amplitude events.  The distributions of SynGAPs C-alpha-1 and A-alpha-2 
seem to more closely match the distribution of control events. 
 
To quantify the changes in distribution I have categorised mEPSCs amplitudes as 
small (5 – 12 pA), medium (13 – 17 pA), large (18 – 27 pA) and very large (28 – 260 
pA) based on the quartiles of the control population (Figure 5. 14).  For example 
small amplitude events (5 -12 pA) constitute 25% of all events recorded from control 
cells.  
   
In the distribution of mEPSC amplitudes from SynGAP A-alpha-1 and B-alpha-1 
expressing cells a larger proportion of events are in the smaller amplitude range of 5 
– 12 pA (46% and 39% respectively).  Accordingly the largest amplitude range of 28 
– 260 pA contains a smaller proportion of SynGAP A-alpha-1 and B-alpha-1 events 
(7% and 14% respectively).  The distribution of SynGAP C-alpha-1 events is shifted 
slightly to the medium (13 – 17 pA, 29%) and large (18 – 27 pA, 30%) ranges and 
away from both small (21%) and very large (21%) ranges.  SynGAP A-alpha-2 
follows the control distribution very closely with approximately 25% of values in each 
category.  In contrast to SynGAP A-alpha-1 and B-alpha-1 distributions the 
distributions of SynGAPs B-alpha-2 and C-alpha-2 have a reduced proportion of 
events in the small (20% and 16% respectively) and medium (19% and 20% 
respectively) ranges and an increase in events in the very large category (36% and 
37% respectively).   
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Figure 5. 13 Frequency distributions of mEPSC amplitudes recorded from wild type 
neurons transfected with various SynGAP isoforms. 
 
Frequency histograms of mEPSC amplitudes recorded from hippocampal cells 
overexpressing SynGAP isoforms (coloured line) are overlayed on the histogram for GFP 
only expressing cells (filled grey area).  GFP, n = 7731, SynGAP A-alpha-1, n = 2756, 
SynGAP B-alpha-1, n = 2664, SynGAP C-alpha-1, n = 4044, SynGAP A-alpha-2, n = 6712, 
SynGAP B-alpha-2 n = 6824, SynGAP C-alpha-2, n=4383.  Data are from 13 transfections 
from 9 separate cultures. 
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Figure 5. 14 Further analysis by classification of mEPSC amplitudes in wild type 
neurons transfected with various SynGAP isoforms 
 
Classification of all mEPSCs recorded from neurons transfected with SynGAP isoforms into 
four amplitude categories; small (5-12 pA), medium (13 – 17 pA), large (18 – 27 pA) and 
extra large (28 – 260 pA).  The amplitude categories are based on the quartiles of the control 
population of events (illustrated by the orange broken line).  The n numbers are given in 
Figure 5. 12 
 
 
Maximum amplitude mEPSCs in SynGAP transfected cells 
Given the change in proportions of large amplitude events among cells transfected 
with different SynGAP isoforms (Figure 5. 14) I plotted the maximum amplitude 
mEPSC achieved by each cell to see if the very largest synapses were affected by 
SynGAP expression (data not shown).  The spread of the data is large but is 
statistically significant by one way ANOVA, however only SynGAP B-alpha-2 vs A-
alpha-1 (p < 0.01) and B-alpha-1 (p < 0.05) reach statistical significance by post hoc 
Tukey t-tests.  However a single students t-test of SynGAP A-alpha-1 against 
control shows a statistically significant decrease in maximum amplitude mEPSC 
reached by SynGAP A-alpha-1 expressing cells (p = 0.018). 
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mEPSC frequency in non-silent SynGAP transfected cells 
Analysis of mEPSC frequency in recordings from non-silent cells overexpressing 
GFP, SynGAP A, B, C-alpha-1 and A, B, C-alpha-2 are shown in Figure 5. 15.  The 
frequency of mEPSCs is generally more variable than that of their amplitude, this is 
evident when each cell is plotted in a scatter plot (Figure 5. 15, a).  According to a 
one way ANOVA is it unlikely that all of the groups are derived from populations with 
the same mean, p = 0.02.  However, no pair of conditions are statistically different 
from each other in pairwise comparisons (post hoc Tukey and Dunnett’s tests).  The 
variances are different between the groups (Barlett’s test for equal variances, 
p<0.0001) and the distributions not normal (D’Agostino and Pearson normality test, 
p<0.05 for all groups).   
 
Transformation of mEPSC frequency data   
I have transformed the data to equalise the standard deviations and make the 
distribution more Gaussian (Figure 5. 15, b). (Additional details regarding the data 
transformation are present in Methods,p86.).  The log of each frequency was 
obtained and then normalised to the mean log frequency of the GFP control.  The 
resulting data are normally distributed (D’Agostino and Pearson normality test, p 
values from 0.32 to 0.84) and no longer have unequal variances (Barlett’s test for 
equal variances, p = 0.56).  The data indicate the (log) fold change from control 
mean frequency. 
 
When the statistical analyses are repeated on the transformed data (Figure 5. 15, 
b), the mEPSC frequency in neurons expressing SynGAP A-alpha-1 is decreased 
from that in neurons expressing GFP only (one way ANOVA, p < 0.0001, post hoc 
Tukey t-test, p < 0.0001).  Additionally, neurons expressing SynGAP A-alpha-1 also 
have a slower mEPSC frequency than neurons expressing other alpha-1 isoforms 
(SynGAP B-alpha-1, p < 0.05, SynGAP C-alpha-1, p < 0.05) and alpha-2 isoforms 
(SynGAP A-alpha-2, p < 0.05, SynGAP B-alpha-2, p < 0.0001, SynGAP C-alpha-2, 
p < 0.0001).   SynGAP A-alpha-2 expressing neurons have a lower mean mEPSC 
frequency than neurons expressing SynGAP B-alpha-2 (post hoc Tukey t-test p < 
0.001). 

























































Figure 5. 15 mEPSC frequencies in non-silent wild type hippocampal neurons 
transfected with various SynGAP isoforms 
 
(a) mEPSCs were recorded from neurons transfected with GFP only or GFP and the 
SynGAP isoform indicated.  Each cell’s mEPSC frequency (Hz) is displayed in the scatter 
plot adjacent to the population mean bar (one-way ANOVA, p = 0.02, Bartlett’s test for equal 
variance, p < 0.0001).  (b) The mEPSC frequency (Hz) is displayed as a log (Hz) 
transformation normalised to the mean log of the GFP control (0.325) (one-way ANOVA, p < 
0.0001, Bartlett’s test for equal variance, p = 0.56).  Pairwise statistical significance between 
the following pairs was reached by post hoc Tukey t-tests; against SynGAP A-alpha-1; GFP, 
p < 0.0001***, SynGAP B-alpha-1, p < 0.05*, SynGAP C-alpha-1, p < 0.05*, SynGAP A-
alpha-2, p < 0.05*, SynGAP B-alpha-2, p < 0.0001***, SynGAP C-alpha-2, p < 0.0001*** 
;and SynGAP A-alpha-2 vs SynGAP B-alpha-2, p < 0.001**).  The n numbers are given in  
Figure 5. 12.  Data are from 13 transfections from 9 separate cultures and are shown as 
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5.2.15 Approach Two: Inclusion of silent cells in mEPSC 
amplitude and frequency analysis 
The second approach to examine the effect of SynGAP overexpression on mEPSCs 
was to include a representative value for silent cells so all cells could be included in 
the same analysis.  As it is possible that ‘silent’ cells do have mEPSCs, but that they 
fall below the detection threshold, this value (5pA) was assigned to silent cells for 
population mean calculations.  ‘Silent’ cells may also have detectable mEPSCs but 
they occur so infrequently that they are not seen during the recording period, 
therefore I assigned the slowest frequency observed (0.6 Hz) as the representative 
frequency value for silent cells.   
 
Figure 5. 16 shows that, when silent cells are included in the analysis, the mEPSC 
amplitude (a) and frequency (b) of all SynGAP-alpha-1 expressing neurons is 
decreased compared to control.  SynGAP A-alpha-2 expressing neurons are 
unchanged in both respects, in contrast to the increase in mEPSC amplitude 
induced by the expression of SynGAPs B-alpha-2 and C-alpha2.  SynGAP B-alpha-
2 also causes an increase in mEPSC frequency (Figure 5. 15, b).  Statistics and 
means are included in the Table C of Figure 5. 15.  The differences observed using 
this method of analysis, inclusion of silent cells, mirror those seen in the distributions 
of mEPSCs recorded from non-silent cells (Figure 5. 13 and Figure 5. 14).
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Figure 5. 16 mEPSC amplitude and frequency, including silent cells, in neurons 
overexpressing various SynGAP isoforms 
 
Recordings were made from hippocampal neurons transfected with GFP only or GFP and 
the SynGAP isoform indicated.  Neurons classified as ‘silent’ were assigned an amplitude of 
the detection threshold value (5pA, dotted line) and the frequency of the slowest cell 
recorded (0.06 Hz) for the purposes of calculating the population mean.  The mEPSC 
frequency (Hz) is displayed as a log (Hz) transformation normalised to the mean log of the 
GFP control (0.015). Statistics are one way ANOVA, (a, amplitude and b, frequency, both p 
< 0.0001), followed by post hoc Tukey t-tests. Pairwise comparisons against control are 
indicated by asterisks over the bar, p < 0.05*, p < 0.01**, p < 0.005***.  Additional pairwise 
comparisons are detailed in the accompanying table (c) of amplitude (shaded box) and log 
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5.2.16 Whole Cell currents in SynGAP alpha-1 transfected 
cells 
The decreases seen in mEPSCs in SynGAP-alpha-1 expressing neurons could be 
caused by a number of mechanisms; altered AMPA receptor surface expression, 
either globally or specifically at synapses (silent synapses), altered synapse number 
or altered neurotransmitter release.  In order to investigate the possibility that global 
receptor surface expression was being affected by SynGAP expression I assessed 
whole cell AMPA and NMDA currents in wild type hippocampal cells overexpressing 
SynGAP isoforms (Figure 5. 17).  Due to their effect in silencing mEPSCs this 
experiment was confined to examining SynGAP alpha-1 isoforms.   
 
If SynGAP was regulating the synaptic content of AMPA receptors one might expect 
total AMPA receptor surface expression to be altered.  However, apart from an 
increase in capacitance in neurons overexpressing SynGAP C-alpha-1 (86.12 +/- 
7.61 pF) compared to that of neurons overexpressing SynGAP B-alpha-1 (62.18 +/- 
4.37 pF, one way ANOVA, p = 0.04, post hoc Tukey t-test, p = <0.05, Figure 5. 15, 
c), there are no overall changes in AMPA or NMDA whole cell currents or current 
density in SynGAP-alpha-1 expressing cells (one way ANOVA, Figure 5. 15).  
Strikingly there is no correlation between a cell’s current density and its status as 
silent or non-silent (Figure 5. 15, d).  It would be expected that the ratio of AMPA 
receptor current density to NMDA receptor current density would be altered if 
SynGAP had a role in specifically regulating AMPA receptor trafficking to the cell 
surface. For example, if overexpression of SynGAP-alpha-1 isoforms led to a 
reduction of surface AMPA receptor, but not NMDA receptor, we would expect the 
AMPA/NMDA ratio to decrease.  Clearly there is no change in AMPA/NMDA ratio in 
SynGAP alpha-1 expressing neurons (Figure 5. 15, e).  
 
The lack of changes in AMPA and NMDA whole cell currents therefore leads me to 
conclude that SynGAP-alpha-1 expressing neurons have normal levels of surface 
expression of AMPA and NMDA receptors.  This finding reduces the likelihood that 
the reduction in mEPSCs is due to an increase in silent synapse number (see foot 
note 9, (Isaac et al., 1995; Liao et al., 1995; Kerchner & Nicoll, 2008)) . 
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This result presents us with a question.  If SynGAP-alpha-1 expressing neurons 
often lack mEPSCs, yet appear to have normal amounts of functional AMPA 
receptor, are they actually receiving presynaptic input? 
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Figure 5. 17 AMPA and NMDA whole cell currents in wild type neurons transfected 
with SynGAP alpha-1 isoforms 
 
Whole cell currents from wild type hippocampal cells transfected with GFP (n = 17), SynGAP 
A-alpha-1 (n = 14), SynGAP B-alpha-1 (n = 14) and SynGAP C-alpha-1 (n = 14), recorded at 
DIV 10-11 (b).   An example trace is shown in (a). Capacitance (c) is lower in cells 
expressing SynGAP B-alpha-1 (62.18 +/- 4.372 pF) compared to those expressing SynGAP 
C-alpha-1 (86.12 +/- 7.61 pF, t-test, p = 0.04).  NMDA and AMPA current density (pA/pF) are 
calculated by normalising whole cell currents (pA) to capacitance (pF) (d).  The current 
densities of the individual cells are shown in the adjacent scatter plots, the cell’s status as 
silent is illustrated by the colour red, the clear circles represent neurons that had mEPSCs.  
The ratio of AMPA receptor current density to NMDA receptor current density (e).  Data are 
from four transfections from three separate cultures, and are displayed as mean +/- SEM.  
Statistics are one way ANOVA followed by post hoc Tukey t-test. 
 
     
205 
5.2.17 Spontaneous and stimulated action potential mediated 
activity 
To address this question I removed TTX from the recording solution to allow the 
neurons to fire action potentials.  In this situation neurotransmitter release onto the 
postsynaptic patched cell is no longer limited to spontaneous quantal packets but is 
driven by the firing of presynaptic neurons.   When the cell is voltage clamped below 
firing threshold it cannot fire action potentials but we can monitor the flow of current 
into the cell caused by the firing of synapsing cells.  Spontaneous neurotransmitter 
release can still occur but cannot be definitively distinguished from action potential 
driven release  (Figure 5. 18, a). 
 
After monitoring spontaneous activity I stimulated the activity of the neural network 
to increase the excitatory input onto the patched cell.   To this end bicuculine (Bic, 
50 µM), which induces waves of firing by blocking the inhibitory GABA-A receptor 
thus reducing the inhibitory input in the network, and 4-amino pyridine (4-AP, 250 µ 
M), a potassium channel blocker which increases the intrinsic excitability of all 
neurons, were bath applied (Figure 5. 15, b). 
 
The spontaneous and stimulated activities of neurons expressing GFP only, 
SynGAP A-alpha-1, SynGAP B-alpha-1 and SynGAP C-alpha-1 were recorded.  
Figure 5. 15 (a) illustrates the spontaneous activity of a DIV 10 GFP transfected cell 
voltage clamped at -70mV.  mEPSC like events are observed and occasionally 
larger spontaneous events are observed (not in this example, see later examples in 
Figure 5. 19).  Bath application of Bic and 4-AP leads immediately to repeated 
influxes of current, which after an initial disorganised phase  (10-30s)  take on the 
form of bursts of inward current (Figure 5. 15, b).  These bursts correspond to action 
potential bursts of the presynaptic cells.  The inward currents are completely 
terminated by the addition of the AMPA receptor antagonist CNQX (5 µM) and are 
recovered when CNQX is removed (not shown).  Addition of TTX also blocks the 
large current bursts, confirming that they are action potential dependant, and 
exposes non action potential dependant mEPSCs (Figure 5. 15, d). 
 
Recordings of spontaneous (a, c) and stimulated (b, d) activity from neurons 
transfected with GFP and SynGAP A-alpha-1 are displayed in Figure 5. 19.  All GFP 
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expressing neurons examined (n=10) were found to have spontaneous EPSCs 
(Figure 5. 15, a).  25% of neurons (n=8) expressing SynGAP A-alpha-1 (Figure 5. 
15, c) and 12.5% of neurons (n=8) expressing SynGAP B-alpha-1 did not exhibit 
any spontaneous EPSCs.  All SynGAP C-alpha-1 expressing neurons examined 
(n=5) were found to have spontaneous EPSCs.  All neurons recorded responded to 
Bic/4-AP stimulation (Figure 5. 15, b, d).  The nature of the response was not 
observed to differ depending on whether or not SynGAP was expressed or on what 
SynGAP isoform was expressed (data not shown).  All inward currents were in every 
case terminated by the application of CNQX (data not shown).   
 
The conclusion of this experiment is that SynGAP alpha-1 expressing neurons are 
capable of receiving excitatory input mediated by AMPA/kainate receptors.  The 
incidence of silent cells that receive apparently normal AMAP mediated input 
indicates that silent cells are not dominated by silent synapses. 
 
Current clamp recordings show that SynGAP expressing cells are capable of firing 
action potentials (Figure 5. 20).  The traces shown are from cells stimulated with 
Bic/4-AP.  
 

















Figure 5. 18 Spontaneous and stimulated activity of a voltage clamped forebrain 
neuron at DIV10. 
 
Whole cell voltage clamp (-70mV) recording from a GFP transfected forebrain neuron at 
DIV10.  Spontaneous mEPSC like events are evident (a).  Simulation by bath application of 
Bic and 4-AP leads to bursts of inward current (b, and inset).   All currents are are terminated 
by the addition of CNQX (c) and return when CNQX is removed (not shown).  Addition of 
TTX removes large current bursts but mEPSCs remain (d).  Data is decimated by 10.  Inset 
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              a                                                       b 
 
             c                                                         d 
 
 
Figure 5. 19 Voltage clamp recordings of spontaneous and stimulated activity from 
neurons transfected with GFP and SynGAP A-alpha-1. 
 
Representative voltage clamp (-70mV) recordings of spontaneous (left panel) and Bic and 4-
AP stimulated (right panel) activity from neurons transfected with GFP only, shown in black 
(a, b), and SynGAP A-alpha-1, shown in orange (c, d), recorded at DIV10-11.  All currents 
were terminated by the application of CNQX.  Note that the y axis scale bar of stimulated 
traces (b, d) is half that of spontaneous traces (a, c).  Data was gathered from four 
transfections of two separate cultures of forebrain neurons. 
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  a 
 




Figure 5. 20 Current clamp recordings from neurons transfected with GFP and 
SynGAP A-alpha-1 
 
Representative current clamp (0 pA) recordings from neurons transfected with GFP only, 
shown in black (a), and SynGAP A-alpha-1, shown in orange (b), recorded at DIV10-11.  
These recordings are from the same cells as shown Figure 5. 19.  Data was gathered from 
four transfections of two separate cultures of forebrain neurons. 
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5.2.18 NMDA mEPSCs 
The conclusion that SynGAP alpha-1 expressing cells are capable of receiving input 
does not preclude the possibility that spontaneous quantal release from presynaptic 
cells may be affected.  An effective way to test for the release of glutamate is to look 
for the effect of its receptors activation.   Until now I’ve been looking to the AMPA 
receptor but presence of NMDA receptor mediated synaptic currents in the presence 
of TTX would serve as a control to indicate that spontaneous neurotransmitter 
release was occurring.   
 
In the conditions used to examine AMPA mEPSCs the NMDA receptor is blocked.  
The hyperpolarised membrane potential (-70 mV) ensures that the voltage 
dependant Mg2+ block of the channel is in place.  NMDA receptors do not contribute 
to the synaptic current under these conditions.  However if the membrane potential 
is held at a positive voltage the Mg2+ block is relieved and current can flow through 
the receptor.  Additionally positive membrane potentials are past the reversal 
potential for the NMDA receptor and so the NMDA current flowing will be reversed to 
an outward current. 
 
Background noise becomes a problem at positive membrane potentials due to 
ambient glutamate activating NMDA receptors in a manner unrelated to synaptic 
release.  In order to reduce noise and allow NMDA mEPSCs to be discerned I 
changed the internal pipette solution from the potassium based solution used in all 
previous experiments to a cesium based solution (see Methods, p81).  Cesium 
blocks potassium channels reducing total membrane conductance and therefore 
noise.  Using a cesium based internal solution rather than a potassium based 
internal does not have any effect on the shape of mEPSCs (data not shown).  
However, recordings made using a cesium based recording solution do have 
reduced background noise, particularly at positive membrane potentials. 
 
Figure 5. 21 shows representative traces recorded from a GFP expressing neuron 
voltage clamped at different transmembrane potentials.  AMPA mEPSCs are evident 
at -70 mV, but their amplitude decreases when the cell is held at - 40 mV due to the 
decrease in electrostatic driving force as the cell is brought closer to the reversal 
potential for AMPA receptors.  Some of the events here may have an NMDA 
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component as the Mg2+ block may be relieved.  Outward currents become apparent 
at positive membrane potentials.  The amplitude of these events is greater at + 60 
mV than at + 40 mV, again because due to the increase in electrostatic driving 
force.  The long decay time of the events indicates that they are NMDA mediated 
currents.  NMDA mEPSCs have a decay time constant of approximately 250 ms 




Figure 5. 21 Representative traces from a GFP transfected forebrain neuron voltage 
clamped at different transmembrane potentials recorded using a cesium based 
internal recording solution. 
 
Representative traces from a GFP transfected neuron voltage clamped at – 70 mV, - 40 mV, 
+ 40 mV and + 60 mV.  In contrast to all previous data these traces were recorded using a 
cesium based internal recording solution instead of a potassium based internal recording 
solution.  Inward AMPA mEPSCs are evident at - 70 and - 40 mV, outward currents become 
apparent at + 40 mV but are much clearer as NMDA mEPSCs at + 60 mV.  Data is 
decimated by 10. 
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NMDA mEPSCs in cells transfected with SynGAP alpha-1 
Having shown that NMDA mEPSCs are detectable in control cells with normal 
AMPA mEPSCs I went on to test if NMDA mEPSCs are also detectable in SynGAP 
A-alpha-1 expressing cells silent for AMPA mEPSCs.   Shown in  
Figure 5. 22 are two cases of cells transfected with SynGAP A-alpha-1 in which no 
mEPSCs were present when the cell was voltage clamped at -70 mV.  When the 
cells were held at + 60 mV there were obvious NMDA mEPSCs.  I recorded from 
another two silent cells in which there were indications of NMDA mEPSCs at + 60 
mV.  There were two silent cells in which there were clearly no NMDA mEPSCs at + 
60 mV (Figure 5. 22, lower traces).   The NMDA mEPSCs were not analysed but 







Figure 5. 22 Representative traces from three SynGAP A-alpha-1 transfected 
forebrain neurons recorded using a cesium based internal recording solution. 
 
Representative traces from three SynGAP A-alpha-1 transfected neurons voltage clamped at 
– 70 mV (left panel) and + 60 mV (right panel) recorded using a cesium based internal 
recording solution. 
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5.2.19 Part Three: 
5.2.20 Electrophysiological properties of SynGAP -/- neurons 
overexpressing various SynGAP isoforms. 
 
Part Two has concentrated on the effect of individual SynGAP isoforms expressed 
on a wild type background.  It is not known what SynGAPs are expressed in vivo 
and the presence of these endogenous SynGAPs may confound the effect of activity 
of the overexpressed isoform.  In order to examine to effect their effect in the 
absence of endogenous isoforms various SynGAPs were transfected into  SynGAP  
-/- neurons.  This experiment was confined to SynGAP-alpha-1 isoforms, which had 
varying silencing effects in wild type neurons, and SynGAP A-alpha-2, which did not 
have a silencing effect. 
5.2.21 Silence in SynGAP transfected SynGAP -/- cells 
The levels of silence observed in cells transfected with SynGAP isoforms is 
comparable between wild type cells and in SynGAP -/- cells (Figure 5. 23 for 
SynGAP -/- data, Figure 5. 11 for wild type data).  Silence was observed in 20% of 
neurons of control SynGAP -/- cells.  When expressing SynGAP A-alpha-1 80% of 
neurons recorded from were silent (Figure 5. 23, a).  All SynGAP B-alpha-1 cells 
and 55% of SynGAP C-alpha-1 were silent.  No SynGAP A-alpha-2 expressing cells 
were silent (Chi squared test, p<0.001).  (Note the lower n numbers for B and C 
alpha-1). 
5.2.22 mEPSC amplitude and frequency in SynGAP 
transfected SynGAP -/- cells 
When silent cells are excluded the amplitude and frequency of the recorded 
mEPSCs of SynGAP overexpressing neurons are no different from control (Figure 5. 
23, b, c).  However differences become apparent when representative threshold 
values are included for silent cells (see page , for approach two) (Figure 5. 24).  
Similar to the case of overexpression in wild type neurons (Figure 5. 16), both 
mEPSC amplitude and frequency are reduced in neurons overexpressing SynGAP 
A-alpha-1 (compared to control and SynGAP A-alpha-2).  Again, SynGAP A-alpha-2 
overexpression has no effect.    





































































Figure 5. 23 AMPA mEPSCs in SynGAP 
-/-





 forebrain neurons were transfected with SynGAPs A, B and C -alpha-1 and 
SynGAP A-alpha-2.  (a) Neurons were categorised as either having mEPSCs (upper portion 
of the bar) or not (silent, lower part of the bar).  Data is displayed as a percentage of cells 
recorded from for each construct.  The percentage of neurons categorised as silent is as 
follows:  GFP only = 20%, SynGAP A-alpha-1 = 80%, p < 0.0001, SynGAP B-alpha-1 = 
100%, SynGAP C-alpha-1 = 55, SynGAP A-alpha-2 = 0%.  Population Chi square test, p < 
0.0001. The total number of cells is displayed above each bar.  mEPSC amplitudes (b) and 
frequencies (c) from a set of non-silent cells were analysed for SynGAP A-alpha-1 (n = 8) 
and A-alpha-2 (n = 10) .  Individual cells’ mean mEPSC amplitude is displayed as a scatter 
plot adjacent to the population mean bar.  Data are displayed as mean +/- SEM and are not 
statistically significantly different, one way ANOVA.  Data were gathered from 5 transfections 
from 3 separate cultures.                                                                                     












































Figure 5. 24 AMPA mEPSCs amplitude and frequency, including silent cells, in 
SynGAP 
-/-




 forebrain neurons were transfected SynGAP A-alpha-1 or A-alph-2.  Neurons 
classified as ‘silent’ were assigned an amplitude of the detection threshold value (5pA, 
dotted line) and the frequency of the slowest cell recorded (0.24 Hz) for the purposes of 
calculating the population mean.  a) mEPSC amplitude, one way ANOVA, p < 0.01, post hoc 
Tukey t-tests; Control (13.36 +/- 1.71 pA) Vs A-alpha-1 (20.15 +/- 1.03 pA), p <0.05*; A-
alpha-1 20.15 +/- 1.03 pA) Vs A-alpha-2 (16.94 +/- 1.29 pA), p < 0.001***.  b)  mEPSC 
frequency, one way ANOVA, p < 0.001, post hoc Tukey t-tests; Control (1.06 +/- 0.25 Hz) Vs 
A-alpha-1 (0.41 +/- 0.07 Hz), p< 0.05*; A-alpha-1 (0.41 +/- 0.07 Hz ) Vs A-alpha-2 ( 1.29 +/- 
0.34 Hz), p < 0.001***.   Data are displayed as mean +/- SEM.  Data were gathered from 5 
transfections from 3 separate cultures 
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5.2.23 Whole Cell Currents in SynGAP transfected SynGAP -/- 
cells 
Whole cell currents were recorded from SynGAP -/- cells expressing GFP only and 
SynGAP A-alpha-1 alongside littermate wild type cells (Fig 3.24).  The wild type 
versus SynGAP-/- data has been presented earlier in Part One (fig 3.8) where an 
increase in capacitance in SynGAP -/- neurons was reported. The increase in 
capacitance in SynGAP -/- cells is not rescued by the expression of SynGAP A-
alpha-1, and consequently neither is a decrease in NMDA receptor current density.  
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Figure 5. 25 NMDA and AMPA whole cell currents in SynGAP 
-/-
 neurons transfected 
with SynGAP A-alpha-1. 
 
(a) Whole cell currents from wild type GFP (n = 6), SynGAP 
-/-
 GFP (n = 9) and SynGAP 
-/-
  
transfected with SynGAP A-alpha-1 (n = 9).  Capacitance is increased in SynGAP 
-/-
  cells 
(b), (WT GFP = 50.1 +/- 4.5 pF, SynGAP 
-/-
 GFP = 73 +/- 5.2 pF, SynGAP 
-/-
 expressing A-
alpha-1 = 69 +/- 4.27 pF, one way ANOVA, p = 0.012, post hoc Tukey t-test, WT GFP vs 
SynGAP 
-/-
 GFP, p < 0.05*, WT GFP vs SynGAP 
-/-
  transfected with SynGAP A-alpha-1, p < 
0.05*).    (c) NMDA and AMPA current density (pA/pF) is calculated by normalising whole 
cell currents (pA) to capacitance (pF).  NMDA receptor current density is reduced in SynGAP 
-/-
 cells irrespective of whether they are transfected with SynGAP A-alpha-1 or not (WT = -
18.6 +/- 1.9 pA/pF, SynGAP 
-/-
 = -12.8 +/- 0.8 pA/pF; SynGAP 
-/-
  transfected with SynGAP A-
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alpha-1 = -14 +/- 0.9 pA/pF,  one way ANOVA, p = 0.0076, post hoc Tukey t-test, WT GFP 
vs SynGAP 
-/-
 GFP, p < 0.01**, WT GFP vs SynGAP 
-/-
  transfected with SynGAP A-alpha-1, 
p < 0.05*). (d) The ratio of AMPA receptor current density to NMDA receptor current density.  
Data are from one culture only, and are displayed as mean +/- SEM.  The wild type and 
untransfected SynGAP 
-/-
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5.3 Discussion 
5.3.1 Part One:   
 
The object of the work outlined in this chapter was to establish if SynGAP isoforms 
have differential effects on the electrophysiological properties of neurons.  The initial 
aim was to reproduce a previously published result showing that in the absence of 
SynGAP AMPA receptor mediated mEPSCs were increased in both amplitude and 
frequency.  This result is consistent with the associated finding of increased 
mushroom type spines in SynGAP -/- neurons (see Chapter One. Figure 1. 3).  The 
envisaged next step was to then express various SynGAP isoforms in SynGAP -/- 
neurons and assess if there was a difference in their ability to rescue the knock out 
phenotype.   
 
However, in the experiments performed for this thesis, there is no difference 
between wild type and SynGAP -/- mEPSC amplitude or frequency (Figure 5. 4 to 
Figure 5. 7).  Experimental protocol was altered in order to closely adhere to 
conditions used in the previous work (cultured hippocampal cells in FBS free growth 
media at 200 neurons/mm2) but the reported phenotype was not observed.  This 
result is constant in cultures derived from cortical and hippocampal tissue (the areas 
with the highest expression of SynGAP) (Kim et al., 1998; Barnett et al., 2006), 
examined at different ages and grown at different cell densities.     
 
5.3.2 Why is there no phenotype in this SynGAP -/- mouse? 
The question therefore arises, why have I found no phenotype?   
Up until this thesis there was no evidence to show that different SynGAP isoforms 
have opposing effects on synaptic function.  Given this information one could easily 
hypothesise that the removal of all isoforms may have no net effect, thus the lack of 
phenotype is consistent with the differential effect of different forms.  However, other 
groups have shown a phenotype in the SynGAP -/- and this needs to be discussed. 
The first thing to be addressed is to determine if the experimental system is 
behaving in an expected manner.   
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Is the neuronal culture behaving as expected? 
Morphologically the cultured neurons used are healthy and similar in appearance to 
other preparations.  The electrophysiological criteria for inclusion in experiments 
include a holding current and noise cut off point which eliminates unstable and 
compromised neurons.    
Electrophysiologically the neurons appear to be normal (Figure 5. 1-Figure 5. 3). 
Spontaneous action potential driven activity is observed in voltage clamp, often in 
bursts, indicating that a neuronal network has formed.  The action potential driven 
events are sensitive to TTX leaving small EPSCs which can now be defined as 
miniature EPSCs (Figure 5. 1). mEPSCs are known to be action potential 
independent that events arise due to the spontaneous fusion of presynaptic vesicle 
membranes and the subsequent release of their contents into the synaptic cleft.  
The mEPSCs are completely abolished by the AMPA receptor antagonist CNQX 
confirming that they are AMPA receptor mediated events.  The mEPSCs observed 
have the characteristic fast decay time constant (5.7 ms) and fast rise time (1.3 ms).  
The distributions of mEPSC amplitude, risetime, decay time constant and inter event 
interval display the expected non-normal distribution with a positive skew in 
individual cells as well as in the pooled population (Figure 5. 2, Figure 5. 3).  There 
is a wealth of data in the literature showing this distribution of mEPSCs  (Jonas et 
al., 1993); (Bekkers et al., 1990; McBain & Dingledine, 1992; Wyllie et al., 1994) 
 
The mean values for mEPSC amplitude correlate very well with those of other 
neuronal culture systems in other labs.  The mean mEPSC frequency (from 3 Hz to 
12 Hz) is occasionally higher than most published values which tend to range from 
0.5 Hz to 5 Hz (Kato et al., 2007), (Li et al., 1998), (Rumbaugh et al., 2006) but there 
are reports of higher frequencies (~ 10 Hz) (Fu et al., 2007) .  Indeed the control 
frequency published by  (Vazquez et al., 2004) is exceptionally low at 0.2 Hz.  All 
electrophysiological experiments were performed on cultures maintained without 
FBS and so have low levels of glial cells.  One could suggest that the high variability 
of mEPSC frequencies observed could be due to the variability of modulation of 
neurotransmitter release by astrocytes (Fiacco & McCarthy, 2004; Perea & Araque, 
2007).   
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Amplitude is observed to correlate with neither decay time constant nor risetime 
indicating that the large variation in mEPSC amplitudes is not due to differential 
filtering of events located at a range of distances from the soma. 
 
Taken together the characteristics described above indicate that the tissue culture 
system is functioning as expected.  Indeed the behaviour of the neurons is 
remarkably reflective of that in vivo despite the absence of cytoarchitecture and 
environment.   
 
Protocol, analysis or test material? 
The absence of a reported phenotype then must be due to differences in protocol, 
analysis or test material.  In the previous chapter I also discussed possible reasons 
for the absence of phenotype in the SynGAP -/- mouse, these reasons remain 
unchanged so some repetition here is unavoidable.   
 
Protocol 
To address protocol, I have previously stated how experimental conditions were 
manipulated in order to replicate conditions in which a SynGAP -/- phenotype were 
observed.  Initially cortical neurons were used, then hippocampal when no 
phenotype was seen, then low density when no phenotype was seen at high 
density.  All these experiments were performed in the absence of FBS and at 
different DIV.  Clearly variation in experimenter may also be implicated but beyond 
strict adherence to protocol this cannot be controlled for.  If the phenotype was 
subtle it is plausible that slight alterations in experimental technique could perturb 
the outcome, however the published results indicate a 70% increase in amplitude 
and a 150% increase in frequency (Vazquez et al., 2004).   
 
Analysis 
Disparity in methods of analyses can lead to divergent conclusions from the same 
data set.  How do I know that the method of analysis used here is not masking a real 
difference that exists in the data?  To address this I went beyond merely calculating 
the mean mEPSC amplitude, and looked also at the distribution of the pooled event 
population (Figure 5. 6) and the maximum amplitude mEPSC per cell (Figure 5. 7).  
An alteration in these parameters would signify a change in a subset of synapses 
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that could be missed by looking at the mean only.  Nevertheless, the resemblance of 
the distribution of wild type to SynGAP -/- events is striking and there is no difference 
in the maximum mEPSC amplitude attained by the individual cells.   
The method of analysis of individual events is a manually overseen semi automated 
fitting of the waveforms which is performed blind.  The inhouse programme is 
internally consistent and the rare case of a misfitting is manually corrected.  
Therefore I am satisfied that if a difference were present it would be exposed.  
 
Test material : the SynGAP -/- mouse 
A richer seam of conjecture lies in the existence of different mouse models of 
SynGAP -/- .  The differences between the models and the possible reasons that 
these might cause differences in phenotype to arise have been outlined in detail in 
the discussion of Chapter 4 (p160).  In this Chapter I have begun to address an 
additional concern regarding our knock out model.  
 
SynGAP ‘B-shift’ in the SynGAP -/- mouse? 
As detailed in Chapter One we have cloned a novel SynGAP transcript that includes 
a 4 bp insertion at the end of the last SynGAP B specific exon.  This insertion 
causes a frameshift mutation that would lead to the expression of a truncated form 
of SynGAP.  Due to the more downstream integration point in the Grant mouse the 
entire coding region of this putative truncated SynGAP is present in the knockout 
mRNA transcript.  The transcripts in the Kennedy and Huganir mice on the other 
hand would not contain the full coding sequence for what we have termed SynGAP 
B-shift. 
 
It is conceivable, but unlikely, that SynGAP B-shift might be expressed and in some 
way affect the penetrance of the knock out phenotype.  Quite separately, it is 
possible that SynGAP B-shift is expressed and does have a function but its 
presence in the SynGAP -/- mouse is unrelated to the lack of phenotype.  It may not 
be expressed at all, or if expressed, it may produce a non-functional peptide. 
 
Unfortunately, there is no antibody against epitopes of the SynGAP B-shift peptide 
so we cannot test for its existence.  Therefore we do not know if it is present in the 
wild type case or in the SynGAP -/- mouse.  I have attempted to address the 
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question of whether or not SynGAP B-shift has any function by transfecting wild type 
neurons with SynGAP B-shift and assessing the effect on AMPA mEPSCs (Figure 5. 
10).  The mEPSC amplitude and frequency are no different in SynGAP B-shift 
transfected cells compared to control cells.  We can conclude regrettably little from 
this outcome, other than that SynGAP B-shift does not have a strong effect on 
AMPA receptor presence at synapses when overexpressed in a neuron that 
contains all the normally expressed SynGAPs.  Ideally, the creation of a specific 
antibody would allow us to determine if SynGAP B-shift exists, if it exists in the 
knockout and therefore if this line of investigation is worth pursuing.  In the absence 
of an antibody one could create a tagged SynGAP B-shift and assess if in cultured 
SynGAP -/- cells it is able to reach synapses as an indication of potential synaptic 
function. 
 
At this time however discussion of a putative peptide’s potential role in the non-
existence of a phenotype is mere speculation. 
 
5.3.3 Total receptor expression in SynGAP -/- neurons 
It is clear that the SynGAP -/- neurons used here do not exhibit altered synaptic 
content of AMPA receptors.  However mechanisms do exist whereby synaptic and 
extra-synaptic AMPA receptor content is differentially regulated (to be further 
discussed later in this chapter, p227).  To assess the total cell surface receptor 
content I bath applied AMPA and NMDA in saturating quantities in order to activate 
all available receptors (Figure 5. 8).  Previous work has shown that SynGAP effects 
AMPA receptor, but not NMDA receptor, trafficking and my finding of no difference 
between the whole cell currents elicited by NMDA application supports this view.  I 
find no difference in the currents elicited by AMPA application, agreeing with my 
finding of no difference in AMPA mEPSCs.  As I have discussed, my AMPA mEPSC 
finding is in opposition to previously published results, however total AMPA receptor 
surface expression has not been functionally assayed in any other SynGAP -/- 
mouse 10.  It would be interesting to see if, in SynGAP -/- mice with mEPSC defects, 
                                               
10
 Quantification of cell surface expression of puncta of certain AMPA receptor subunits have 
been examined by immunocytochemistry (Kim et al., 2003) and electrophysiological 
assessment of AMPA receptor function has been confined to synaptic assays (Komiyama et 
al., 2002; Rumbaugh et al, 2006). 
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total cell surface AMPA receptor expression is affected or if the effect is specific to 
synapses. 
   
5.3.4 Cell size 
One surprising difference between wild type and SynGAP -/- neurons is that I found 
SynGAP -/- neurons have higher capacitance indicating that they are larger (Figure 
5. 8, c).  This is a highly unexpected result that has not been previously described.  
It has been shown that SynGAP -/- pups, while they appear similar at birth, do not 
grow and are often smaller than wild type littermates (Knuesel et al., 2005; Porter et 
al., 2005)  however making a comparison between animal size and the size of a cell 
in a dish is no doubt fallacious.   
To further investigate the result of higher capacitance in SynGAP -/- neurons I turned 
to GFP transfected fixed tissue which allowed the use of different techniques of cell 
size analysis to determine if the effect was real.  Measurement of GFP expression 
neuron’s soma area in epifluorescence microscopy images indicated there was no 
difference in size between wild type and SynGAP -/- neurons (Figure 5. 9).  Counting 
the numbers of projecting neurites in young cultures (DIV 5) also suggested there 
was no difference in the early outgrowth of neurons.  The difference in 
electrophysiological capacity therefore was not mirrored by morphological analysis.  
Additional experiments are required, the capacitance result comes from one culture 
only, but we could suggest that SynGAP -/- neurons respond differently to the 
extracellular recording solution.  Perhaps they are more sensitive than wild type 
neurons or more prone to swelling.  If this is the case the affect is not strong enough 
for it to influence the health of the neurons as assayed by electrophysiological 
criteria (holding current, noise) or morphology, as these parameters are unchanged 
between wild type and knock out.  Kneusel et al have shown increased neuronal 
apoptosis in brains of  SynGAP -/- mice (Kennedy) but I do not see differential rates 
of cell survival in culture (Figure 4. 3). 
 
Although whole cell AMPA and NMDA currents are unchanged in SynGAP -/- 
neurons, because the capacitance is increased, the current density (that is the 
whole cell current normalised to capacitance) of the NMDA current is significantly 
decreased in SynGAP -/- neurons (Figure 5. 1, d).  SynGAP has never been shown 
to affect the NMDA receptor and it should be pointed out that AMPA receptor current 
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density also displays a trend toward reduction (p = 0.083) and that statistical 
significance would likely be reached if additional experiments were performed.  
Despite this the ratio of NMDA to AMPA receptor current density is unchanged 
between wild type and SynGAP -/-  
 
From this set of experiments we can conclude that in the mouse model investigated 
here the absence of SynGAP does not affect synaptic or extra-synaptic expression 
of AMPA receptors.  To reiterate, the finding of no phenotype in the case where 
different isoforms have opposing functions is internally consisitent and could 
potentially render the appearance of a phenotype more sensitive to the factors 




5.3.5 Part Two: 
Although the initial aim of this project was to overexpress individual SynGAP 
isoforms in SynGAP -/- cells the absence of a knock out phenotype for a large part 
invalidates the rational for that experiment.  Although there are clear advantages to 
that approach (Part Three is concerned with SynGAPs expressed in knock out cells) 
the difficulty in obtaining SynGAP -/- tissue lead me to perform a majority of 
overexpression experiments in wild type neurons.   
 
5.3.6 Silent cells  
The most striking finding is that a large portion of neurons overexpressing SynGAPs 
that terminated in the ‘alpha-1’ C-terminal tail entirely lacked AMPA mEPSCs 
(Figure 5. 11).  While a depressing effect on mEPSCs has been demonstrated 
previously for SynGAP alpha-1 no one has ever looked at the effect of the N-
terminus on the functionality of the C-terminus.  Here I show that the extent of this 
mEPSC ‘silencing’ phenomenon is dependent on which N-terminal variant the 
alpha-1 was linked to.  SynGAP A-alpha-1 had the strongest silencing effect and 
SynGAPs B and C-alpha-1 had a milder silencing affect.  In stark contrast to the 
silencing effect of alpha-1 isoforms the alpha-2 isoforms did not increase the 
percentage of silent cells from control values.   
     
225 
 
Previous work examining the effect of SynGAP overexpression has been confined to 
only one isoform, SynGAP C-alpha-1.  When Rumbaugh et al. (2006) 
overexpressed an N-terminally linked GFP fusion SynGAP C-alpha-1 they observed 
a 50% decrease in mEPSC amplitude and an 85% decrease in mEPSC frequency.  
No mention is made of the proportion of neurons that did or did not have mEPSCs.  
Mutation of the last residue of the protein (QTRV/E), part of the PDZ binding 
domain, removed the ability of SynGAP to decrease mEPSC amplitude and 
frequency.  The PDZ binding domain has been shown to be crucial for SynGAP’s 
association with the scaffolding protein PSD-95, and for its ability to rescue the 
knock out dendritic spine phenotype (Kim et al., 1998; Vazquez et al., 2004).  
Therefore my finding that the SynGAP alpha-1 isoforms have a depressing affect on 
mEPSCs is not surprising.  Additionally, the lack of a depressing effect in the 
absence of a PDZ binding domain is repeated here with the PDZ binding domain 
lacking SynGAP alpha-2 isoforms.   
 
What is surprising is the nature of the depressing effect.  I observe a large 
proportion of neurons to completely lack mEPSCs, a phenomenon which has 
certainly not been reported in the case of SynGAP overexpression, and one which is 
rarely, if ever, reported in the literature.  It is possible that the ‘silent’ cells do have 
mEPSCs but that they are of an amplitude that falls below the detection threshold 
(5pA).  Indeed, in one of the rare cases in which a manipulation has lead to the 
absence of mEPSCs, cerebellar granule cells expressing a mutant form of the TARP 
stargazin, the authors designate the detection threshold level to every cell in which 
no mEPSCs were observed (Milstein & Nicoll, 2009).   It would be illuminating to 
know how often ‘silent’ cells are encountered in the cell preparations used by other 
labs, and if treatments which are reported to decrease mEPSC amplitude and 
frequency also increase the proportion of silent cells.  It would appear however that 
cells which lack mEPSCs are often discarded and not included in analyses.   
 
5.3.7 Effect of SynGAP overexpression on mEPSCs 
I decided to examine the data in two ways; the first of which entailed ignoring the 
silent cells and examining the data that was derived from the non-silent cells only 
(Figure 5. 9); the second approach approximated that of Chen et al. (2000)  and 
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Milstein et al. (2009)  and involved assigning a threshold value for amplitude and 
frequency to the silent cells to allow them to contribute to the population mean 
(Figure 5. 16).   
 
Under the first approach, despite the obvious differences in silencing, mean mEPSC 
amplitudes do not differ between control and SynGAP expressing neurons (one way 
ANOVA, post hoc Tukey t-tests).  The decrease in statistical power due to multiple 
comparisons is obvious as a single t-test indicates a statistically significant decrease 
in SynGAP A-alpha-1 from control values.  There are however clear differences 
between mean mEPSC amplitudes of SynGAP alpha-1 expressing neurons 
compared to SynGAP alpha-2 expressing neurons again indicating differential 
function for the C-termini (Figure 5. 12). 
 
Under the second approach, where a threshold value was included for silent cells, a 
clearer picture emerges (Figure 5. 16).  Expression of any alpha-1 isoform leads to a 
reduction in mEPSC amplitude and frequency while the magnitude of the decrease 
is dependent on the N-terminus.  There is a noteworthy disparity in the effect of 
expression of the alpha-2 isoforms; SynGAP A-alpha-2 has no effect on mEPSC 
amplitude or frequency, but SynGAPs B and C-alpha2 induce an increase in 
mEPSC amplitude, with SynGAP B-alpha-2 also increasing the mEPSC frequency. 
 
Some may not agree with the strategy of including threshold values for cells which 
essentially have no value but it does allow all the recorded cells to be represented 
together.  As long as it is clear that the means resultant from this approach do not 
signify absolute values, but are rather a comparative representation, I believe this 
method is valid. 
 
Closer examination exposes more subtle differences between the populations of 
mEPSCs recorded from SynGAP expressing neurons (Figure 5. 13, Figure 5. 14).  
Looking at the event distribution the six SynGAP isoforms seem to fall into three 
categories; SynGAPs A-alpha-1 and B-alpha1 which decrease mEPSC amplitudes; 
SynGAPs C-alpha-1 and A-alpha-2 which have little effect on mEPSC amplitudes; 
SynGAPs B-alpha-2 and C-alpha-2 which increase mEPSC amplitudes.  These 
classifications closely resemble the isoforms’ effect on population mean (approach 
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two) adding support to the argument that using a threshold value for a silent cell is a 
valid approach to communicating the data.    
 
The data outlined above are the first indication that SynGAP alpha-2 isoforms may 
have a distinct role at the synapse other than merely lacking the functionality of 
alpha-1 isoforms.  It is also the first example of a role for the N-terminus of SynGAP, 
which has previously been entirely neglected in the literature.   
 
We could speculate that SynGAP alpha-2 contains in its unique regions moieties 
that specify a function whose effect is the opposite of SynGAP alpha-1.  The role of 
the N-termini seems to be to modulate the function determined by the C-terminus.  
SynGAP A-alpha-1 has the strongest effect, in terms of silencing and reduced 
mEPSC amplitude and frequency but SynGAP A-alpha-2 has no effect.  Perhaps 
SynGAP A enhances the alpha-1 function but when combined with alpha-2 works to 
mitigate its effect.  As outlined in the Introduction to this thesis SynGAP has been 
demonstrated to operate as a RapGAP as well as a RasGAP  (Kim et al., 1998; 
Krapivinsky et al., 2004) and we hypothesise that the different termini may 
determine which function it performs.  Sequences outside the GAP domain can be 
essential for the bifunctionality of Ras/RapGAPs (Kupzig et al., 2006).  As Pena and 
co-workers (2008) demonstrated the presence of the N-terminal C2 domain is 
necessary for SynGAP to function as a RapGAP, while the isolated GAP domain 
predominantly acts as a RasGAP.   Therefore there is precedent for suggesting the 
N-termini could have a strong effect on SynGAP function. 
 
 
5.3.8 Synaptic and extra-synaptic AMPA receptors 
What of the finding of no difference in whole cell AMPA elicited currents in SynGAP 
alpha-1 cells, a large proportion of which were ‘silent’?  Should we expect that, 
because synaptic AMPA receptor content is altered that total cell surface expression 
should also have changed?  Probably not, while circumstances that alter both 
synaptic and total receptor levels are common, so are situations that can alter either 
independently.   
Clearly, physiological processes analogous to LTP and LTD require the rapid 
movement of AMPA receptors into and out of specific synapses.   This redistribution 
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can involve, but is not limited to an interior-surface transition mediated by exocytosis 
and endocytosis (Passafaro et al., 2001).  In addition to this mechanism lateral 
diffusion from extra-synaptic to synaptic sites been shown to play a major part 
(Ehlers et al., 2007).   Additionally, the process of synaptic scaling involves the 
strengthening or weakening of synapses without changing the relative strength of 
individual synapses and is accompanied by a change in total surface AMPA 
receptors (O'Brien et al., 1998; Turrigiano et al., 1998; Shepherd et al., 2006) 
 
Manipulations which alter both surface and synaptic expression have been shown 
by a number of groups; (Fu et al., 2007) have shown how overexpression of a 
constitutively active form of Rap2 leads to a decrease in mEPSC amplitude and a 
decrease in cell surface expression of GluR2.  Similarly, the Arc/Arg3.1 knock out 
mouse has increased surface expression of GluR1 and increased mEPSC 
amplitude and frequency (Shepherd et al., 2006).   
 
The decorrelation of surface and synaptic expression can occur in a number of 
ways; there can be large changes in total AMPA receptor without changes becoming 
apparent at the synapse (overexpression of the TARP stargazin, (Schnell et al., 
2002) the GluRA -/- mouse, (Zamanillo et al., 1999); an increase in synaptic AMPA 
receptors while total surface expression stays constant (overexpression of PSD-95, 
(Schnell et al., 2002)); or even an increase in total surface expression combined 
with a decrease in synaptic receptors (overexpression of the beta, but not the alpha,  
isoform of SAP97, (Rumbaugh et al., 2003; Waites et al., 2009)).   
 
Evidence particularly relevant to SynGAP and our central hypothesis has come from 
the group that initially demonstrated Ras’ involvement with AMPA receptor delivery 
and Rap’s role in AMPA receptor removal.   A recent paper has shown that the 
Ras/Rap controlled trafficking can be mediated by the shuttling of AMPA receptors 
from a peri-synaptic ‘deliverable pool’ into the PSD (Kielland et al., 2009).  This 
‘deliverable pool’ resides near the PSD (~30–100 nm from the postsynaptic 
membrane) in the cytosol or on the plasma membrane. 
 
Different mechanisms therefore can regulate surface delivery and synaptic delivery, 
and it seems from the evidence presented here that SynGAP may regulate the latter 
rather than the former.  Many papers in the literature refer to SynGAP’s role in 
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AMPA receptor trafficking but do not specify or examine the distinction between 
surface and synaptic trafficking. As mentioned previously all evidence showing 
altered AMPA receptor trafficking has been focused on synaptic responses or 
synaptic ‘puncta’.  The only study which has specifically addressed the insertion of 
new AMPA receptors into the plasma membrane focused its attention on GluR1 
‘clusters’, presumptive synapses.  The authors overexpressed SynGAP C-alpha-1 
and found a decrease in newly inserted GluR1 cluster area, density and intensity of 
staining, but no change in total synapse number, as indicated by Bassoon and NR1 
puncta (Rumbaugh et al., 2006).  Contrary to my finding, this work implies 
SynGAP’s role is in regulating the surface insertion of AMPA receptors but is not 
conclusive as total and extrasynaptic expression are not addressed and only one 
AMPA receptor subunit is examined. 
 
5.3.9 A presynaptic mechanism for decreased mEPSCs ? 
Another potential explanation suggested for the decrease in mEPSCs is that 
presynaptic release sites had been affected by the postsynaptic expression of 
SynGAP.  This scenario could arise if SynGAP was able to exert some kind of 
retrograde effect on the presynaptic termini.  The secreted neurotrophin BDNF’s 
effect of increasing post synaptic mEPSC frequency by modulating presynaptic 
release probability is a classic example of this type of mechanism (Li et al., 1998) 
(Stoop & Poo, 1996).  While it is obvious how a secreted molecule can assert its 
influence on a neighbouring neuron the mechanism by which a cytosolically 
confined protein may accomplish this is less immediately clear.  Nevertheless it may 
be possible that overexpression of SynGAP could influence, for example, 
extracellular matrix or cell adhesion molecules (CAMs) or their receptors, which in 
turn could cause changes in the presynaptic neuron.  Cell adhesion molecules have 
been shown to be key players in trans-synaptic communication and can precisely 
coordinate presynaptic differentiation with postsynaptic specialization. At 
glutamatergic synapses, their retrograde signaling has been proposed to control 
presynaptic vesicle clustering at active zones.  Several trans-synaptic adhesion 
systems that promote the formation and maturation of synapses have been 
identified including ephrin/Eph receptors, neuroligin/neurexins, SynCAMs and 
cadherins (Stan et al.) (Klein, 2009).  For example the postsynaptic overexpression 
of the dominant negative form of synaptic cell adhesion molecule, SynCAM, reduces 
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the number of recycling synaptic vesicles (as visualised by FM dye puncta) in 
presynaptic neurons (Biederer et al., 2002) and overexpression of its functional form 
increases mEPSC frequency (Sara et al., 2005).   
 
Intriguingly the overexpression of post synaptic scaffolding molecules, PSD-95 (El-
Husseini et al., 2000), Shank (Sala et al., 2001), SAP97 and SAP102 (Regalado et 
al., 2006) can all induce enhanced presynaptic function.  The mechanisms by which 
they do so have not yet been fully elucidated.  The molecules ‘upstream’ of the 
scaffolding molecules which constitute the reverse signalling component are likely to 
be CAMs.  In the case of SAP 97 interference with N-cadherin, integrin, and 
ephrinB/EphB all effects its ability to modulate presynaptic function.   
There must be molecules downstream of the scaffolding molecules which mediate 
signalling in the conventional direction. In the case of SAP 97 PDZ domains were 
shown to be essential but the downstream binding molecules which presumably 
mediated the effect were not identified.   
 
Many of these adhesion molecules interact strongly with scaffolding molecules 
containing PDZ domains, to which SynGAP alpha-1 binds, suggesting a potential 
mode of action (Yamagata et al., 2003).  CAM interacting PDZ proteins which have 
been shown to bind to SynGAP alpha-1 include PSD-95 and MAGI-1/ S-SCAM 
(neuron specific synaptic scaffolding molecule) which bind to neuroligins (Irie et al., 
1997; Hirao et al., 1998) (SynGAP interaction with MAGI-1/S-SCAM, Noboru 
Komiyama, personal communication).    
 
An interaction between GTPase-activating protein spine-associated RapGAP 
(SPAR) and the EphA4 receptor intracellular tail is required to mediate EphA4-
dependent inactivation of Rap1 and Rap2 and subsequent growth cone collapse 
(Richter et al., 2007). In turn Rap1 (but not Rap2) inactivation is required for ephrin-
A-dependent downregulation of integrin-mediated adhesion in neuronal cells.  This 
highlights a potential mechanism of a transynaptic effect whereby post synaptic 
protein activity alters the surface expression of molecules involved in trans-synaptic 
adhesion. 
 
The mechanism by which neuroligin binding to its presynaptic partner protein, beta 
neurexin, induces synapse maturation is unclear, but it is thought to trigger both 
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presynaptic and postsynaptic signal transduction events that activate synaptic 
function and specify synaptic properties.  The ability of postsynaptic neuroligins to 
regulate presynaptic maturation has been shown to be dependent on an intact 
neuroligin intracellular domain (Wittenmayer et al., 2009).     
 
 
Taking the above points into consideration it is perhaps not so far fetched that 
SynGAP alpha-1 could effect presynaptic release.  However, increasing input onto a 
SynGAP alpha-1 overexpressing neuron by stimulating excitatory activity in the 
neural network shows that these neurons are in fact able to receive input from 
neighbouring neurons and therefore are unlikely to be subjected to greatly impaired 
presynaptic release (Figure 5. 19).  In fact they are able to respond normally to it, as 
is indicated by their ability to fire normal action potentials (Figure 5. 20).   It remains 
possible that action potential driven release is normal, while non-action potential 
quantal release is impaired.  The observation that SynGAP A-alpha-1 expressing 
neurons do have NMDA mEPSCs shows that quantal release can occur onto these 
neurons, but still appears to not be as common as in the control case (Figure 5. 22).  
It is therefore possible that modulation of presynaptic release is part of the 
mechanism by which SynGAP alpha-1 decreases mEPSCs.  
 
5.3.10 AMPA receptors are present at the synapses of 
SynGAP alpha-1 expressing neurons; silent synapses vs 
silent cells 
The working hypothesis after finding a decrease in mEPSCs but no change in whole 
cell currents was that overexpression of SynGAP alpha-1 had caused the removal of 
AMPA receptors from synaptic to extra-synaptic sites.  If a synapse lacks AMPA 
receptors, but contains NMDA receptors, it is defined as a silent synapse (Isaac et 
al., 1995; Liao et al., 1995; Kerchner & Nicoll, 2008) p189).  However, the lack of 
mEPSCs in SynGAP A-alpha-1 expressing neurons is not due to an increase in 
silent synapses because this set of experiments (Figure 5. 19-Figure 5. 22) shows, 
crucially, that there are AMPA receptors at the synapses of neurons overexpressing 
SynGAP-alpha-1 isoforms.  All inward currents recorded from these cells were 
entirely terminated by the application of the AMPA receptor antagonist CNQX.  
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Figure 5. 19 (c, middle trace) includes an example of a SynGAP A-alpha-1 neuron 
that would be classified as silent, but when neighbouring neurons fired was able to 
normally receive AMPA receptor mediated current influx (d, middle trace.  (See 
below for a footnote an a technical aspect of this experiment,11.)  The finding that 
there are receptors at the synapses necessitates a refinement of the synaptic / extra 
synaptic argument.  We can no longer argue that the effect of SynGAP-alpha-1 
overexpression is to drive AMPA receptors from synaptic (a depression of mEPSCs) 
to extra-synaptic sites (unchanged whole cell AMPA currents) therefore we must 
consider a more nuanced perspective.   
 
When we stimulate current influx are we seeing the activation of peri-or extra-
synaptic AMPA receptors?  Is it possible there is glutamate spillover, comparable to 
the case in stroke where extra-synaptic NMDA receptors become activated and lead 
to cell death (Hardingham et al., 2002)?  Again this is doubtful as extrasynaptic 
AMPAR activation, unlike NMDA receptors, is probably absent or less common at 
most central synapses owing to their much lower glutamate affinity (Lisman & 
Raghavachari, 2006) and the low concentrations of extracellular glutamate (Herman 
& Jahr, 2007). 
 
Subsynaptic AMPA receptor localistation 
Now we have considered extrasynaptic and perisynaptic localisation we must 
consider subsynaptic localisation.  Spontaneous neurontransmitter release and 
trains of action potential mediated neurotransmitter differ hugely in the amount of 
neurotransmitter released into the synaptic cleft.  Accumulated evidence suggests 
that single quantal release is insufficient to saturate postsynaptic receptors and due 
                                               
11
 Ideally this experiment would have been done slightly differently; I would have assessed if 
each neuron was ‘silent’ before recording spontaneous and stimulated activity.  However, 
mEPSCs (TTX present) were not recorded at the beginning of the experiment due to the 
difficulty of washing out TTX and the concern that residual TTX would have impaired the 
bursting activity of the neurons.   mEPSCs were recorded at the end of each stimulation 
(data not shown) but at this time the neurons had undergone extensive firing and it is 
possible that the quantal release likelihood had changed.  If this were the case the ‘silence’ 
data would not have been directly comparable to that outlined in Figure 5. 11.  The purpose 
of the experiment was to assess if SynGAP expressing cells were capable of receiving 
presynaptic input, and the conclusion that they are is unaffected by not being able to 
establish a relationship between mEPSC silence and spontaneous or stimulated EPSC 
activity.  
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to their relatively low affinity for glutamate only a subpopulation of AMPA receptors 
in the PSD are believed to be close enough to the site of vesicle fusion to respond to 
neurotransmitter (Liu et al., 1999) (McAllister & Stevens, 2000; Raghavachari & 
Lisman, 2004).  Therefore, in addition to the absolute number of glutamate receptors 
inside synapses, packing density and the subsynaptic localisation of AMPA 
receptors are crucial components of their signalling capacity.   
 
Microdomains 
Both EM images and single-particle tracking experiments support restricted spatial 
domains within the postsynaptic membrane. For example, the mobility of individual 
AMPA receptors is confined within subregions of the synaptic membrane and 
becomes more confined when the synapse is active (Ehlers et al., 2007).  EM 
studies show the presence of proteinaceous clumps and voids in isolated PSDs and 
the nonhomogeneous clustered distribution of AMPA receptors (Petersen et al., 
2003)  (Masugi-Tokita et al., 2007).  It is conceivable therefore that AMPA receptors 
may be present in PSDs, and activatable upon bulk exocytosis of neurotransmitter, 
but that those not directly aligned with release sites are not exposed by 
spontaneous release. 
 
Determining the impact of receptor packing density and subsynaptic confinement 
remains a difficult experimental problem.  A recent study provides clues as to how 
the spatial positioning and density of glutamate receptors can be established inside 
the PSD (Blanpied et al., 2008).  Using high-resolution optical tagging of PSD 
subregions, it was found that the PSD-95 behaves as a topologically stable matrix 
with very little internal molecular movement, although the overall structure of the 
matrix is plastic and flexible. By stretching or compressing the PSD-95 matrix, actin-
based elasticity of the PSD might enable glutamate receptors to become locally 
concentrated without the need for adding or removing receptors but allowing them to 
align with release sites of the presynaptic active zone.  This effect that could have a 
large influence on postsynaptic responses to released glutamate. Indeed, reducing 
AMPA receptor surface mobility by antibody cross-linking alters postsynaptic 
responses to trains of action potentials, indicating that small-scale positioning and 
lateral movement of AMPA receptors tune synaptic strength (Heine et al., 2008).   
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Discussion of the role of microdomains and packing density in relation to SynGAP is 
especially tempting for a number of reasons.  First; total AMPA receptor number 
appears unchanged in SynGAP alpha-1 overexpressors despite decreases in AMPA 
mediated mEPSCs, therefore its mechanism of trafficking seems to be limited to 
surface rearrangements.  Second; SynGAP alpha-1 overexpressing neurons do 
have AMPA receptors at the synapses but these are often not activated by quantal 
release indicating a very fine rearrangement of receptors.  Third; overexpression of 
SynGAP alpha-1, despite its effect on mEPSCs, does not dramatically change 
dendritic spine morphology but changes in gross spine morphology would not 
necessarily be expected if effects were limited to within subdomains of the PSD 
(Figure 4. 8).  Fourth; the elasticity of the PSD is based on a remodelling actin 
network and SynGAP alpha-1 has been shown to regulate the activity of the F-actin 
severing protein cofilin. 
 
5.3.11 Part Three: 
SynGAP A, B and C-alpha-1 and SynGAP A-alpha-2 were chosen to be expressed 
in knock out tissue in order to ascertain if their effect was the same once the 
potentially confounding effect of endogenous SynGAP was removed (Figure 5. 23 -  
Figure 5. 25).  We considered this confounding effect a possibility especially in the 
case of SynGAP A-alpha-2, which unlike the other isoforms tested, has no influence 
on the proportion of silent cells or on the profiles of the mEPSCs recorded.  The 
similarity of this data to that derived from expression in wild type tissue indicates that 
the endogenous expression of a range of undefined SynGAP isoforms should not be 
a major concern in the interpretation of the data. 
 
5.3.12 Variability in the mEPSC data 
One technical point to note is regarding variability of the data.  This point applies to 
neurons of the transgenic SynGAP line (wild type and knock out) but not wild type 
neurons from wild type only cultures as these are of slightly different genetic 
background strain. The data presented in experiments when neurons were 
transfected with GFP (Part 3) are of lower variability than those that were not 
transfected with GFP (Part 1).  The ability to more accurately identify cell type by 
morphology in GFP expressing cells could supply a possible explanation for this 
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phenomenon.  In all experiments I try to select only neurons of a pyramidal 
morphology for recording.  This is much more difficult when only an untransfected 
soma is visible in a sea of neurites compared to the entire dendritic tree being lit up 
with GFP.   It has been shown that subsets of neurons have much higher mEPSC 
frequencies.  El-Husseini et al. (2000) showed that GABAergic neurons have a 
mean frequency of 20 Hz compared to 1 Hz of pyramidal glutamatergic neurons.  
This question could quite easily be resolved by testing if a patched cell is GABAergic 
or glutamatergic by examining the profile of its action potential spiking behaviour.   
 
 
To summarise, we have found no electrophysiological phenotype in SynGAP -/- 
cultured neurons, potential reasons for this are discussed above.  However, an 
opposing effect on synaptic function was found for different SynGAP isoforms; 
SynGAP A-alpha-1 caused a profound silencing of mEPSCs, SynGAPs B-and C- 
alpha-1 had a less strong effect.  SynGAP A-alpha-2 had no effect on mEPSCs 
presence, amplitude or frequency, while SynBAPs B- and C-alpha-2 appeared to 
increase synaptic strength.  Surprisingly the silencing of mEPSCs was not caused 
by loss of synaptic AMPA receptors as these were activated when the neuronal 
network was stimulated, which also shows that presynaptic neurons have the ability 
to release neurotransmitter.  The presence of NMDA mEPSCs in some SynGAP A-
alpha-1 expressing silent cells shows that some spontaneous neurotransmitter 
release can occur occasionally.  These data indicate that the mechanism by which  
SynGAP alpha-1 has its effect may be different to previously thought (removal of 
synaptic AMPA receptors) and point toward a subtle postsynaptic and presynaptic 
rearrangement.  The specific effects of different N and C terminal isoform 
combinations illustrates that both ends of the molecule need to be considered 
together, a point which has been previously neglected. 
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6 Final Thoughts and Future Experiments 
 
The initial hypothesis of this thesis was that different isoforms of SynGAP have 
different functions.  While it was known that the C-terminal tail of SynGAP-alpha-1 
was important for its function there was no data available on roles of the other 
isoforms.  The primary finding of this thesis is the conclusion that different isoforms 
do result in differential functional effects of SynGAP. 
 
The result that SynGAP alpha-1 isoforms have a striking reducing effect on AMPA 
mEPSCs is consistent with previous work and fits the recognised model of SynGAP 
operating as a RasGAP, which downregulates the ERK/MAPK signalling pathway, 
and ultimately results in the removal of synaptic AMPA receptors.  However, the 
finding that the N-terminal isoform specific region of the protein can modulate 
SynGAP’s function in a neuronal setting is novel.  SynGAP A-alpha-1 has the 
greatest synapse weakening effect, followed by SynGAPs B-alpha-1 and C-alpha-1. 
 
SynGAP alpha-2 may then work as a RapGAP, as SynGAPs B-alpha-2 and C-
alpha-2 both increase AMPA mEPSCs, potentially via the downregulation of p38 
MAPK which would result in the synaptic delivery of AMPA receptors.  Again, the N 
termini modify this effect as, mirroring the SynGAP alpha-1 case, the SynGAP A 
isoform has a different effect to that of SynGAPs B and C.   
 
Interestingly, in both C-terminal scenarios the SynGAP A isoform results in less 
synaptic transmission than the corresponding SynGAP B and C isoforms 
(summarised in Figure 6. 1).  The punctate, apparently synaptic localisation of 
SynGAP A-alpha-2 contrasts with the more diffuse localisation pattern of the 
SynGAP B-alpha-2 and C-alpha-2 isoforms, suggesting that the longer SynGAP A 
specific region may independently mediate synaptic localisation.  The differential 
regulation of SynGAP variants also reflects this ‘A vs B/C’ pattern, where SynGAP A 
is downregulated and SynGAPs B and C are upregulated in response to synaptic 
activity.  One could suggest that this downregulation of SynGAP A, and upregulation 
of SynGAPs B and C could be involved in the potentiation of the synapses induced 
by the waves of synaptic activity.   
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 A caveat to this interpretation is that we do not know that this stimulation paradigm 
induces functional plasticity (15 minutes of Bic./4AP simulation is sufficient to induce 
an increase in mEPSC frequency, known as chemical LTP, (Martel et al., 2009).  An 
extended temporal regulation profile of different isoforms in response to different 
stimulation paradigms, for example, in neurons that exhibit functional plasticity (the 
induction of ‘chemical LTP or LTD’) would facilitate the interpretation of 














































Figure 6. 1 The effect of various SynGAP isoforms on synaptic strength. 
A slider scale is used to illustrate the effect of SynGAP isoforms on synaptic strength.  The 
left panel shows the outcomes of the overexpression of individual isoforms as determined by 
the experiments in this thesis.  The control synaptic strength is indicated with a dashed line, 
increased synaptic strength (+) and decreased synaptic strength (-).  From this data we can 
infer the influences of each individual component, or terminus, illustrated in the right panel.   
N termini B and C are combined due to their similar, but not identical, effects.  A larger arrow 
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Unfortunately, such experiments would not reveal a key aspect of SynGAP structure 
that we now know is crucial to its function, namely which N-terminal is linked to each 
C-terminal.  The nuanced way in which N and C-termini synergistically alter the 
outcome of SynGAP localisation and regulated events goes beyond SynGAP A 
being different to SynGAPs B and C.  For example, expression of SynGAPs B-
alpha-1 and C-alpha-1 cause the same percentage of silencing, but the two isoforms 
have different effects on the population of mEPSCs that remain and have different 
dendritic localisation patterns.  Also, SynGAP C-alpha-2 causes an increase in 
mEPSC amplitude, but not frequency, while SynGAP B-alpha-2 increases both 
amplitude and frequency but both have grossly similar localisation patterns.  (Figure 
4. 10, Figure 5. 11, Figure 5. 16).    It appears that the combinatorial possibilities 
allow for synergistic regulation of the localisation and alteration of functional 
outcomes. 
 
As discussed, such N and C-terminal linkages are difficult to asses with current 
technologies.  Development of technology generally requires an impetus and as 
transcriptional variation is becoming more and more apparent, hopefully it will be 
recognised that matching variant ends of proteins is important to their functional 
interpretation.  Sequencing technologies like RNA paired end reads, if developed, 
could facilitate a comprehensive analysis of the N and C linkage of the 
transcriptome via large scale screening.  The knowledge of which protein isoforms, 
of all proteins, exist would be a powerful tool in biological research. 
 
The subtlety and complexity of the SynGAP protein may contribute to the difficulty, 
seen in this thesis, in exactly recapitulating the obvious knock out mEPSC and 
dendritic spine phenotypes previously described by other labs.  The differences that 
are seen here, between wild tpe and SynGAP -/- data distributions rather than 
population means, perhaps reflect that  only a subset of synapses contain SynGAPs 
that actively effect AMPA receptor mediated synaptic function or spine morphology.  
It could also indicate that the equilibrium of SynGAP regulation is finely balanced 
and acutely sensitive to differences in genetic strain etc.  It is possible that 
differences in baseline neurotransmission are not greatly altered but the system may 
not correctly respond when perturbed, for example there may be deficits in the 
induction of plasticity paradigms (as is seen hippocampal slices from SynGAP +/- 
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animals, (Komiyama et al., 2002)).  Therefore, we should not dismiss changes as 
functionally insignificant just because they are small, especially since these SynGAP 
-/- mice have major deficits in cortical organisaiton and, like all other SynGAP -/- mice, 
die postnatally.  
 
In attempting to rationalise how different SynGAP isoforms are exerting opposing 
effects I am invoking previous work which indicates that SynGAP can regulate the 
often antagonistic ERK/MAPK and p38 MAPK pathways through its action on Ras 
and Rap respectively (Figure 6. 2).  I have no direct evidence that this is the case 
and gathering such evidence was not the aim of this work.  Now that a differential 
functional effect has been determined, investigation of the mechanism is merited.  
The in vitro Ras/Rap GTPase promoting activities of different SynGAP isoforms, as 
well as the activation states of the proposed downstream signalling pathways, 
including those less studied (JNK/PI3K), are obvious avenues of further 
investigation.  A simple experiment such as assaying the levels of activated 
phospho-ERK and phospho-p38 MAPK, both in neurons (to include the effects of 
synaptic interactions) and in a heterologous cell line, upon the expression of 
different isoforms would be illuminating.  
 
The striking electrophysiological effect of SynGAP alpha-1 is not reflected in the 
morphological aspect of the synaptic sites but it is increasingly becoming apparent 
that spine dimension and synaptic responses are not always correlated (Segal).  As 
already mentioned SynGAP is capable of regulating processes in which a 
decorrelation between morphology and function has been seen.   
 
The theme of the points I have discussed up to here could have been predicted 
given the hypothesis of this thesis.  However, when composing the hypothesis we 
did not explicitly consider a potential presynaptic effect of SynGAP expression, as 
there was no evidential basis for so doing.   Given the data presented here we now 
need to and this is an entirely new, and unexpected, aspect of SynGAP function 
(see Figure 6. 2 for a speculative model).  The finding that neurons whose AMPA 
mEPSCs have been silenced by the expression of SynGAP alpha-1 still have 
normal levels of surface AMPA receptors, and are able to respond to stimulated 
synaptic input is an intriguing one and merits further investigation. 
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Figure Legend 6.2 Speculative model of SynGAP function based on data and ideas 
Two speculative scenarios are shown for the purpose of illustration, on the left where 
SynGAP alpha-1 isoforms predominate and on the right where SynGAP alpha-2 isoforms.   
predominate.  In the case of SynGAP alpha-1; under conditions allowing only spontaneous 
quantal release events (top panel, left) reduced AMPA receptor activation occurs due to less 
dense clustering or increased receptor mobility but AMPA receptors are present at the 
synapse.  The probablility of synaptic vesicle fusion is reduced, possibly due to altered trans-
synaptic or retrograde messenger signalling.  Both presynaptic and postsynaptic effects are 
mediated by reduced Ras activity.  Previously unactivated synaptic AMPA receptors become 
activated when the neural network is stimulated (middle panel, left) due to increased 
glutamate concentration in the synaptic cleft.  When the network is undergoing long term 
potentiation the most potent SynGAP-alpha-1 ‘weakener’ of synapses, SynGAP A, is down 
regulated and the two less potent SynGAP-alpha-1 isoforms, B and C, are upregulated in 
order to allow synapses to be strengthened.    
In the case of SynGAP alpha-2, underconditions allowing only spontaneous quantal release 
(top panel, right) increased AMPA receptor activation occurs due to dense clustering, 
reduced receptor mobility or increased receptor insertion.  The probability of release is 
increase due to altered trans-synaptic or retrograde messenger signalling.  Both presynaptic 
and postsynaptic effects are mediated by reduced Rap activity.  Upon stimulation (middle 
panel, right) the synapse receives more current input.  When the network is undergoing long 
term potentiation the ineffective SynGAP alpha-2 variant, SynGAP A is downregulated and 
the two synaptic strengthening alpha- 2 variant, B and C, are upregulated allowing synapses 
to be strengthened.       
 
 
Clearly additional work needs to be done to determine if the postsynaptic SynGAP 
alpha-1 cell’s response to synaptic activity is completely normal, as this was not 
quantified in this thesis.  Whether normal spontaneous neurotransmitter release 
onto SynGAP over expressing cells is occurring is a question that also needs to be 
addressed.  FM dye labelling would indicate if terminals synapsing onto SynGAP 
overexpressing neurons are normally recycling synaptic vesicles.  This functional 
assay would be advantageous over the labelling of presynaptic terminal by 
immunofluorescence due to its functional nature, and the fact that we know that 
presynaptic terminals are present and functional when stimulated.   
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If a presynaptic deficit was found we could postulate the following mechanism for a 
presynaptic effect of SynGAP alpha-1.  Postsynaptic clustering of adhesion 
molecules is controlled by scaffolding proteins and overexpression of postsynaptic 
scaffolding proteins retrogradely enhances maturation of presynaptic terminals (El-
Husseini et al., 2000; Regalado et al., 2006).  If SynGAP alpha-1 is binding to the 
scaffolding proteins via its PDZ binding domain it could potentially affect presynptic 
function in two ways.  One, that SynGAP alpha-1 has some specific signalling 
function that affects the retrograde signalling capacity of transynaptic molecules to 
which it binds via its PDZ domain, for example clustering or modulation of Ras/Rap 
effectors.   
Two, that overexpressed SynGAP-alpha-1, by virtue of the over abundance of its 
PDZ binding domain is binding to these scaffolding molecules but the effect seen is 
non-specific and due to SynGAP outcompeting and thereby removing other PDZ 
binding proteins that mediate presynaptic terminal maturation.  The question 
regarding specificity could be addressed by the overexpression of a SynGAP alpha-
1 with a non-functional GAP domain.  (The lack of function of SynGAP A-alpha-2 
provides these experiments with an internal control for the non-physiological over-
abundance of non-PDZ binding protein which is present at synapses.) 
 
If a presynaptic deficit is not found, examination of the AMPA receptor content of  
SynGAP alpha-1 overexpressing synapses by electron microscopy or single particle 
tracking, combined with conventional surface labelling immunohistochemistry, may 
provide a more detailed view of microdomains and movement  within the synapse.  
The same argument regarding the specificity of the effect of an overexpressed PDZ 
binding domain applies, as the scaffolding molecules crucial for the trafficking, 
clustering and synaptic motility of AMPA receptors are also dependent on PDZ 
binding domains, eg Stargazin.(Chen et al., 2000; Schnell et al., 2002; Milstein & 
Nicoll, 2009).  
 
To conclude, SynGAP is a molecule of great complexity; at the level of gene, mRNA 
transcript and protein.  The data presented in this thesis add to this picture of 
complexity and further it by demonstrating differential functional effects of various N- 
and C-terminal isoform combinations.  This molecule illustrates the folly of believing 
that one protein has one function. 
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7 Appendices 
7.1 Appendix 1 Transfection 
 
In this appendix I outline some technical issues associated with liposome based co-
transfection.   
7.1.1 Co-transfection  
Liposome based transfection is used throughout this thesis to make neurons 
express the protein products of two separate plasmids, a marker protein, eGFP, and 
the protein of interest, SynGAP.  For the experiments to be interpretable it is crucial 
that neurons expressing GFP should also express SynGAP.  
Co-expression of two fluorophores 
To determine if two co-transfected plasmids are co-expressed and to optimise co-
expression conditions I performed a co-transfection assay using varying ratios of 
two plasmids encoding different fluorophores, eGFP and the red fluorophore 
mCherry ( 
Appendix Figure 7. 1 , a).  Fluorescing neurons were classified as expressing eGFP 
only, mCherry only, or both.  I found that co-expression was almost ubiquitous.   A 
small percentage (4% and 10%) of cells expressed only green at the highest 
eGFP:mCherry ratios (3 and 4 times eGFP DNA: mCherry DNA).  No red only 
fluorescing cells were ever observed.  It should be noted that the filter cube used to 
visualise red fluorescence is not optimal for the visualisation of mCherry.  The filter 
cube used excites optimally at 515-560 nm whereas the peak excitation wavelength 
of mCherry is 587 nm, therefore it is likely that under these conditions the presence 
of mCherry is under reported.  The absence of red only cells at the highest 
mCherry:eGFP DNA ratios also indicates that the appearance of green only cells is 
likely to be due to mCherry detection problems rather than true lack of expression. 
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Co-expression of eGFP and SynGAP isoforms 
The experiment described above shows that two co-transfected fluorophore 
plasmids will likely co-express.  For all experiments described in this thesis I chose 
to use a eGFP:SynGAP DNA ratio of 1:2.  The most conservative interpretation of 
this scenario in light of the ‘two fluorophores experiment’ is that it is possible that 
there might be a few cells expressing SynGAP but not eGFP, but the reverse is very 
unlikely.  SynGAP only expressing cells are not significant as only green fluorescing 
cells are recorded from.   
 
It could be argued that the co-expression of eGFP and mCherry does not 
necessarily predict co-expression of eGFP and SynGAP.  Evidence against this 
possibility comes from co-transfection of SynGAP -/- cells with eGFP and SynGAP, 
followed by an immunocytochemical probe for SynGAP.  I have never observed an 
instance where a green cell did not also stain for SynGAP, and vice versa.   




7.1.2 Patch clamp recordings from transfected cells 
Great difficulty was experienced in obtaining good quality electrophysiological 
recordings from eGFP expressing neurons transfected under the conditions used for 
the morphology experiments.  Recordings from fluorescent cells transfected under 
these conditions were often characterised by high levels of noise and low holding 
currents (< -150 pA).  In contrast neighbouring untransfected cells in the same well 
were typically in good electrophysiological condition.  For transfection in a 24 well 
plate these conditions were; 0.6 µg total DNA composed of 0.2 µg eGFP and 0.4 µg 
empty vector or SynGAP and 2.33 µl Lipofectamine 2000. 
 
To optimise transfection conditions for electrophysiology I altered DNA to 
Lipofectamine ratios, eGFP to empty vector DNA ratios and total DNA amounts.  
Lipofectamine at the lowest amounts (0.1, 0.25 µl) resulted in very low transfection 
efficiency (0 – 0.2%), but from 0.5 - 3 µl there was very little difference in 
transfection rates (0.4 – 0.6%).   The inclusion of increasing amounts of empty 
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vector had little effect on transfection efficiency or cell fluorescence (as measured by 
the integrated density of the cell soma) (data not shown).   Trial patch clamp 
recordings were made from each transfection condition and the condition which 
yielded the most acceptable recordings was used in all subsequent experiments.  
These conditions were; 0.3 µg total DNA composed of 0.1 µg eGFP and 0.2 µg 
































































































































Appendix Figure 7. 1 Co-expression and transfection efficiency controls 
 
To calculate co-transfection neurons were transfected at DIV 9 with varying ratios of eGFP to 
mCherry plasmid DNA, indicated schematically to the left of the Y axis (a).  At DIV 10 the 
cells were assessed by epifluorescence microscopy to determine if they were co-expressing 
both fluorophores.  White bars indicate the percentage of cells that were co-expressing both 
eGFP and mCherry.  Green bars indicate the percentage of cells that were fluorescing only 
green.  3 coverslips were transfected per condition, and fluorescence was assessed in 5-8 
fields of view per coverslip with a x 20 objective.  
(b) Transfection efficiency of neurons transfected with fixed amounts of eGFP (0.1 µg) and 




























Appendix Table 1. 1  Neuronal functions of small G protein families 
The small G protein superfamily is divided into five major families according to their homologous sequences and functional 
similarities.  General functions are given here however, it is difficult to disentangle the separate functions of small G proteins 
as they often operate in sequential signalling cascades, where a member of one family can act directly on another member.  
Further complexity is added by extensive crosstalk between families where distinct families can regulate various cellular 
functions in a cooperative manner.  For example the Rho and Rab families appear to co-operate in cell migration, and 
Rho/Rac/Cdc42 and Ras crosstalk is necessary for Ras induced cell transformation (Takai et al., 2001).   
 
Ras superfamily small 
G protein families
General cellular function Neuronal function
 Ras                                 
(Ras, Rap, Ral, Rheb, 
Rin and Rit)
regulate gene expression and cell 
proliferation
Classically associated with cell proliferation, has been co-opted in terminally differentiated non-
dividing neurons to serve in activity dependent regulation of neuronal function, that is synaptic 
plasticity, as well as the regulation of neuronal survival (Sweatt, 2001)
Rho
regulate cytoskeletal reorganization and 
gene expression
Important regulators of the actin cytoskeleton and are critical for several aspects of neuronal 
development including the establishment of neuronal polarity, extension of axon and 
dendrites, neurite branching, axonal navigation and synapse formation (de Curtis, 2008).  
Rab regulate vesicle trafficking
Participates in central nervous system development, polarized neurite growth, endocytosis 
and axonal retrograde transport .  At chemical synapses, Rabs perform specific functions in 
synaptic vesicle exocytosis and postsynaptic compartment dynamics of glutamate receptors 
(Ng and Tang, 2008).  
Ran
regulate nucleocytoplasmic transport 
and microtubule organization.  
Involved in nucleocytoplasmic transport and as such are spatial regulators of transport and 
signaling in distal axonal cytoplasm (Yudin and Fainzilber, 2009).  
Arf regulate vesicle trafficking 
Mediates a variety of neuronal functions accompanying the structural changes of developing 
and mature neurons through its regulation of actin cytoskeleton reorganization and membrane 



























Appendix Table 1. 2 Cellular signalling properties of Ras and Rap  
Ras family G protein Ras Rap
Genes (splice variants) H-Ras, K-Ras (4A, 4B) N-Ras Rap1 (A,B) Rap2 (A,B)
General cellular function Central in a network controlling cell proliferation and cell survival 
In lower eukaryotes predominantly controls cell adhesion, cell junction formation, 
cell secretion, and cell polarity . In higher eukaryotes roles are more diverse, 
being implicated in processes from exocytosis, phagosomal oxidation to cAMP 
induced neurite outgrowth.  (Raaijmakers and Bos, 2009)
Subcellular localisation
Predominantly localised to the inner leaflet of the plasma membrane.  
Additionally individual Ras isoforms preferentially associate with different 
organelles and microdomains depending upon the type of membrane anchor, 
post-translational modification and activation state and thus, by engaging 
with distinct groups of effectors and activators, are capable of preferentially 
engaging distinct signalling pathways (Omerovic et al., 2007).  
Located primarily at intracellular membranes in the perinuclear region and at 
endocytic and exocytic vesicles, but also at the plasma membrane (Pizon et al., 
1994).
Effectors
Raf and phosphatidlylinositol 3-kinase (PI3K) were the first Ras effectors to be 
identified but since then at least 20 other effectors have been identified.
 A range of effectors, partially overlapping with those of Ras, have been described.  
Effector roles
As an effector of Ras signalling Raf remains the classic and most well studied 
example.  It is the point of entry into a three tiered kinase cascade called the 
ERK/MAPK pathway (extracellular regulated kinase/mitogen activated protein 
kinase).  MAPK signalling entails the Raf mediated phosphorylation and 
activation of MEK followed by the MEK mediated phosphorylation and 
ultimately the activation of ERK/MAPK (MEK; MAPK/ERK kinase).  ERK/MAPK 
has over 70 substrates which include nuclear transcription factors, 
cytoskeletal proteins, signalling proteins and receptors (Kolch, 2005).  
The Ras regulated ERK/MAPK cascade is a prototype for a family of signalling 
cascades that share the motif of three serially linked kinases regulating each other 
by sequential phosphorylation.  The superfamily of MAPK signaling cascades 
comprises the ERKs, the JNKs and the p38 pathway and it appears that Rap1 can 
regulate another of these pathways, the p38 MAPK pathway, in a neuronal setting 
(Zhu et al., 2002).  It is thought that Rap2 stimulates JNK activity in nonneuronal 
cells (Machida et al., 2004) and a similar role has been demonstrated in neurons 
(Zhu et al., 2005). 
Crosstalk between pathways
Many Ras effectors are GEFs/ stimulators of other small G proteins which can 
regulate diverse processes such as cytoskeletal organisation, membrane 
trafficking and transcription, again emphasising the important of crosstalk 
between different G proteins. 
The notion of a Rap function antagonistic to Ras came when it was observed that 
Ras induced transformation was inhibited by Rap1A, probably by the sequestration 
of its primary effector Raf (Kitayama et al., 1989). However, like Ras, Rap1 can be 
activated by a wide range of growth-promoting stimuli, indicating that it is not 
merely an antagonist to Ras signalling (Zwartkruis et al., 1998).   To further 
complicate matters, in some cell types Rap1 has been shown to lead to the 
activation, rather than the inhibition, of the ERK pathway, possibly through 
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